@NP	Human adult olfactory neural progenitors rescue	1
@NP	rodent rubrospinal neurons	60
@NP	recovery Ming Xiaoa , b , Kathleen M.	110
@NP	recovery Ming Xiaoa	110
@NP	b , Kathleen M.	131
@NP	b	131
@NP	Kathleen M.	134
@NP	Kluebera , Chengliang Lua , Zhanfang Guoa , Charles T.	146
@NP	Kluebera	146
@NP	Chengliang Lua	156
@NP	Zhanfang Guoa	172
@NP	Charles T.	187
@NP	Marshalla , Heming Wanga , b , Fred J.	198
@NP	Marshalla	198
@NP	Heming Wanga	209
@NP	b	222
@NP	Fred J.	225
@NP	Roisena	233
@NP	T Abstract	241
@NP	our lab	265
@NP	the isolation	282
@NP	patient-specific neurosphere-forming progenitor lines	299
@NP	human adult olfactory epithelium	358
@NP	cadavers as well as patients	396
@NP	nasal sinus surgery	436
@NP	RT-PCR and ELISA	457
@NP	the neurosphere-forming cells -LRB- NSFCs -RRB-	492
@NP	the neurosphere-forming cells	492
@NP	NSFCs	523
@NP	BDNF	539
@NP	rubrospinal tract -LRB- RST -RRB- neurons	551
@NP	rubrospinal tract	551
@NP	RST	570
@NP	exogenous BNDF	613
@NP	it	629
@NP	the NSFCs	657
@NP	viable following engraftment	676
@NP	traumatized spinal cord	710
@NP	they	735
@NP	RS neurons	764
@NP	retrograde cell atrophy	780
@NP	functional recovery	816
@NP	One week	837
@NP	a partial cervical hemisection	852
@NP	GFP-labeled NSFCs suspended in MatrigelR matrix or MatrigelR matrix	884
@NP	GFP-labeled NSFCs	884
@NP	MatrigelR matrix or MatrigelR matrix	915
@NP	MatrigelR matrix	915
@NP	MatrigelR matrix	935
@NP	the lesion site	976
@NP	GFP-labeled cells	993
@NP	12 weeks in the lesion cavity	1026
@NP	12 weeks	1026
@NP	the lesion cavity	1038
@NP	the ipsilateral white matter ; the apparent number	1075
@NP	the ipsilateral white matter	1075
@NP	the apparent number	1105
@NP	somal area of fluorogold -LRB- FG -RRB-	1134
@NP	somal area	1134
@NP	fluorogold -LRB- FG -RRB-	1148
@NP	fluorogold	1148
@NP	FG	1160
@NP	axotomized RST neurons	1172
@NP	the NSFC-engrafted rats	1211
@NP	lesion controls	1243
@NP	Twelve weeks	1260
@NP	engraftment	1279
@NP	retrograde tracing with FG	1292
@NP	retrograde	1292
@NP	FG	1316
@NP	some RST neurons	1333
@NP	axons 4 -- 5 segments caudal	1362
@NP	axons 4	1362
@NP	5 segments	1370
@NP	the engraftment site	1391
@NP	dextran amine	1451
@NP	regeneration of RST axons	1475
@NP	regeneration	1475
@NP	RST axons	1491
@NP	the transplants	1509
@NP	the white matter for 3	1532
@NP	the white matter	1532
@NP	3	1553
@NP	6 segments caudal to the grafts	1555
@NP	6 segments	1555
@NP	the grafts	1576
@NP	A few RST axons	1588
@NP	gray matter close	1618
@NP	motoneurons	1639
@NP	Matrix	1652
@NP	regeneration	1680
@NP	Behavioral analysis	1694
@NP	NSFC-engrafted rats	1728
@NP	better performance	1758
@NP	spontaneous vertical exploration and horizontal rope walking	1784
@NP	spontaneous vertical exploration	1784
@NP	horizontal rope walking	1821
@NP	lesion MatrigelR	1850
@NP	11 weeks post transplantation	1881
@NP	11 weeks	1881
@NP	These results	1912
@NP	the unique potential	1936
@NP	human olfactory neuroepithelial-derived progenitors	1960
@NP	an autologous source of stem cells for spinal cord repair	2015
@NP	an autologous source	2015
@NP	stem cells for spinal cord repair	2039
@NP	stem cells	2039
@NP	spinal cord repair	2054
@NP	Introduction The limited regeneration of the adult CNS	2075
@NP	Introduction The limited regeneration	2075
@NP	Introduction	2075
@NP	The limited regeneration	2088
@NP	the adult CNS	2116
@NP	a variety	2153
@NP	factors including glial scaring -LRB- Geller and Fawcett , 2002 -RRB-	2166
@NP	factors	2166
@NP	glial scaring	2184
@NP	glial	2184
@NP	Geller and Fawcett	2199
@NP	2002	2219
@NP	inhibitory factors -LRB- Fawcett , 1997 ; Niederost et al. , 1999 -RRB-	2226
@NP	inhibitory factors	2226
@NP	Fawcett , 1997 ; Niederost et al. , 1999	2246
@NP	Fawcett	2246
@NP	1997 ; Niederost et al.	2255
@NP	1997	2255
@NP	Niederost et al.	2261
@NP	Niederost	2261
@NP	et al.	2271
@NP	1999	2279
@NP	lack of trophic support -LRB- Beattie et al. , 1997 -RRB-	2290
@NP	lack	2290
@NP	trophic support	2298
@NP	Beattie	2315
@NP	et al. , 1997	2323
@NP	et al.	2323
@NP	1997	2331
@NP	the regenerative capacity of the olfactory system	2857
@NP	the regenerative capacity	2857
@NP	the olfactory system	2886
@NP	attention	2921
@NP	Olfactory ensheathing cells -LRB- OECs -RRB- from adult olfactory bulbs	2932
@NP	Olfactory ensheathing cells -LRB- OECs -RRB-	2932
@NP	Olfactory ensheathing cells	2932
@NP	OECs	2961
@NP	adult olfactory bulbs	2972
@NP	limited axonal regeneration	3020
@NP	Li et al. , 1998 ; Ruitenberg et al. , 2003 ; Ramer et al. , 2004	3049
@NP	Li	3049
@NP	et al. , 1998 ; Ruitenberg et al. , 2003 ; Ramer et al. , 2004	3052
@NP	et al. , 1998	3052
@NP	et al.	3052
@NP	1998	3060
@NP	Ruitenberg et al. , 2003	3066
@NP	Ruitenberg	3066
@NP	et al. , 2003	3077
@NP	et al.	3077
@NP	2003	3085
@NP	Ramer et al. , 2004	3091
@NP	Ramer	3091
@NP	et al. , 2004	3097
@NP	et al.	3097
@NP	2004	3105
@NP	repair	3115
@NP	regions	3135
@NP	the CNS	3146
@NP	Franklin and Barnett	3155
@NP	Franklin	3155
@NP	Barnett	3168
@NP	2000 ; Nieto-Sampedro , 2003 ; Santos-Benito and Ramon - Cueto , 2003	3177
@NP	2000	3177
@NP	Nieto-Sampedro , 2003 ; Santos-Benito and Ramon - Cueto , 2003	3183
@NP	Nieto-Sampedro , 2003	3183
@NP	Nieto-Sampedro	3183
@NP	2003	3199
@NP	Santos-Benito and Ramon	3205
@NP	Santos-Benito	3205
@NP	Ramon	3223
@NP	Cueto , 2003	3230
@NP	Cueto	3230
@NP	2003	3237
@NP	the harvest of OECs from the olfactory bulb	3253
@NP	the harvest	3253
@NP	OECs from the olfactory bulb	3268
@NP	OECs	3268
@NP	the olfactory bulb	3278
@NP	highly invasive surgery	3306
@NP	this a problematic source	3338
@NP	clinical therapy -LRB- Barnett et al. , 2000 ; Lu et al. , 2002 -RRB-	3368
@NP	clinical therapy	3368
@NP	Barnett	3386
@NP	et al. , 2000 ; Lu et al. , 2002	3394
@NP	et al.	3394
@NP	2000 ; Lu et al.	3402
@NP	2000	3402
@NP	Lu et al.	3408
@NP	Lu	3408
@NP	et al.	3411
@NP	2002	3419
@NP	The olfactory neuroepithelium -LRB- ONe -RRB-	3426
@NP	The olfactory neuroepithelium	3426
@NP	ONe	3457
@NP	lifelong repair	3472
@NP	progenitors	3491
@NP	neuronal and supporting cells -LRB- Calof and Chikaraishi , 1989 -RRB-	3540
@NP	neuronal	3540
@NP	supporting cells -LRB- Calof and Chikaraishi , 1989 -RRB-	3553
@NP	supporting cells	3553
@NP	Calof and Chikaraishi , 1989	3571
@NP	Calof	3571
@NP	Chikaraishi , 1989	3581
@NP	Chikaraishi	3581
@NP	1989	3594
@NP	our lab	3613
@NP	the procedures	3631
@NP	isolation and culture	3650
@NP	human ONe-derived neurosphere-forming cells -LRB- NSFCs -RRB-	3675
@NP	human ONe-derived neurosphere-forming cells	3675
@NP	NSFCs	3720
@NP	cadavers and patients	3732
@NP	nasal sinus surgery	3765
@NP	characteristics	3825
@NP	progenitors -LRB- Roisen et al. , 2001 ; Winstead et al. , 2005 -RRB-	3844
@NP	progenitors	3844
@NP	Roisen	3857
@NP	et al. , 2001 ; Winstead et al. , 2005	3864
@NP	et al.	3864
@NP	2001 ; Winstead et al.	3872
@NP	2001	3872
@NP	Winstead et al.	3877
@NP	Winstead	3877
@NP	et al.	3886
@NP	2005	3894
@NP	The location of ONe	3901
@NP	The location	3901
@NP	ONe	3917
@NP	it	3927
@NP	harvest cells	3942
@NP	damage	3972
@NP	the donor	3982
@NP	our pilot studies	4006
@NP	the NSFC lines	4040
@NP	brain-derived neurotrophic factor -LRB- BDNF -RRB-	4078
@NP	brain-derived neurotrophic factor	4078
@NP	BDNF	4113
@NP	passage number , donor age , or sex -LRB- Marshall et al. , 2003 -RRB-	4136
@NP	passage number	4136
@NP	donor age	4152
@NP	sex	4166
@NP	Marshall	4171
@NP	et al. , 2003	4180
@NP	et al.	4180
@NP	2003	4188
@NP	ELISA and RT-PCR studies -LRB- Marshall et al. , 2004 -RRB-	4213
@NP	ELISA and RT-PCR studies	4213
@NP	Marshall	4239
@NP	et al. , 2004	4248
@NP	et al.	4248
@NP	2004	4256
@NP	the therapeutic potential of NSFCs	4275
@NP	the therapeutic potential	4275
@NP	NSFCs	4304
@NP	the red nucleus -LRB- RN -RRB-	4311
@NP	the red nucleus	4311
@NP	RN	4328
@NP	rubrospinal tract -LRB- RST -RRB-	4336
@NP	rubrospinal tract	4336
@NP	RST	4355
@NP	the adult rat , which respond to exogenous BDNF -LRB- Kwon et al. , 2002 -RRB-	4363
@NP	the adult rat	4363
@NP	exogenous BDNF -LRB- Kwon et al. , 2002 -RRB-	4395
@NP	exogenous BDNF	4395
@NP	Kwon	4411
@NP	et al. , 2002	4416
@NP	et al.	4416
@NP	2002	4424
@NP	an ideal in vivo model	4446
@NP	an ideal	4446
@NP	model	4463
@NP	Infusion	4470
@NP	exogenous BDNF	4482
@NP	Houle	4498
@NP	Ye , 1999 ; Kobayashi et al. , 1997 ; Namiki et al. , 2000 ; Novikova et al.	4508
@NP	Ye , 1999	4508
@NP	Ye	4508
@NP	1999	4512
@NP	Kobayashi et al. , 1997	4518
@NP	Kobayashi	4518
@NP	et al. , 1997	4528
@NP	et al.	4528
@NP	1997	4536
@NP	Namiki et al. , 2000	4542
@NP	Namiki	4542
@NP	et al. , 2000	4549
@NP	et al.	4549
@NP	2000	4557
@NP	Novikova et al.	4563
@NP	Novikova	4563
@NP	et al.	4572
@NP	2000	4580
@NP	transplants of BDNF-engineered fibroblasts/OECs	4589
@NP	transplants	4589
@NP	BDNF-engineered fibroblasts/OECs	4604
@NP	Liu	4638
@NP	et al. , 1999 , 2002 ; Ruitenberg et al. , 2003 ; Tobias et al. , 2003	4642
@NP	et al.	4642
@NP	1999 , 2002 ; Ruitenberg et al. , 2003 ; Tobias et al.	4650
@NP	1999 , 2002	4650
@NP	1999	4650
@NP	2002	4656
@NP	Ruitenberg et al. , 2003	4662
@NP	Ruitenberg	4662
@NP	et al. , 2003	4673
@NP	et al.	4673
@NP	2003	4681
@NP	Tobias et al.	4687
@NP	Tobias	4687
@NP	et al.	4694
@NP	2003	4702
@NP	atrophy	4718
@NP	RN neurons	4729
@NP	regenerative axonal growth	4752
@NP	rubrospinal axons in the RST	4782
@NP	rubrospinal axons	4782
@NP	the RST	4803
@NP	The current study aimed to determine if engrafted human adult NSFCs	4812
@NP	The current study	4812
@NP	human adult NSFCs	4862
@NP	rescue axotomized adult rat RN neurons from retrograde atrophy	4923
@NP	rescue	4923
@NP	adult rat RN neurons	4941
@NP	retrograde atrophy	4967
@NP	RST axonal regeneration	4998
@NP	cervical spinal cord dorsolateral/lateral funiculotomy	5032
@NP	Our long-term goal	5088
@NP	procedures	5121
@NP	a victim of spinal cord injury or other neurological degenerative conditions	5146
@NP	a victim	5146
@NP	spinal cord injury or other neurological degenerative conditions	5158
@NP	spinal cord injury	5158
@NP	other neurological degenerative conditions	5180
@NP	the donor of progenitors for his/her	5238
@NP	the donor	5238
@NP	progenitors for his/her	5251
@NP	progenitors	5251
@NP	his/her	5267
@NP	own restorative grafts	5275
@NP	the need for immunosuppression or ethical controversy	5306
@NP	the need	5306
@NP	immunosuppression or ethical controversy	5319
@NP	Materials and methods	5362
@NP	Materials	5362
@NP	methods	5376
@NP	Transduction	5384
@NP	NSFCs with LERS-EGFP vector	5400
@NP	NSFCs	5400
@NP	LERS-EGFP vector	5411
@NP	Our lab	5428
@NP	the culture procedure	5449
@NP	ONe-derived NSFC lines	5488
@NP	postmortem	5516
@NP	patients undergoing nasal sinus surgery	5543
@NP	patients	5543
@NP	nasal sinus surgery	5563
@NP	Roisen et al. , 2001 ; Winstead et al. , 2005 , respectively	5584
@NP	Roisen et al.	5584
@NP	Roisen	5584
@NP	et al.	5591
@NP	2001 ; Winstead et al.	5599
@NP	2001	5599
@NP	Winstead et al.	5605
@NP	Winstead	5605
@NP	et al.	5614
@NP	2005 , respectively	5622
@NP	2005	5622
@NP	Both ELISA and RT-PCR studies	5643
@NP	15 evaluated NSFC lines	5689
@NP	15	5689
@NP	NSFC lines	5702
@NP	BDNF	5721
@NP	passage number , donor age , or sex -LRB- Marshall et al. , 2004 -RRB-	5742
@NP	passage number	5742
@NP	donor age	5758
@NP	sex	5772
@NP	Marshall	5777
@NP	et al. , 2004	5786
@NP	et al.	5786
@NP	2004	5794
@NP	the present experiments	5805
@NP	two of these well-characterized NSFC lines	5830
@NP	two	5830
@NP	these well-characterized NSFC lines	5837
@NP	green fluorescent protein -LRB- GFP -RRB-	5917
@NP	green fluorescent protein	5917
@NP	GFP	5944
@NP	the LERS-EGFP vector -LRB- Kinsella and Nolan , 1996 -RRB-	5955
@NP	the LERS-EGFP vector	5955
@NP	Kinsella and Nolan , 1996	5977
@NP	Kinsella	5977
@NP	Nolan , 1996	5990
@NP	Nolan	5990
@NP	1996	5997
@NP	transfection	6010
@NP	the GFP-labeled cells	6024
@NP	7 DIV	6066
@NP	medium	6075
@NP	90 % Minimal Essential Medium -LRB- MEM -RRB-	6101
@NP	90 % Minimal Essential Medium	6101
@NP	MEM	6131
@NP	Hanks ' salts	6141
@NP	Hanks '	6141
@NP	lglutamine	6159
@NP	10 % fetal bovine serum -LRB- FBS -RRB-	6171
@NP	10 % fetal bovine serum	6171
@NP	FBS	6195
@NP	10 mg % gentamycin	6205
@NP	378C	6240
@NP	an atmosphere of humidified 5 % CO2 in air	6248
@NP	an atmosphere	6248
@NP	humidified 5 % CO2 in air	6265
@NP	humidified 5 % CO2	6265
@NP	air	6286
@NP	These two GFP-labeled NSFC lines	6291
@NP	up to 40 passages	6342
@NP	a feeding schedule of every other day	6365
@NP	a feeding schedule	6365
@NP	every other day	6387
@NP	alternate feedings	6419
@NP	Representative passages	6439
@NP	liquid nitrogen for future use	6478
@NP	liquid nitrogen	6478
@NP	future use	6498
@NP	Preparation of NSFCs for engraftment One week	6510
@NP	Preparation	6510
@NP	NSFCs for engraftment One week	6525
@NP	NSFCs	6525
@NP	engraftment	6535
@NP	One week	6547
@NP	transplantation , GFP-labeled NSFCs	6565
@NP	MEM + 10 % FBS	6636
@NP	MEM	6636
@NP	10 % FBS	6642
@NP	FBS 10 % , 5 % to 2.5 % every 2 DIV , then maintained in MEM + 2.5 % FBS	6667
@NP	FBS	6667
@NP	10 % , 5 % to 2.5 % every 2 DIV ,	6671
@NP	10 %	6671
@NP	5 % to 2.5 % every 2 DIV	6676
@NP	5 % to 2.5 %	6676
@NP	every 2 DIV	6687
@NP	MEM + 2.5 % FBS	6719
@NP	MEM	6719
@NP	2.5 % FBS	6725
@NP	Fifteen to thirty minutes prior to injection , NSFCs	6735
@NP	Fifteen	6735
@NP	thirty minutes	6746
@NP	injection , NSFCs	6770
@NP	injection	6770
@NP	NSFCs	6781
@NP	low-speed centrifugation -LRB- 900 rpm for 5 min -RRB-	6814
@NP	low-speed centrifugation	6814
@NP	900 rpm for 5 min	6840
@NP	900 rpm	6840
@NP	5 min	6852
@NP	MEM	6885
@NP	2.5 % FBS	6891
@NP	MatrigelR matrix -LRB- 1:1 ; BD Biosciences -RRB- at a concentration of 2	6904
@NP	MatrigelR matrix -LRB- 1:1 ; BD Biosciences -RRB-	6904
@NP	MatrigelR matrix	6904
@NP	1:1 ; BD Biosciences	6922
@NP	1:1	6922
@NP	BD Biosciences	6927
@NP	a concentration of 2	6946
@NP	a concentration	6946
@NP	2	6965
@NP	10 ∧ 4/µl	6969
@NP	48C	7000
@NP	The remaining cells	7005
@NP	3	7056
@NP	4 days for in vitro immunocytochemical characterization	7058
@NP	4 days	7058
@NP	immunocytochemical characterization	7078
@NP	BDNF RT-PCR	7119
@NP	ELISA analysis	7136
@NP	BDNF RT-PCR and ELISA analysis The RNA	7152
@NP	BDNF RT-PCR and ELISA analysis	7152
@NP	The RNA	7183
@NP	NSFCs	7209
@NP	the two	7220
@NP	GFP-labeled NSFC-lines	7237
@NP	RNA Stat-60 reagent -LRB- Tel-Test , Inc -RRB-	7267
@NP	RNA Stat-60 reagent	7267
@NP	Tel-Test	7288
@NP	Inc	7298
@NP	The GeneAmp RNA PCR Kit -LRB- Applied Biosystems , N808-0017 -RRB-	7304
@NP	The GeneAmp RNA PCR Kit	7304
@NP	Applied Biosystems	7329
@NP	N808-0017	7349
@NP	BDNF RNA	7379
@NP	The BDNF primers	7389
@NP	the basis	7422
@NP	published sequence -LRB- 298 bp -RRB- -LRB- Yamamoto et al. , 1996 -RRB-	7435
@NP	published sequence -LRB- 298 bp -RRB-	7435
@NP	published sequence	7435
@NP	298 bp	7455
@NP	Yamamoto	7464
@NP	et al. , 1996	7473
@NP	et al.	7473
@NP	1996	7481
@NP	Integrated DNA Technologies , Coralville , IA	7510
@NP	Integrated DNA Technologies	7510
@NP	Coralville , IA	7539
@NP	indicated	7558
@NP	5V : 5V-AGCCTCCTCTGCTCTTTCTGCTGGA - 3V ; 3V : 5V-CTTTTGTCTATGCCCCQ TGCAGCCTT-3V	7569
@NP	5V	7569
@NP	5V-AGCCTCCTCTGCTCTTTCTGCTGGA - 3V ; 3V : 5V-CTTTTGTCTATGCCCCQ TGCAGCCTT-3V	7573
@NP	5V-AGCCTCCTCTGCTCTTTCTGCTGGA - 3V	7573
@NP	5V-AGCCTCCTCTGCTCTTTCTGCTGGA	7573
@NP	3V	7603
@NP	3V : 5V-CTTTTGTCTATGCCCCQ TGCAGCCTT-3V	7607
@NP	3V	7607
@NP	5V-CTTTTGTCTATGCCCCQ TGCAGCCTT-3V	7611
@NP	The PCR procedures	7647
@NP	protocol	7696
@NP	the kit	7709
@NP	positive -LRB- pAW109 RNA -RRB-	7728
@NP	positive	7728
@NP	pAW109 RNA	7738
@NP	negative controls -LRB- Eppendorf Mastercycler Gradient -RRB-	7754
@NP	negative controls	7754
@NP	Eppendorf Mastercycler Gradient	7773
@NP	The procedure	7807
@NP	an initial step	7834
@NP	958C , 2 m	7854
@NP	958C	7854
@NP	2 m	7860
@NP	35 cycles	7866
@NP	melt -LRB- 958C , 1 m -RRB-	7879
@NP	melt	7879
@NP	958C , 1 m	7885
@NP	958C	7885
@NP	1 m	7891
@NP	annealextend -LRB- 608C , 1 m -RRB- and the final step -LRB- 728C , 7 m -RRB-	7897
@NP	annealextend -LRB- 608C , 1 m -RRB-	7897
@NP	annealextend	7897
@NP	608C , 1 m	7911
@NP	608C	7911
@NP	1 m	7917
@NP	the final step -LRB- 728C , 7 m -RRB-	7926
@NP	the final step	7926
@NP	728C , 7 m	7942
@NP	728C	7942
@NP	7 m	7948
@NP	Separation	7954
@NP	2 % agarose gel , stained with 0.05 % ethidium bromide	7988
@NP	2 % agarose gel	7988
@NP	0.05 % ethidium bromide	8017
@NP	Band intensities	8041
@NP	Alpha Innotech TMM-20 Transilluminator	8076
@NP	BDNF protein levels	8129
@NP	these two GFPlabeled NSFCs	8152
@NP	these two	8152
@NP	NSFCs	8173
@NP	ELISA analysis of cell lysates for BDNF	8180
@NP	ELISA analysis	8180
@NP	cell lysates for BDNF	8198
@NP	cell lysates	8198
@NP	BDNF	8215
@NP	Emax ImmunoAssay system , part #TB257 , Promega , Madison , WI	8221
@NP	Emax ImmunoAssay system	8221
@NP	part #TB257	8246
@NP	Promega	8259
@NP	Madison	8268
@NP	WI	8277
@NP	Cells	8296
@NP	lysis buffer -LRB- 1 x 10 ∧ 6 cells/100 µl lysis buffer -RRB- for 10 min on ice	8329
@NP	lysis buffer -LRB- 1 x 10 ∧ 6 cells/100 µl lysis buffer -RRB-	8329
@NP	lysis buffer	8329
@NP	1 x 10 ∧ 6 cells/100 µl lysis buffer	8343
@NP	1 x 10 ∧ 6 cells/100	8343
@NP	1	8343
@NP	10 ∧ 6 cells/100	8347
@NP	10 ∧	8347
@NP	6 cells/100	8350
@NP	µl lysis buffer	8362
@NP	10 min on ice	8383
@NP	10 min	8383
@NP	ice	8393
@NP	Acid treatment	8398
@NP	the protein	8441
@NP	the protein content	8458
@NP	a Bio-Rad protein assay -LRB- Bio-Rad laboratories , Hercules , CA -RRB-	8497
@NP	a Bio-Rad protein assay	8497
@NP	Bio-Rad laboratories	8522
@NP	Hercules	8544
@NP	CA	8554
@NP	Samples containing the same amounts of protein	8559
@NP	Samples	8559
@NP	the same amounts of protein	8578
@NP	the same amounts	8578
@NP	protein	8598
@NP	the procedures	8626
@NP	the BDNF ELISA following the manufacturer 's protocol	8645
@NP	the BDNF ELISA	8645
@NP	the manufacturer 's protocol	8670
@NP	the manufacturer 's	8670
@NP	Tertiary antibodies	8699
@NP	horseradish peroxidase	8738
@NP	Wells	8762
@NP	tetramethylbenzidine	8788
@NP	450 nm on a standard microplate reader	8825
@NP	450 nm	8825
@NP	a standard microplate reader	8835
@NP	BDNF content	8865
@NP	a standard curve calibrated with known amounts of protein	8901
@NP	a standard curve	8901
@NP	known amounts of protein	8934
@NP	known amounts	8934
@NP	protein	8951
@NP	The detection limit	8960
@NP	less than 2.9 pg/ml for BDNF	8984
@NP	less than 2.9 pg/ml	8984
@NP	BDNF	9008
@NP	Experimental design Ninety-four female Sprague -- Dawley rats	9014
@NP	Experimental design	9014
@NP	Ninety-four female Sprague -- Dawley rats	9034
@NP	Dawley	9061
@NP	220	9074
@NP	270 g ; Charles River , Wilmington , MA	9078
@NP	270 g	9078
@NP	Charles River , Wilmington , MA	9085
@NP	a control group -LRB- n = 12 -RRB-	9134
@NP	a control group	9134
@NP	n	9151
@NP	12	9155
@NP	3 experimental groups -LRB- n = 82 -RRB- -LRB- Table 1 -RRB-	9163
@NP	3 experimental groups -LRB- n = 82 -RRB-	9163
@NP	3 experimental groups	9163
@NP	n	9186
@NP	82	9190
@NP	Table 1	9195
@NP	Body weight of experimental animals	9205
@NP	Body weight	9205
@NP	experimental animals	9220
@NP	the experiment as a general measure of health	9262
@NP	the experiment	9262
@NP	a general measure of health	9280
@NP	a general measure	9280
@NP	health	9301
@NP	The control animals	9309
@NP	baseline information	9352
@NP	the size and number of cells	9384
@NP	the size and number	9384
@NP	cells	9407
@NP	both the left and right RNs	9420
@NP	anterograde	9463
@NP	the RN	9509
@NP	Table 1	9517
@NP	All rats in the experimental groups	9527
@NP	All rats	9527
@NP	the experimental groups	9539
@NP	a dorsolateral/lateral funiculotomy	9572
@NP	the right side of the mid-cervical spinal cord	9611
@NP	the right side	9611
@NP	the mid-cervical spinal cord	9629
@NP	a transplant	9669
@NP	GFP-labeled NSFCs	9685
@NP	MatrigelR matrix or MatrigelR matrix alone 1 week	9716
@NP	MatrigelR matrix or MatrigelR matrix	9716
@NP	1 week	9759
@NP	the lesion	9772
@NP	Rats in experimental group I -LRB- n = 12 -RRB-	9793
@NP	Rats	9793
@NP	experimental group I -LRB- n = 12 -RRB-	9801
@NP	experimental group I	9801
@NP	n	9823
@NP	12	9827
@NP	1 or 2 weeks	9847
@NP	the survival and migration	9888
@NP	the transplanted NSFCs in the injured spinal cord -LRB- Table 1 -RRB-	9918
@NP	the transplanted NSFCs	9918
@NP	the injured spinal cord -LRB- Table 1 -RRB-	9944
@NP	the injured spinal cord	9944
@NP	Table 1	9969
@NP	Rats in experimental group II -LRB- n = 40 -RRB-	9979
@NP	Rats	9979
@NP	experimental group II -LRB- n = 40 -RRB-	9987
@NP	experimental group II	9987
@NP	n	10010
@NP	40	10014
@NP	the effects	10040
@NP	engrafted NSFCs	10055
@NP	the axotomized RN neurons and functional recovery -LRB- Table 1 -RRB-	10074
@NP	the axotomized RN neurons	10074
@NP	functional recovery -LRB- Table 1 -RRB-	10104
@NP	functional recovery	10104
@NP	Table 1	10125
@NP	The RNs of these animals	10135
@NP	The RNs	10135
@NP	these animals	10146
@NP	FG injection	10179
@NP	the cervical spinal cord partial hemisection	10198
@NP	2 weeks -LRB- IIA , n = 16 -RRB-	10270
@NP	IIA , n = 16	10279
@NP	IIA	10279
@NP	n = 16	10284
@NP	n	10284
@NP	16	10288
@NP	12 weeks -LRB- IIB , n = 24 -RRB-	10295
@NP	IIB , n = 24	10305
@NP	IIB	10305
@NP	n = 24	10310
@NP	n	10310
@NP	24	10314
@NP	post transplantation for RN	10318
@NP	post transplantation	10318
@NP	RN	10343
@NP	histological and image analysis	10346
@NP	addition	10382
@NP	animals in group IIB	10392
@NP	animals	10392
@NP	group IIB	10403
@NP	the effect	10435
@NP	NSFCs	10459
@NP	functional recovery	10468
@NP	spontaneous vertical exploration and horizontal ropewalking tests	10491
@NP	Rats in experimental group III -LRB- n = 30 -RRB-	10558
@NP	Rats	10558
@NP	experimental group III -LRB- n = 30 -RRB-	10566
@NP	experimental group III	10566
@NP	n	10590
@NP	30	10594
@NP	the potential	10620
@NP	axotomized RST axonal regeneration -LRB- Table 1 -RRB-	10664
@NP	axotomized RST axonal regeneration	10664
@NP	Table 1	10700
@NP	The RST of some animals -LRB- IIIA , n = 18 -RRB-	10710
@NP	The RST	10710
@NP	some animals -LRB- IIIA , n = 18 -RRB-	10721
@NP	some animals	10721
@NP	IIIA , n = 18	10735
@NP	IIIA	10735
@NP	n = 18	10741
@NP	n	10741
@NP	18	10745
@NP	anterograde transport	10764
@NP	dextran amine -LRB- BDA -RRB- 12 weeks post transplantation	10802
@NP	dextran amine -LRB- BDA -RRB-	10802
@NP	dextran amine	10802
@NP	BDA	10817
@NP	12 weeks	10822
@NP	The animals	10853
@NP	an additional 2 weeks	10901
@NP	Other animals -LRB- IIIB , n = 12 -RRB-	10924
@NP	Other animals	10924
@NP	IIIB , n = 12	10939
@NP	IIIB	10939
@NP	n = 12	10945
@NP	n	10945
@NP	12	10949
@NP	an injection of FG	10964
@NP	an injection	10964
@NP	FG	10980
@NP	the right side of the spinal cord at T1	10988
@NP	the right side	10988
@NP	the spinal cord at T1	11006
@NP	the spinal cord	11006
@NP	T1	11025
@NP	2 level	11028
@NP	3 days	11062
@NP	All procedures	11070
@NP	the University of Louisville Institutional Animal Care and Use Committee	11102
@NP	the University	11102
@NP	Louisville Institutional Animal Care and Use Committee	11120
@NP	accord	11187
@NP	the National Institutes of Health guidelines	11199
@NP	Health	11226
@NP	the care and use of laboratory animals	11248
@NP	the care and use	11248
@NP	laboratory animals	11268
@NP	Prevention	11288
@NP	inflammation with penicillin and immunosuppression	11302
@NP	inflammation	11302
@NP	penicillin and immunosuppression	11320
@NP	cyclosporine	11358
@NP	all experimental rats	11375
@NP	NSFCs engrafted and lesion MatrigelR matrix only	11398
@NP	NSFCs engrafted	11398
@NP	NSFCs	11398
@NP	lesion MatrigelR matrix only	11418
@NP	lesion MatrigelR matrix	11418
@NP	daily Penicillin G -LRB- subcutaneous , 100,000 units/kg ; G.C.	11449
@NP	daily Penicillin G -LRB- subcutaneous , 100,000 units/kg ;	11449
@NP	daily Penicillin G	11449
@NP	subcutaneous , 100,000 units/kg	11469
@NP	subcutaneous	11469
@NP	100,000 units/kg	11483
@NP	G.C.	11501
@NP	Hanford Mfg. , NY -RRB-	11506
@NP	Hanford	11506
@NP	Mfg.	11514
@NP	NY	11520
@NP	cyclosporine	11528
@NP	intramuscular , 10 mg/kg ; Ben Venue Labs , OH	11542
@NP	intramuscular	11542
@NP	10 mg/kg ; Ben Venue Labs	11557
@NP	10 mg/kg	11557
@NP	Ben Venue Labs	11567
@NP	OH	11583
@NP	injections	11587
@NP	the day of spinal cord injury	11621
@NP	the day	11621
@NP	spinal cord injury	11632
@NP	1 week after transplantation	11654
@NP	1 week	11654
@NP	transplantation	11667
@NP	Cyclosporine -LRB- 10 mg/kg -RRB-	11684
@NP	Cyclosporine	11684
@NP	10 mg/kg	11698
@NP	6 weeks post transplantation	11742
@NP	6 weeks	11742
@NP	the dose	11784
@NP	5 mg/kg	11808
@NP	the remainder	11833
@NP	the experimental period -LRB- Liu et al. , 1999 ; Ruitenberg et al. , 2003 -RRB-	11850
@NP	the experimental period	11850
@NP	Liu	11875
@NP	et al. , 1999 ; Ruitenberg et al. , 2003	11879
@NP	et al.	11879
@NP	1999 ; Ruitenberg et al.	11887
@NP	1999	11887
@NP	Ruitenberg et al.	11893
@NP	Ruitenberg	11893
@NP	et al.	11904
@NP	2003	11912
@NP	the end of the 12-week experimental period	11922
@NP	the end	11922
@NP	the 12-week experimental period	11933
@NP	all animals	11966
@NP	body weights of 450 -- 500 g	11982
@NP	body weights of 450	11982
@NP	body weights	11982
@NP	450	11998
@NP	500 g	12002
@NP	the cyclosporine treatment	12025
@NP	not impact	12056
@NP	the animals ' health	12081
@NP	the animals '	12081
@NP	Surgical procedures	12102
@NP	Unilateral C3	12122
@NP	4 cervical spinal cord dorsolateral/lateral funiculotomy model	12136
@NP	the RST	12210
@NP	Liu et al. , 1999	12258
@NP	Liu	12258
@NP	et al.	12262
@NP	1999	12270
@NP	rats	12286
@NP	an intraperitoneal injection	12319
@NP	ketamine	12351
@NP	100 mg/kg body weight ; Ben Venue Labs , OH	12361
@NP	100 mg/kg body weight	12361
@NP	Ben Venue Labs , OH	12384
@NP	Ben Venue Labs	12384
@NP	OH	12400
@NP	xylazine	12408
@NP	10 mg/kg ; Butler , OH	12418
@NP	10 mg/kg	12418
@NP	Butler , OH	12428
@NP	Butler	12428
@NP	OH	12436
@NP	The spinal cord	12441
@NP	dorsal laminectomy of the C3 and C4 vertebrae	12472
@NP	dorsal laminectomy	12472
@NP	the C3 and C4 vertebrae	12494
@NP	a cavity 1 -- 2 mm in length	12523
@NP	cavity 1	12525
@NP	2 mm in length	12534
@NP	2 mm	12534
@NP	length	12542
@NP	microscissors and gentle aspiration	12565
@NP	microscissors	12565
@NP	gentle aspiration	12583
@NP	the lateral funiculus on the right side of the cervical spinal cord	12604
@NP	the lateral funiculus	12604
@NP	the right side of the cervical spinal cord	12629
@NP	the right side	12629
@NP	the cervical spinal cord	12647
@NP	The lesion	12673
@NP	the axons of the RST in the ipsilateral dorsolateral funiculus	12703
@NP	the axons	12703
@NP	the RST in the ipsilateral dorsolateral funiculus	12716
@NP	the RST	12716
@NP	the ipsilateral dorsolateral funiculus	12727
@NP	the ipsilateral ventral funiculus and gray matter	12786
@NP	the ipsilateral ventral funiculus	12786
@NP	gray matter	12824
@NP	the dorsal columns	12845
@NP	experimental group II	12875
@NP	experimental group	12875
@NP	II	12894
@NP	the cavity	12898
@NP	a small piece of Gelfoam	12925
@NP	a small piece	12925
@NP	Gelfoam	12942
@NP	1 Al 2 %	12962
@NP	1 Al	12962
@NP	FG -LRB- Fluorochrome , Englewood , CO -RRB-	12970
@NP	FG	12970
@NP	Fluorochrome	12974
@NP	Englewood	12988
@NP	CO	12999
@NP	The dura mater	13004
@NP	a piece of deep fascia removed from the subcutaneous tissue of the neck	13036
@NP	a piece	13036
@NP	deep fascia removed from the subcutaneous tissue of the neck	13047
@NP	deep fascia	13047
@NP	the subcutaneous tissue of the neck	13072
@NP	the subcutaneous tissue	13072
@NP	the neck	13099
@NP	The muscles	13109
@NP	layers	13136
@NP	the skin	13149
@NP	wound clips	13174
@NP	surgery	13193
@NP	the animals	13202
@NP	a subcutaneous injection of 5 ml	13225
@NP	a subcutaneous injection	13225
@NP	5 ml	13253
@NP	physiological saline to compensate for blood loss	13258
@NP	blood loss	13297
@NP	heating pads , closely observed until awake ,	13323
@NP	heating pads	13323
@NP	their home cages	13388
@NP	1 week	13412
@NP	the animals	13420
@NP	the lesion site	13451
@NP	The cavity	13480
@NP	micro-scissors	13509
@NP	cellular debris	13528
@NP	aspiration	13559
@NP	A piece of gel foam	13571
@NP	A piece	13571
@NP	gel foam	13582
@NP	the cavity	13607
@NP	bleeding	13626
@NP	5 -- 10 min	13659
@NP	5	13659
@NP	10 min	13661
@NP	The	13669
@NP	NSFCs	13684
@NP	8 -- 10 µl , 2 x 10 ∧ 4 / µl cells	13691
@NP	8 -- 10 µl , 2 x 10 ∧ 4 /	13691
@NP	8	13691
@NP	10 µl , 2 x 10 ∧ 4	13693
@NP	10 µl	13693
@NP	2 x 10 ∧ 4	13700
@NP	2	13700
@NP	10 ∧ 4	13704
@NP	10 ∧	13704
@NP	4	13707
@NP	µl cells	13710
@NP	MEM + 2.5 % FBS and MatrigelR matrix -LRB- 1:1 -RRB-	13733
@NP	MEM	13733
@NP	2.5 % FBS and MatrigelR matrix -LRB- 1:1 -RRB-	13739
@NP	2.5 % FBS	13739
@NP	MatrigelR matrix -LRB- 1:1 -RRB-	13752
@NP	MatrigelR matrix	13752
@NP	1:1	13770
@NP	MEM + 2.5 % FBS and MatrigelR matrix	13778
@NP	MEM	13778
@NP	2.5 % FBS and MatrigelR matrix	13784
@NP	2.5 % FBS	13784
@NP	MatrigelR matrix	13797
@NP	a 25	13835
@NP	Al Hamilton syringe attached to a glass pipette -LRB- 50 µm tip diameter -RRB-	13841
@NP	Al Hamilton syringe attached to a glass pipette	13841
@NP	Al Hamilton syringe	13841
@NP	a glass pipette	13873
@NP	50 µm tip diameter	13890
@NP	The syringe	13911
@NP	1	13948
@NP	2 min	13950
@NP	the MatrigelR to partially solidify	13965
@NP	the gel	14011
@NP	the lesion site	14044
@NP	The wound	14061
@NP	the procedures outlined above	14092
@NP	the procedures	14092
@NP	anterograde tracing	14127
@NP	anterograde	14127
@NP	2 weeks	14148
@NP	termination of the experiment , animals in experimental group IIIA	14163
@NP	termination	14163
@NP	the experiment , animals in experimental group IIIA	14178
@NP	the experiment	14178
@NP	animals in experimental group IIIA	14194
@NP	animals	14194
@NP	experimental group IIIA	14205
@NP	a stereotaxic apparatus	14284
@NP	A burr hole	14309
@NP	the left surface of the skull over the RN with a dental drill	14333
@NP	the left surface	14333
@NP	the skull over the RN with a dental drill	14353
@NP	the skull	14353
@NP	the RN with a dental drill	14368
@NP	the RN	14368
@NP	a dental drill	14380
@NP	the	14398
@NP	Mori et al. , 1997	14436
@NP	Mori	14436
@NP	et al.	14441
@NP	1997	14449
@NP	1 µl	14459
@NP	10 % BDA	14467
@NP	10,000 molecular weight in double distilled water ; Molecular Probes	14476
@NP	10,000 molecular weight	14476
@NP	double distilled water ; Molecular Probes	14503
@NP	double distilled water	14503
@NP	Molecular Probes	14527
@NP	Leiden , The Netherlands	14545
@NP	Leiden	14545
@NP	The Netherlands	14553
@NP	2	14595
@NP	3 min in five 200 nl pulses	14597
@NP	3 min	14597
@NP	five 200 nl pulses	14606
@NP	a 10 µl Hamilton syringe	14631
@NP	The needle	14657
@NP	place for an additional 20 min	14680
@NP	place	14680
@NP	an additional 20 min	14690
@NP	2 -- 3 min	14740
@NP	2	14740
@NP	3 min	14742
@NP	retrograde tracing	14753
@NP	retrograde	14753
@NP	animals in experimental group IIIB	14773
@NP	animals	14773
@NP	experimental group IIIB	14784
@NP	the right side of their spinal cords	14830
@NP	the right side	14830
@NP	their spinal cords	14848
@NP	T1	14882
@NP	2 level for pressure-injection of 0.5 µl 2 % FG	14885
@NP	pressure-injection of 0.5 µl	14897
@NP	pressure-injection	14897
@NP	0.5 µl	14919
@NP	the right spinal cord and animals	14937
@NP	the right spinal cord	14937
@NP	animals	14963
@NP	3 days later	14987
@NP	Behavioral testing	15001
@NP	forelimb use	15030
@NP	spontaneous vertical exploration	15050
@NP	limb use asymmetries	15121
@NP	Kozlowski	15143
@NP	et al. , 1996	15153
@NP	et al.	15153
@NP	1996	15161
@NP	Liu et al. , 1999	15167
@NP	Liu	15167
@NP	et al. , 1999	15171
@NP	et al.	15171
@NP	1999	15179
@NP	McDermott et al. , 1995	15185
@NP	McDermott	15185
@NP	et al. , 1995	15195
@NP	et al.	15195
@NP	1995	15203
@NP	Schallert and Jones , 1993	15209
@NP	Schallert and Jones	15209
@NP	1993	15230
@NP	Schallert and Lindner , 1990	15236
@NP	Schallert and Lindner	15236
@NP	1990	15259
@NP	Horizontal rope walking	15266
@NP	a sensitive test	15311
@NP	partial spinal cord hemisection models	15332
@NP	specific aspects of behavioral deficits such as posture and balance	15381
@NP	specific aspects	15381
@NP	behavioral deficits such as posture and balance	15401
@NP	behavioral deficits	15401
@NP	posture and balance	15429
@NP	gait	15456
@NP	Murray and Fischer , 2001 ; Ruitenberg et al. , 2003 ; Shumsky et al. , 2003	15462
@NP	Murray and Fischer	15462
@NP	2001 ; Ruitenberg et al. , 2003 ; Shumsky et al.	15482
@NP	2001	15482
@NP	Ruitenberg et al. , 2003 ; Shumsky et al.	15488
@NP	Ruitenberg	15488
@NP	et al. , 2003 ; Shumsky et al.	15499
@NP	et al. , 2003	15499
@NP	et al.	15499
@NP	2003	15507
@NP	Shumsky et al.	15513
@NP	Shumsky	15513
@NP	et al.	15521
@NP	2003	15529
@NP	the animals	15547
@NP	surgery and baseline behavior measurements	15579
@NP	The animals in experimental group IIB	15637
@NP	The animals	15637
@NP	experimental group IIB	15652
@NP	11 weeks	15687
@NP	surgery	15702
@NP	the 2 behavioral tests	15716
@NP	spontaneous vertical exploration	15740
@NP	horizontal rope walking	15778
@NP	Two individuals	15803
@NP	the scoring of all behavioral performance tests in a double-blind study	15829
@NP	the scoring	15829
@NP	all behavioral performance tests in a double-blind study	15844
@NP	all behavioral performance tests	15844
@NP	a double-blind study	15880
@NP	spontaneous vertical exploration testing at 11 weeks after transplantation	15906
@NP	spontaneous vertical exploration testing	15906
@NP	11 weeks after transplantation	15950
@NP	11 weeks	15950
@NP	transplantation	15965
@NP	the rats	15982
@NP	a clear glass cylinder -LRB- 20 cm in diameter and 30 cm high -RRB- for 5 min	16006
@NP	a clear glass cylinder -LRB- 20 cm in diameter and 30 cm high -RRB-	16006
@NP	a clear glass cylinder	16006
@NP	20 cm in diameter and 30 cm	16030
@NP	20 cm	16030
@NP	diameter and 30 cm	16039
@NP	diameter	16039
@NP	30 cm	16052
@NP	5 min	16068
@NP	independent use	16089
@NP	the left -LRB- non-impaired -RRB- forelimb , right -LRB- impaired -RRB- forelimb	16108
@NP	the left -LRB- non-impaired -RRB- forelimb	16108
@NP	the left -LRB- non-impaired -RRB-	16108
@NP	the left	16108
@NP	right -LRB- impaired -RRB-	16142
@NP	right	16142
@NP	both -LRB- left and right -RRB- forelimbs	16176
@NP	the wall of the cylinder	16223
@NP	the wall	16223
@NP	the cylinder	16235
@NP	vertical posturing along the wall	16255
@NP	vertical posturing	16255
@NP	the wall	16280
@NP	Each behavior	16290
@NP	terms of percentage forelimb use of the left	16321
@NP	terms	16321
@NP	percentage forelimb use of the left	16330
@NP	percentage forelimb use	16330
@NP	the left	16357
@NP	the total number of limb usages -LRB- left , right , and both -RRB-	16394
@NP	the total number of limb usages -LRB- left , right	16394
@NP	the total number	16394
@NP	limb usages -LRB- left , right	16414
@NP	limb usages	16414
@NP	left	16427
@NP	both	16444
@NP	horizontal rope walking at 11 weeks after engraftment	16455
@NP	horizontal rope	16455
@NP	11 weeks	16482
@NP	engraftment	16497
@NP	the animal 's gait	16510
@NP	the animal 's	16510
@NP	3 untimed separate	16547
@NP	a 1.25-m-long rope -LRB- 4 cm diameter -RRB-	16579
@NP	a 1.25-m-long rope	16579
@NP	4 cm diameter	16599
@NP	one platform to another	16619
@NP	one platform	16619
@NP	another	16635
@NP	Rats	16644
@NP	their general performance	16665
@NP	rope locomotion	16698
@NP	a deficit rating scale : -LRB- 0 -RRB- normal rope locomotion	16720
@NP	a deficit rating scale	16720
@NP	-LRB- 0 -RRB- normal rope locomotion	16744
@NP	-LRB- 0 -RRB- normal rope	16744
@NP	0	16745
@NP	locomotion	16760
@NP	normal locomotion with occasional deficits such as inability	16785
@NP	normal locomotion	16785
@NP	occasional deficits such as inability	16808
@NP	occasional deficits	16808
@NP	inability	16836
@NP	consistent weight-supported limb placement	16858
@NP	traverse ; -LRB- 2 -RRB- able to cross the rope	16908
@NP	traverse	16908
@NP	-LRB- 2 -RRB- able to cross the rope	16918
@NP	able	16922
@NP	the rope	16936
@NP	deficits ; and -LRB- 3 -RRB- great difficulty to cross the rope	16963
@NP	deficits	16963
@NP	-LRB- 3 -RRB- great difficulty to cross the rope	16977
@NP	great difficulty	16981
@NP	the rope	17007
@NP	frequent	17017
@NP	loss of balance	17033
@NP	loss	17033
@NP	balance	17041
@NP	the rope	17064
@NP	the animal	17088
@NP	the rope	17108
@NP	it	17118
@NP	only three times	17135
@NP	rope traverse	17160
@NP	the number of	17175
@NP	the number	17175
@NP	total steps for each limb	17210
@NP	total steps	17210
@NP	each limb	17226
@NP	the btotal error/stepQ ratio , which was calculated and defined as the following	17262
@NP	the btotal error/stepQ ratio	17262
@NP	the following	17328
@NP	number of slips + 2 -LRB- number of falls -RRB-	17344
@NP	number of slips	17344
@NP	number	17344
@NP	2 -LRB- number of falls -RRB-	17362
@NP	2	17362
@NP	number of falls	17365
@NP	number	17365
@NP	total number	17383
@NP	steps	17399
@NP	Each rat	17406
@NP	three times	17428
@NP	final scores	17445
@NP	the mean of the 6 scores obtained by the two independent observers	17463
@NP	the mean	17463
@NP	the 6 scores obtained by the two independent observers	17475
@NP	the 6 scores	17475
@NP	the two independent observers	17500
@NP	Tissue preparation Animals	17531
@NP	an overdose	17588
@NP	ketamine -LRB- 200 mg/kg body weight -RRB-	17603
@NP	ketamine	17603
@NP	200 mg/kg body weight	17613
@NP	xylazine -LRB- 20 mg/kg body weight -RRB-	17640
@NP	xylazine	17640
@NP	20 mg/kg body weight	17650
@NP	the heart	17690
@NP	0.01 M PBS	17705
@NP	pH 7.4	17717
@NP	200 ml	17725
@NP	4 % paraformaldehyde in 0.1 M PB , pH 7.4 -LRB- 48C , 500 ml -RRB-	17745
@NP	4 % paraformaldehyde	17745
@NP	0.1 M PB , pH 7.4 -LRB- 48C , 500 ml -RRB-	17768
@NP	0.1 M PB	17768
@NP	pH 7.4 -LRB- 48C , 500 ml -RRB-	17777
@NP	pH 7.4	17777
@NP	48C , 500 ml	17785
@NP	48C	17785
@NP	500 ml	17790
@NP	The midbrain plus cervical and thoracic segments of the spinal cord	17799
@NP	The midbrain	17799
@NP	cervical and thoracic segments of the spinal cord	17817
@NP	cervical and thoracic segments	17817
@NP	the spinal cord	17851
@NP	the same fixative	17902
@NP	48C overnight	17923
@NP	cytoprotection at 48C in PB	17949
@NP	cytoprotection	17949
@NP	48C in PB	17967
@NP	48C	17967
@NP	PB	17974
@NP	30 % sucrose	17988
@NP	1	18004
@NP	2 days	18006
@NP	Spinal cord and brain tissue	18014
@NP	Spinal cord	18014
@NP	brain tissue	18030
@NP	OCT compound -LRB- Fisher Scientific , Pittsburgh , PA -RRB-	18060
@NP	OCT compound	18060
@NP	Fisher Scientific	18074
@NP	Pittsburgh	18093
@NP	PA	18105
@NP	a cryostat	18121
@NP	The spinal cord	18133
@NP	either transverse or horizontal sections	18169
@NP	transverse	18176
@NP	horizontal sections	18190
@NP	20 µm	18213
@NP	gelatincoated slides	18236
@NP	the entire RN	18273
@NP	the midbrains	18302
@NP	20 µm from caudal to rostral extent	18356
@NP	20 µm	18356
@NP	caudal to rostral extent	18367
@NP	Every third serial section -LRB- 70 -- 80 -RRB-	18393
@NP	Every third serial section	18393
@NP	70 -- 80	18421
@NP	70	18421
@NP	80	18424
@NP	gelatin-coated slides in sequence	18445
@NP	gelatin-coated slides	18445
@NP	sequence	18470
@NP	The first series of sections	18480
@NP	The first series	18480
@NP	sections	18500
@NP	toluidine blue staining	18522
@NP	analysis of total neuronal number and size for both RN magnocellular regions	18550
@NP	analysis of total neuronal number	18550
@NP	analysis	18550
@NP	total neuronal number	18562
@NP	size for both RN magnocellular regions	18588
@NP	size	18588
@NP	both RN magnocellular regions	18597
@NP	The other series of sections	18628
@NP	The other series	18628
@NP	sections	18648
@NP	analysis of the number and size of FG-labeled RN neurons	18671
@NP	analysis	18671
@NP	the number and size of FG-labeled RN neurons	18683
@NP	the number and size	18683
@NP	FG-labeled RN neurons	18706
@NP	Histology	18729
@NP	immunocytochemistry Toluidine blue staining and immunocytochemical procedures	18743
@NP	our laboratory -LRB- Othman et al. , 2003 -RRB-	18846
@NP	our laboratory	18846
@NP	Othman	18862
@NP	et al. , 2003	18869
@NP	et al.	18869
@NP	2003	18877
@NP	the NSFCs on coverslips	18893
@NP	the NSFCs	18893
@NP	coverslips	18906
@NP	4V	18943
@NP	6-diamidino-2-phenylindole dihydrochloride	18947
@NP	DAPI , 1:500 ; Molecular Probes , Eugene , OR	18991
@NP	DAPI	18991
@NP	1:500 ; Molecular Probes , Eugene	18997
@NP	1:500	18997
@NP	Molecular Probes , Eugene	19004
@NP	Molecular Probes	19004
@NP	Eugene	19022
@NP	OR	19030
@NP	the nuclei -LRB- 378C , 30 min -RRB-	19046
@NP	the nuclei	19046
@NP	378C , 30 min	19058
@NP	378C	19058
@NP	30 min	19064
@NP	staining	19081
@NP	extensive washing	19097
@NP	extensive	19097
@NP	both coverslips and the tissue on slides	19116
@NP	both coverslips	19116
@NP	the tissue on slides	19136
@NP	the tissue	19136
@NP	slides	19150
@NP	overnight at 48C	19176
@NP	overnight	19176
@NP	48C	19189
@NP	the primary antibodies listed in Table 2	19198
@NP	the primary antibodies	19198
@NP	Table 2	19231
@NP	secondary antibodies Texas Red-conjugate goat anti-mouse IgG	19255
@NP	secondary antibodies	19255
@NP	Texas Red-conjugate goat	19276
@NP	anti-mouse IgG	19301
@NP	Texas Red-conjugate goat anti-rabbit IgG	19320
@NP	Texas Red-conjugate goat	19320
@NP	anti-rabbit IgG	19345
@NP	all	19362
@NP	1:100	19374
@NP	FITC	19381
@NP	Cappel	19387
@NP	West Chester , PA	19395
@NP	West Chester	19395
@NP	PA	19409
@NP	Texas Red	19413
@NP	Molecular Probes	19424
@NP	Eugene	19442
@NP	OR	19450
@NP	Omission of primary or secondary antibodies	19468
@NP	Omission	19468
@NP	primary or secondary antibodies	19480
@NP	the specificity of the reaction	19520
@NP	the specificity	19520
@NP	the reaction	19539
@NP	The BDA staining procedures	19553
@NP	protocols	19600
@NP	Kelly	19613
@NP	et al. -LRB- 2003 -RRB-	19619
@NP	et al.	19619
@NP	2003	19627
@NP	slides with RN and spinal cord sections	19643
@NP	slides	19643
@NP	RN and spinal cord sections	19655
@NP	three times , 10 min each ,	19695
@NP	three times	19695
@NP	10 min each	19708
@NP	10 min	19708
@NP	each	19715
@NP	0.1 M PB , pH 7.4 ,	19724
@NP	0.1 M PB	19724
@NP	pH 7.4	19734
@NP	10 %	19762
@NP	normal goat serum -LRB- NGS -RRB-	19766
@NP	normal goat serum	19766
@NP	NGS	19785
@NP	phosphate-buffered saline PBS , pH 7.4 -LRB- 30 min -RRB-	19793
@NP	phosphate-buffered saline PBS	19793
@NP	pH 7.4 -LRB- 30 min -RRB-	19824
@NP	pH 7.4	19824
@NP	30 min	19832
@NP	The slides	19841
@NP	room temperature in avidin	19880
@NP	room temperature	19880
@NP	avidin	19900
@NP	horseradish peroxidase -LRB- 1:50 ; ABC ; Vector , Burlingame , CA -RRB-	19924
@NP	horseradish peroxidase	19924
@NP	1:50	19948
@NP	ABC ; Vector , Burlingame , CA	19954
@NP	ABC	19954
@NP	Vector , Burlingame , CA	19959
@NP	PBS	19986
@NP	1 % NGS and 0.5 % Triton X-100	19996
@NP	1 % NGS	19996
@NP	0.5 % Triton X-100	20007
@NP	three 10 min	20032
@NP	PB and a 10 min rinse	20055
@NP	PB	20055
@NP	a 10 min rinse	20062
@NP	0.1 M sodium acetate , pH 6.0	20080
@NP	0.1 M sodium acetate	20080
@NP	pH 6.0	20102
@NP	the sections	20110
@NP	Sigma Fast-DAB compounds -LRB- Sigma , St.	20141
@NP	Sigma Fast-DAB compounds	20141
@NP	Sigma	20167
@NP	St.	20174
@NP	Louis , MO -RRB- for 5 -- 10 min .	20178
@NP	Louis , MO -RRB- for 5	20178
@NP	Louis , MO -RRB-	20178
@NP	Louis	20178
@NP	5	20193
@NP	10 min	20195
@NP	PB washes	20213
@NP	PB	20213
@NP	some sections	20224
@NP	toluidine blue counterstained	20243
@NP	ETOH	20293
@NP	DPX -LRB- Fluka Chemie AG , Buchs , Switzerland -RRB-	20321
@NP	DPX	20321
@NP	Fluka Chemie AG , Buchs , Switzerland	20326
@NP	Fluka Chemie	20326
@NP	AG , Buchs , Switzerland	20339
@NP	Cell counts and image analysis	20364
@NP	Cell counts	20364
@NP	image analysis	20380
@NP	consistency between animals and groups	20405
@NP	consistency	20405
@NP	animals and groups	20425
@NP	sequential sections	20445
@NP	the spinal cord lesion site as well as the brain stem for each animal	20485
@NP	the spinal cord lesion site	20485
@NP	the brain stem for each animal	20524
@NP	the brain stem	20524
@NP	each animal	20543
@NP	Images of NSFCs in culture , spinal cord , and midbrain	20556
@NP	Images	20556
@NP	NSFCs in culture , spinal cord , and midbrain	20566
@NP	NSFCs	20566
@NP	culture , spinal cord , and midbrain	20575
@NP	culture	20575
@NP	spinal cord	20584
@NP	midbrain	20601
@NP	the Olympus confocal microscope	20630
@NP	the Nikon microscope with Olympus video camera system	20665
@NP	the Nikon microscope with Olympus	20665
@NP	the Nikon microscope	20665
@NP	Olympus	20691
@NP	video camera system	20699
@NP	Photoshop Adobe software	20740
@NP	Cell size	20766
@NP	NIH image analysis software	20797
@NP	analysis	20830
@NP	GFP-labeled NSFC migration into the host spinal cord 2 weeks after engraftment	20842
@NP	GFP-labeled NSFC migration	20842
@NP	the host spinal cord 2 weeks after engraftment	20874
@NP	the host spinal cord	20874
@NP	2 weeks	20895
@NP	engraftment	20909
@NP	serial cross sections -LRB- 20 µm -RRB-	20922
@NP	serial cross sections	20922
@NP	20 µm	20945
@NP	cervical spinal cord containing the lesion site	20955
@NP	cervical spinal cord	20955
@NP	the lesion site	20987
@NP	GFP antibody	21021
@NP	The sections containing the caudal and rostral extent of the graft	21035
@NP	The sections	21035
@NP	the caudal and rostral extent of the graft	21059
@NP	the caudal and rostral extent	21059
@NP	the graft	21092
@NP	Micrographs -LRB- 200x -RRB-	21114
@NP	Micrographs	21114
@NP	200x	21127
@NP	sections	21136
@NP	50 µm	21148
@NP	100 µm	21155
@NP	250 µm	21163
@NP	500 µm	21171
@NP	1000 µm , 1500 µm , 2000 µm distance from the rostral or caudal host	21183
@NP	1000 µm	21183
@NP	1500 µm	21192
@NP	2000 µm distance from the rostral	21201
@NP	2000 µm distance	21201
@NP	the rostral	21223
@NP	caudal host	21238
@NP	graft interface	21250
@NP	cell counts	21280
@NP	Only those GFP-labeled cells with distinct cytoplasm and nuclei	21293
@NP	Only those GFP-labeled cells	21293
@NP	distinct cytoplasm and nuclei	21327
@NP	analysis of the RN	21375
@NP	analysis	21375
@NP	the RN	21387
@NP	the first toluidine-blue-stained section containing 3 -- 10 neurons	21395
@NP	the first toluidine-blue-stained section	21395
@NP	3 -- 10 neurons	21447
@NP	3	21447
@NP	10 neurons	21449
@NP	beginning of the caudal pole of the RN	21476
@NP	beginning	21476
@NP	the caudal pole of the RN	21489
@NP	the caudal pole	21489
@NP	the RN	21508
@NP	Only sections	21516
@NP	the magnocellular region of the RN	21535
@NP	the magnocellular region	21535
@NP	the RN	21563
@NP	the spinal cord	21588
@NP	this study -LRB- Mori et al. , 1997 ; Kwon et al. , 2002 -RRB-	21622
@NP	this study	21622
@NP	Mori	21634
@NP	et al. , 1997 ; Kwon et al. , 2002	21639
@NP	et al.	21639
@NP	1997 ; Kwon et al.	21647
@NP	1997	21647
@NP	Kwon et al.	21653
@NP	Kwon	21653
@NP	et al.	21658
@NP	2002	21666
@NP	The number and size of neurons on both sides of RN	21673
@NP	The number and size	21673
@NP	neurons on both sides of RN	21696
@NP	neurons	21696
@NP	both sides of RN	21707
@NP	both sides	21707
@NP	RN	21721
@NP	Sections 4 , 7 , 10 , and 13 , 16 , 19 of set I	21743
@NP	Sections 4	21743
@NP	7 , 10 , and 13 , 16 , 19 of set I	21755
@NP	7 , 10 , and 13	21755
@NP	16	21770
@NP	19 of set I	21774
@NP	19	21774
@NP	I	21784
@NP	the number and size of FG-labeled RN neurons	21787
@NP	the number and size	21787
@NP	FG-labeled RN neurons	21810
@NP	Sections 5 , 8 , 11 , and 14 , 17 , 20 of set II	21849
@NP	Sections 5	21849
@NP	8 , 11 , and 14	21861
@NP	17	21876
@NP	20 of set II	21880
@NP	20	21880
@NP	set II	21886
@NP	toluidine blue staining	21898
@NP	only those cells	21923
@NP	identifiable nuclei , nucleoli , and characteristic neuronal morphology	21945
@NP	identifiable nuclei	21945
@NP	nucleoli	21966
@NP	characteristic neuronal morphology	21980
@NP	FG-labeled neuron counts	22033
@NP	overestimation of neuronal numbers	22068
@NP	overestimation	22068
@NP	neuronal numbers	22086
@NP	adjacent sections -LRB- section sets II and III -RRB-	22104
@NP	adjacent sections	22104
@NP	section sets II and III	22123
@NP	section sets	22123
@NP	II and III	22136
@NP	only those cells appearing on 1 section	22166
@NP	1 section	22196
@NP	Liu et al. , 1999	22220
@NP	Liu	22220
@NP	et al.	22224
@NP	1999	22232
@NP	The cross-sectional area of toluidine-blue-stained or FG-labeled RN neurons	22239
@NP	The cross-sectional area	22239
@NP	toluidine-blue-stained or FG-labeled RN neurons	22267
@NP	200x counting box using an NIH image macro program	22334
@NP	200x counting box	22334
@NP	an NIH image macro program	22358
@NP	The maximal cross-sectional area for each neuron	22386
@NP	The maximal cross-sectional area	22386
@NP	each neuron	22423
@NP	A total of 150 -- 200 RN neurons was measured for each RN .	22449
@NP	A total of 150	22449
@NP	A total	22449
@NP	150	22460
@NP	200 RN neurons was measured for each RN	22464
@NP	200 RN neurons	22464
@NP	each RN	22496
@NP	Statistical analysis Data	22505
@NP	the histological assessments and behavioral tests	22545
@NP	the histological assessments	22545
@NP	behavioral tests	22578
@NP	significant differences	22613
@NP	animal groups using either Student 's t test or oneway ANOVA	22645
@NP	animal groups	22645
@NP	Student 's t test or oneway ANOVA	22672
@NP	Student 's t test	22672
@NP	Student 's	22672
@NP	oneway ANOVA	22692
@NP	The Pearson correlation test	22706
@NP	there	22767
@NP	possible relationships between different outcome parameters	22778
@NP	possible relationships	22778
@NP	different outcome parameters	22809
@NP	P	22887
@NP	0.01	22891
@NP	All quantitative data	22897
@NP	mean ± standard deviation -LRB- SD -RRB-	22937
@NP	mean ± standard deviation	22937
@NP	SD	22964
@NP	The graphs	22969
@NP	Microsoft Excel software	23000
@NP	Results Table	23027
@NP	1 Animal groups Table	23041
@NP	1 Animal groups	23041
@NP	Table	23058
@NP	2 Primary antibodies Table 3 Neuronal counts and mean soma size in RN	23064
@NP	2 Primary antibodies	23064
@NP	3 Neuronal counts	23092
@NP	soma size	23119
@NP	RN	23132
@NP	toluidine blue	23136
@NP	± SD Fig. 1	23158
@NP	± SD Fig.	23158
@NP	1	23169
@NP	NSFCs	23172
@NP	green fluorescent protein -LRB- GFP -RRB-	23200
@NP	green fluorescent protein	23200
@NP	GFP	23227
@NP	the LERS-EGFP vector	23238
@NP	4 DIV	23266
@NP	60 % of the cells	23272
@NP	60 %	23272
@NP	the cells	23279
@NP	The level of fluorescence of individual cells	23307
@NP	The level	23307
@NP	fluorescence of individual cells	23320
@NP	fluorescence	23320
@NP	individual cells	23336
@NP	the length of time	23371
@NP	the length	23371
@NP	time	23385
@NP	the previous division -LRB- DIC , confocal optics -RRB-	23395
@NP	the previous division	23395
@NP	DIC , confocal optics	23418
@NP	DIC	23418
@NP	confocal optics	23423
@NP	Fig. 2 .	23442
@NP	Fig.	23442
@NP	2	23447
@NP	transplantation	23456
@NP	the remaining GFP-labeled NSFCs	23473
@NP	3 -- 4 DIV	23533
@NP	3	23533
@NP	4 DIV	23535
@NP	BDNF	23583
@NP	A	23590
@NP	The majority of the cells with nuclei	23593
@NP	The majority	23593
@NP	the cells with nuclei	23609
@NP	the cells	23609
@NP	nuclei	23624
@NP	4V	23652
@NP	6-diamidino-2-phenylindole dihydrochloride	23656
@NP	the neuronal marker , h-tubulin III	23723
@NP	the neuronal marker	23723
@NP	h-tubulin III	23744
@NP	-LRB- B -RRB- A few cells	23759
@NP	-LRB- B -RRB-	23759
@NP	A few cells	23763
@NP	A2B5	23799
@NP	Trk pan immunoreactivity	23809
@NP	some GFP	23852
@NP	positive and negative cells	23861
@NP	Trk B immunoreactivity	23894
@NP	some cellular surfaces	23933
@NP	an intensely stained region -LRB- arrow -RRB-	23983
@NP	an intensely stained region	23983
@NP	arrow	24012
@NP	-LRB- E -RRB- A few NSFCs	24020
@NP	-LRB- E -RRB-	24020
@NP	A few NSFCs	24024
@NP	Trk A	24041
@NP	-LRB- F -RRB- Most of the NSFCs	24057
@NP	-LRB- F -RRB- Most	24057
@NP	-LRB- F -RRB-	24057
@NP	Most	24061
@NP	the NSFCs	24069
@NP	BDNF -LRB- DIC -RRB- , confocal optics	24103
@NP	BDNF -LRB- DIC -RRB-	24103
@NP	BDNF	24103
@NP	DIC	24109
@NP	confocal optics	24115
@NP	Fig. 3 .	24133
@NP	Fig.	24133
@NP	3	24138
@NP	RT-PCR and ELISA analysis	24141
@NP	both of the NSFC lines used in these studies	24181
@NP	both	24181
@NP	the NSFC lines used in these studies	24189
@NP	the NSFC lines	24189
@NP	these studies	24212
@NP	BDNF mRNA and protein	24236
@NP	-LRB- A -RRB- RT-PCR for BDNF	24273
@NP	-LRB- A -RRB-	24273
@NP	BDNF	24288
@NP	a clear PCR product of 298 bp in the cDNA samples	24303
@NP	a clear PCR product	24303
@NP	298 bp in the cDNA samples	24326
@NP	298 bp	24326
@NP	the cDNA samples	24336
@NP	each of the two GFP-labeled NSFC lines	24358
@NP	each	24358
@NP	the two GFP-labeled NSFC lines	24366
@NP	PCR for BDNF in the absence of reverse transcriptase -LRB- control -RRB-	24398
@NP	PCR	24398
@NP	BDNF in the absence of reverse transcriptase -LRB- control -RRB-	24406
@NP	BDNF	24406
@NP	the absence of reverse transcriptase -LRB- control -RRB-	24414
@NP	the absence	24414
@NP	reverse transcriptase -LRB- control -RRB-	24429
@NP	reverse transcriptase	24429
@NP	control	24452
@NP	no reaction product	24469
@NP	the BDNF amplification product	24506
@NP	contaminating or genomic DNA	24556
@NP	contaminating	24556
@NP	genomic DNA	24573
@NP	-LRB- B -RRB- ELISA of cell lysates	24586
@NP	-LRB- B -RRB-	24586
@NP	cell lysates	24599
@NP	BDNF protein	24635
@NP	each of the two NSFC lines	24664
@NP	each	24664
@NP	the two NSFC lines	24672
@NP	Fig. 4 .	24693
@NP	Fig.	24693
@NP	4	24698
@NP	Photomicrographs of horizontal sections from an	24701
@NP	Photomicrographs	24701
@NP	horizontal sections from an	24721
@NP	horizontal sections	24721
@NP	an	24746
@NP	rat cervical spinal cord reveal NSFCs within the lesion cavity	24759
@NP	rat	24759
@NP	cervical spinal cord	24763
@NP	NSFCs	24791
@NP	the lesion cavity	24804
@NP	the host spinal cord -LRB- A -- C -RRB- 1 week or -LRB- D -- G -RRB- 2 weeks	24826
@NP	the host spinal cord -LRB- A -- C -RRB- 1 week	24826
@NP	the host spinal cord	24826
@NP	A -- C	24848
@NP	A	24848
@NP	C	24850
@NP	1 week	24853
@NP	D -- G	24864
@NP	D	24864
@NP	G	24866
@NP	2 weeks	24869
@NP	engraftment	24883
@NP	The orientation of all sections	24896
@NP	The orientation	24896
@NP	all sections	24915
@NP	left-caudal and right-rostral	24932
@NP	left-caudal	24932
@NP	right-rostral	24948
@NP	-LRB- A -RRB-	24963
@NP	A	24964
@NP	the large number	24972
@NP	GFP-labeled NSFCs -LRB- green -RRB- in the lesion cavity	24992
@NP	GFP-labeled NSFCs -LRB- green -RRB-	24992
@NP	GFP-labeled NSFCs	24992
@NP	the lesion cavity	25021
@NP	a few cells within the host spinal cord bridging the injury site	25050
@NP	a few cells	25050
@NP	the host spinal cord bridging the injury site	25069
@NP	the host spinal cord	25069
@NP	the injury site	25099
@NP	Several GFP-labeled cells	25116
@NP	the adjacent host spinal cord -LRB- arrows -RRB-	25161
@NP	the adjacent host spinal cord	25161
@NP	arrows	25192
@NP	B and C	25202
@NP	B	25202
@NP	C	25208
@NP	Higher-magnification images of area	25211
@NP	Higher-magnification images	25211
@NP	area	25242
@NP	in A	25256
@NP	the host	25270
@NP	graft	25279
@NP	interface -LRB- dashed line -RRB-	25285
@NP	interface	25285
@NP	line	25303
@NP	B	25310
@NP	A modest GFAPpositive astrocytic presence	25314
@NP	few astrocytes being detected in the graft -LRB- C -RRB-	25375
@NP	few astrocytes	25375
@NP	the graft -LRB- C -RRB-	25408
@NP	the graft	25408
@NP	C	25419
@NP	-LRB- D and E -RRB-	25423
@NP	D	25424
@NP	E	25430
@NP	Low and high power	25433
@NP	rostral cervical spinal cord horizontal sections	25455
@NP	the level	25507
@NP	the dorsolateral columns	25520
@NP	numerous GFP-labeled cells	25553
@NP	the white matter for up to 2.0 mm	25605
@NP	the white matter	25605
@NP	up to 2.0 mm	25626
@NP	A few of these cells	25640
@NP	A few	25640
@NP	these cells	25649
@NP	long processes that extended into the surrounding tissue -LRB- box in D -RRB-	25665
@NP	long processes	25665
@NP	the surrounding tissue -LRB- box in D -RRB-	25699
@NP	the surrounding tissue	25699
@NP	box in D	25723
@NP	box	25723
@NP	D	25730
@NP	-LRB- F -RRB- Most of the GFP-labeled cells	25734
@NP	-LRB- F -RRB- Most	25734
@NP	-LRB- F -RRB-	25734
@NP	Most	25738
@NP	the GFP-labeled cells	25746
@NP	Trk B receptors	25786
@NP	G	25804
@NP	The majority of the GFP	25807
@NP	The majority	25807
@NP	the GFP	25823
@NP	cells	25839
@NP	h-tubulin III	25850
@NP	Fig. 5 .	25875
@NP	Fig.	25875
@NP	5	25880
@NP	Photomicrographs of cervical spinal cord cross sections	25883
@NP	Photomicrographs	25883
@NP	cervical spinal cord cross sections	25903
@NP	the lesion and GFP-labeled NSFCs	25947
@NP	the lesion	25947
@NP	GFP-labeled NSFCs	25962
@NP	the lesion site 2 weeks	25983
@NP	the lesion site	25983
@NP	2 weeks	25999
@NP	transplantation	26013
@NP	A -- H	26031
@NP	A	26031
@NP	H	26033
@NP	Caudal to rostral ,	26036
@NP	Caudal	26036
@NP	rostral	26046
@NP	sections	26061
@NP	a single rat at 750-Am intervals	26075
@NP	a single rat	26075
@NP	750-Am intervals	26091
@NP	the extent of the lesion and the distribution of engrafted NSFCs	26144
@NP	the extent	26144
@NP	the lesion and the distribution of engrafted NSFCs	26158
@NP	the lesion	26158
@NP	the distribution of engrafted NSFCs	26173
@NP	the distribution	26173
@NP	engrafted NSFCs	26193
@NP	-LRB- I -- N -RRB- High-magnification images	26210
@NP	I -- N	26211
@NP	I	26211
@NP	N	26213
@NP	corresponding	26245
@NP	outlined areas	26259
@NP	A -- D and F --	26277
@NP	D and F	26279
@NP	D	26279
@NP	F	26285
@NP	H.	26287
@NP	A and B -RRB- NSFCs	26291
@NP	up to 1.5 mm from the interface of the lesion cavity	26326
@NP	up to 1.5 mm	26326
@NP	the interface of the lesion cavity	26344
@NP	the interface	26344
@NP	the lesion cavity	26361
@NP	the host spinal cord white matter	26386
@NP	the host spinal cord	26386
@NP	white matter	26407
@NP	Some cells	26421
@NP	the corticospinal tract -LRB- cst -RRB- -LRB- I -RRB-	26440
@NP	the corticospinal tract -LRB- cst -RRB-	26440
@NP	the corticospinal tract	26440
@NP	cst	26465
@NP	I	26471
@NP	most cells	26484
@NP	the dorsolateral funiculus -LRB- dlf -RRB- -LRB- J -RRB-	26509
@NP	the dorsolateral funiculus -LRB- dlf -RRB-	26509
@NP	the dorsolateral funiculus	26509
@NP	dlf	26537
@NP	J	26543
@NP	a few cells	26551
@NP	the ventrolateral funiculus	26566
@NP	vlf	26595
@NP	the ventral columns	26603
@NP	vc	26624
@NP	-LRB- C -RRB- The caudal host	26629
@NP	-LRB- C -RRB-	26629
@NP	The caudal host	26633
@NP	graft interface	26649
@NP	numerous blood vessels	26675
@NP	the transplant site -LRB- arrows in K -RRB-	26719
@NP	the transplant site	26719
@NP	arrows in K	26740
@NP	arrows	26740
@NP	K	26750
@NP	-LRB- D and E -RRB- The epicenter of lesion cavity	26754
@NP	-LRB- D and E -RRB- The epicenter	26754
@NP	-LRB- D and E -RRB-	26754
@NP	D	26755
@NP	E	26761
@NP	The epicenter	26764
@NP	lesion cavity	26781
@NP	many engrafted NSFCs	26805
@NP	many	26805
@NP	NSFCs	26820
@NP	The lesion -LRB- dashed line -RRB-	26827
@NP	The lesion	26827
@NP	line	26846
@NP	the dlf -LRB- containing the rubrospinal tract -RRB- , the lateral funiculus	26873
@NP	the dlf -LRB- containing the rubrospinal tract -RRB-	26873
@NP	the dlf	26873
@NP	the rubrospinal tract	26893
@NP	the lateral funiculus	26917
@NP	lf	26940
@NP	the vlf and the gray matter -LRB- GM -RRB-	26968
@NP	the vlf and the gray matter	26968
@NP	the vlf	26968
@NP	the gray matter	26980
@NP	-LRB- F -RRB- Cells	27002
@NP	the rostral interface of lesion cavity	27031
@NP	the rostral interface	27031
@NP	lesion cavity	27056
@NP	G and H -RRB- NSFCs	27072
@NP	the white matter up to 2.0 mm from the lesion cavity	27114
@NP	the white matter	27114
@NP	to 2.0 mm	27134
@NP	the lesion cavity	27149
@NP	They	27168
@NP	the dlf and lf -LRB- L -RRB-	27195
@NP	the dlf and lf	27195
@NP	L	27211
@NP	some in the fasciculus gracilis -LRB- fg -RRB-	27215
@NP	some	27215
@NP	the fasciculus gracilis	27223
@NP	fg	27248
@NP	fasciculus cuneatus -LRB- fc -RRB-	27253
@NP	fasciculus cuneatus	27253
@NP	fc	27274
@NP	cst -LRB- N -RRB-	27283
@NP	cst	27283
@NP	N	27288
@NP	a few	27296
@NP	the vlf and vc -LRB- M -RRB-	27305
@NP	the vlf and vc	27305
@NP	M	27321
@NP	The scale bar in H	27325
@NP	The scale bar	27325
@NP	H	27342
@NP	A -- G.	27355
@NP	G.	27357
@NP	The scale bar in N	27360
@NP	The scale bar	27360
@NP	N	27377
@NP	I , K -- M.	27390
@NP	I	27390
@NP	K -- M.	27393
@NP	K	27393
@NP	M.	27395
@NP	Fig. 6 .	27399
@NP	Fig.	27399
@NP	6	27404
@NP	The number of the GFP-labeled NSFCs	27407
@NP	The number	27407
@NP	the GFP-labeled NSFCs	27421
@NP	the white matter of the host spinal cord	27452
@NP	the white matter	27452
@NP	the host spinal cord	27472
@NP	2 weeks	27493
@NP	engraftment	27507
@NP	n	27520
@NP	= 6 ; Mean ± SD	27522
@NP	= 6	27522
@NP	Mean ± SD	27527
@NP	The GFPlabeled cells	27539
@NP	20 µm cross sections	27579
@NP	cervical spinal cords	27617
@NP	distances approximately 50 µm	27642
@NP	distances	27642
@NP	approximately 50 µm	27652
@NP	100 µm , 250 µm , 500 µm , and 1000 µm	27673
@NP	100 µm	27673
@NP	250 µm	27681
@NP	500 µm	27689
@NP	1000 µm	27701
@NP	1500 µm	27710
@NP	2000 µm from the rostral	27719
@NP	2000 µm	27719
@NP	the rostral	27732
@NP	the lesion cavity	27766
@NP	More GFP-labeled cells -LRB- P < 0.05 -RRB-	27785
@NP	More GFP-labeled cells	27785
@NP	P < 0.05	27809
@NP	P	27809
@NP	< 0.05	27811
@NP	<	27811
@NP	0.05	27813
@NP	the rostral than the caudal white matter	27827
@NP	the rostral	27827
@NP	the caudal white matter	27844
@NP	Fig. 7 .	27870
@NP	Fig.	27870
@NP	7	27875
@NP	Histological analysis of the injury sites	27878
@NP	Histological analysis	27878
@NP	the injury sites	27903
@NP	12 weeks	27920
@NP	A and B , toluidine blue	27947
@NP	A and B	27947
@NP	toluidine blue	27956
@NP	the lesion only animals	27976
@NP	the lesion	27976
@NP	only animals	27987
@NP	the sites	28001
@NP	many cells -LRB- arrows -RRB- but no axons	28028
@NP	many cells -LRB- arrows -RRB-	28028
@NP	many cells	28028
@NP	arrows	28040
@NP	no axons	28052
@NP	C and D	28063
@NP	C	28063
@NP	D	28069
@NP	However , within the lesion site of	28072
@NP	However , within the lesion site	28072
@NP	the lesion	28088
@NP	animals	28117
@NP	transplanted cells that extended processes -LRB- arrows -RRB-	28126
@NP	transplanted cells	28126
@NP	processes -LRB- arrows -RRB-	28159
@NP	processes	28159
@NP	arrows	28170
@NP	the site	28203
@NP	addition	28216
@NP	a large population of axons	28226
@NP	a large population	28226
@NP	axons	28248
@NP	the rostral end of the lesion site -LRB- arrowheads -RRB-	28274
@NP	the rostral end	28274
@NP	the lesion site -LRB- arrowheads -RRB-	28293
@NP	the lesion site	28293
@NP	arrowheads	28310
@NP	E -- H	28324
@NP	E	28324
@NP	H	28326
@NP	the center of the lesion cavity	28332
@NP	the center	28332
@NP	the lesion cavity	28346
@NP	many engrafted cells -LRB- arrows -RRB-	28365
@NP	many	28365
@NP	cells -LRB- arrows -RRB-	28380
@NP	cells	28380
@NP	arrows	28387
@NP	GAP-43 and MAP-2	28419
@NP	arrows in E and F , and G and H , respectively	28437
@NP	arrows in E and F , and G and H	28437
@NP	arrows in E and F	28437
@NP	arrows	28437
@NP	E and F	28447
@NP	G and H	28460
@NP	axons from the host 's spinal cord	28484
@NP	axons	28484
@NP	the host 's spinal cord	28495
@NP	the host 's	28495
@NP	GAP-43 or MAP-2 positive -LRB- arrowheads in E and G and H , respectively -RRB-	28528
@NP	GAP-43 or MAP-2	28528
@NP	arrowheads in E and G and H , respectively	28554
@NP	arrowheads in E and G and H	28554
@NP	arrowheads	28554
@NP	E and G and H	28568
@NP	Fig. 8 .	28599
@NP	Fig.	28599
@NP	8	28604
@NP	Photomicrographs of midbrain toluidine blue	28607
@NP	Photomicrographs	28607
@NP	midbrain toluidine blue	28627
@NP	cross sections	28657
@NP	the RNs	28680
@NP	2 weeks -LRB- A and B -RRB- and 12 weeks -LRB- C and D -RRB-	28688
@NP	2 weeks -LRB- A and B -RRB-	28688
@NP	A and B	28697
@NP	A	28697
@NP	B	28703
@NP	12 weeks -LRB- C and D -RRB-	28710
@NP	C and D	28720
@NP	C	28720
@NP	D	28726
@NP	cervical spinal cord injury and NSFCs engraftment	28735
@NP	All sections	28786
@NP	approximately 380 µm	28804
@NP	the caudal pole of the RN	28830
@NP	the caudal pole	28830
@NP	the RN	28849
@NP	-LRB- A -RRB-	28857
@NP	A	28858
@NP	the left RN , modest atrophy and apparent neuronal loss	28869
@NP	the left RN	28869
@NP	modest atrophy	28882
@NP	apparent neuronal loss	28901
@NP	2 weeks	28924
@NP	hemisection in the lesion only group	28938
@NP	hemisection	28938
@NP	the lesion only group	28953
@NP	the lesion	28953
@NP	only group	28964
@NP	-LRB- B -RRB- Partial preservation	28976
@NP	B	28977
@NP	the size of the left RN neurons as well as apparent numbers of neurons	29004
@NP	the size of the left RN neurons	29004
@NP	the size	29004
@NP	the left RN neurons	29016
@NP	apparent numbers of neurons	29047
@NP	apparent numbers	29047
@NP	neurons	29067
@NP	NSFCs engraftment	29095
@NP	-LRB- C -RRB-	29114
@NP	C	29115
@NP	2 weeks	29130
@NP	apparent neuronal loss and atrophy of the left RN	29139
@NP	apparent neuronal loss	29139
@NP	atrophy of the left RN	29166
@NP	atrophy	29166
@NP	the left RN	29177
@NP	12 weeks in the lesion	29217
@NP	12 weeks	29217
@NP	the lesion	29229
@NP	group	29245
@NP	contrast	29259
@NP	the lesion plus engrafted NSFCs group	29269
@NP	the lesion	29269
@NP	NSFCs group	29295
@NP	a survival of approximately 80 % of the left RN neurons	29311
@NP	a survival	29311
@NP	approximately 80 % of the left RN neurons	29325
@NP	approximately 80 %	29325
@NP	the left RN neurons	29346
@NP	less atrophy	29380
@NP	12 weeks	29396
@NP	Fig. 9 .	29407
@NP	Fig.	29407
@NP	9	29412
@NP	Histogram	29415
@NP	the relative number -LRB- A -RRB-	29435
@NP	the relative number	29435
@NP	A	29456
@NP	soma size	29468
@NP	B	29479
@NP	FG-labeled RN neurons between lesion only	29485
@NP	FG-labeled RN neurons	29485
@NP	lesion only	29515
@NP	lesion plus NSFCs engrafted animals 2 and 12 weeks after surgery	29531
@NP	lesion plus NSFCs	29531
@NP	animals	29559
@NP	2 and 12 weeks	29567
@NP	surgery	29588
@NP	-LRB- A -RRB- More -LRB- * P < 0.001 -RRB- RN neurons were labeled in the	29597
@NP	-LRB- A -RRB- More -LRB- * P < 0.001 -RRB-	29597
@NP	-LRB- A -RRB- More	29597
@NP	-LRB- A -RRB-	29597
@NP	More	29601
@NP	P <	29608
@NP	P	29608
@NP	<	29610
@NP	0.001	29612
@NP	RN neurons	29619
@NP	the	29646
@NP	animals -LRB- 2 weeks : 360 ± 39 ; 12 weeks : 300 ± 35 -RRB-	29660
@NP	animals	29660
@NP	2 weeks : 360 ± 39 ; 12 weeks : 300 ± 35	29669
@NP	2 weeks	29669
@NP	360 ± 39 ; 12 weeks : 300 ± 35	29678
@NP	360 ± 39	29678
@NP	360 ±	29678
@NP	39	29684
@NP	12 weeks	29688
@NP	12	29688
@NP	weeks	29691
@NP	300 ± 35	29698
@NP	300 ±	29698
@NP	35	29704
@NP	those in the lesion	29713
@NP	those	29713
@NP	the lesion	29722
@NP	animals -LRB- 2 weeks : 270 ± 25 ; 12 weeks : 200 ± 25 -RRB-	29738
@NP	animals	29738
@NP	2 weeks : 270 ± 25 ; 12 weeks : 200 ± 25	29747
@NP	2 weeks	29747
@NP	270 ± 25 ; 12 weeks : 200 ± 25	29756
@NP	270 ± 25	29756
@NP	270 ±	29756
@NP	25	29762
@NP	12 weeks	29766
@NP	12	29766
@NP	weeks	29769
@NP	200 ± 25	29776
@NP	200 ±	29776
@NP	25	29782
@NP	-LRB- B -RRB- The mean soma size of surviving RN neurons was	29787
@NP	-LRB- B -RRB-	29787
@NP	The mean soma size of surviving RN neurons	29791
@NP	The mean soma size	29791
@NP	surviving RN neurons	29813
@NP	P < 0.001	29839
@NP	P	29839
@NP	< 0.001	29841
@NP	<	29841
@NP	0.001	29843
@NP	smaller	29850
@NP	the lesion	29861
@NP	only animals -LRB- 2 weeks : 390 ± 25 µm2 ; 12 weeks : 300 ± 25 µm2 -RRB-	29872
@NP	only animals	29872
@NP	2 weeks : 390 ± 25 µm2 ; 12 weeks : 300 ± 25 µm2	29886
@NP	2 weeks	29886
@NP	390 ± 25 µm2 ; 12 weeks : 300 ± 25 µm2	29895
@NP	390 ± 25 µm2	29895
@NP	390 ±	29895
@NP	25 µm2	29901
@NP	12 weeks	29909
@NP	12	29909
@NP	weeks	29912
@NP	300 ± 25 µm2	29919
@NP	300 ±	29919
@NP	25 µm2	29925
@NP	the	29941
@NP	animals -LRB- 2 weeks : 470 ± 30 µm2 ; 12 weeks : 405 ± 25 µm2 -RRB-	29955
@NP	animals	29955
@NP	2 weeks : 470 ± 30 µm2 ; 12 weeks : 405 ± 25 µm2	29964
@NP	2 weeks	29964
@NP	470 ± 30 µm2 ; 12 weeks : 405 ± 25 µm2	29973
@NP	470 ± 30 µm2	29973
@NP	470 ±	29973
@NP	30 µm2	29979
@NP	12 weeks	29987
@NP	12	29987
@NP	weeks	29990
@NP	405 ± 25 µm2	29997
@NP	405 ±	29997
@NP	25 µm2	30003
@NP	Fig. 10 .	30013
@NP	Fig.	30013
@NP	10	30018
@NP	Fluorescence photomicrographs of midbrain cross sections	30022
@NP	Fluorescence photomicrographs	30022
@NP	midbrain cross sections	30055
@NP	FG-labeled RN neuronal soma -LRB- A and B -RRB- 2 weeks	30084
@NP	FG-labeled RN neuronal soma -LRB- A and B -RRB-	30084
@NP	FG-labeled RN neuronal soma	30084
@NP	A and B	30113
@NP	A	30113
@NP	B	30119
@NP	2 weeks	30122
@NP	C and D	30135
@NP	C	30135
@NP	D	30141
@NP	12 weeks	30144
@NP	surgery	30159
@NP	All sections	30168
@NP	approximately 400 µm	30186
@NP	the caudal pole of the RN	30212
@NP	the caudal pole	30212
@NP	the RN	30231
@NP	A and B	30240
@NP	A	30240
@NP	B	30246
@NP	Two weeks	30249
@NP	surgery	30265
@NP	the apparent number and mean soma area of FG-labeled RN neurons	30274
@NP	the apparent number	30274
@NP	mean soma area of FG-labeled RN neurons	30298
@NP	soma area	30303
@NP	FG-labeled RN neurons	30316
@NP	the lesion	30354
@NP	group -LRB- B -RRB-	30379
@NP	group	30379
@NP	B	30386
@NP	the lesion only group -LRB- A -RRB-	30397
@NP	the lesion only group	30397
@NP	the lesion	30397
@NP	A	30420
@NP	C and D	30425
@NP	C	30425
@NP	D	30431
@NP	Twelve weeks	30434
@NP	surgery	30453
@NP	the apparent number and soma area of FG-labeled RN neurons	30462
@NP	the apparent number and soma area	30462
@NP	FG-labeled RN neurons	30499
@NP	the lesion only	30547
@NP	C	30564
@NP	the lesion	30600
@NP	group -LRB- D -RRB-	30625
@NP	group	30625
@NP	D	30632
@NP	Fig. 11 .	30637
@NP	Fig.	30637
@NP	11	30642
@NP	Photomicrographs of C2 BDA-immunostained	30646
@NP	Photomicrographs	30646
@NP	C2 BDA-immunostained	30666
@NP	toluidine blue counterstained spinal cord sections	30691
@NP	toluidine	30691
@NP	blue counterstained spinal cord sections	30701
@NP	the distribution of BDAlabeled RST axons rostral	30755
@NP	the distribution	30755
@NP	BDAlabeled RST axons rostral	30775
@NP	the lesion site	30807
@NP	The BDA-labeled RST axons	30824
@NP	the dorsolateral funiculus -LRB- dlf -RRB-	30863
@NP	the dorsolateral funiculus	30863
@NP	dlf	30891
@NP	both lesion only -LRB- A and B -RRB-	30899
@NP	both lesion only	30899
@NP	A and B	30917
@NP	A	30917
@NP	B	30923
@NP	animals -LRB- C and D -RRB-	30940
@NP	animals	30940
@NP	C and D	30949
@NP	C	30949
@NP	D	30955
@NP	14 weeks	30958
@NP	injury and engraftment	30973
@NP	BDA-labeled axons	30997
@NP	the lesion	31030
@NP	group	31046
@NP	those found in the engrafted animals	31064
@NP	those	31064
@NP	the engrafted animals	31079
@NP	the	31079
@NP	animals	31093
@NP	Fig. 12 .	31103
@NP	Fig.	31103
@NP	12	31108
@NP	Photomicrographs of cervical spinal cord horizontal sections	31112
@NP	Photomicrographs	31112
@NP	cervical spinal cord horizontal sections	31132
@NP	BDA	31181
@NP	RST axons	31205
@NP	the lesion region	31218
@NP	14 weeks	31236
@NP	transplantation	31251
@NP	all sections	31272
@NP	the lesion cavity	31315
@NP	right	31339
@NP	lines	31363
@NP	graft	31378
@NP	host interfaces	31384
@NP	A and B -RRB- Numerous normal	31402
@NP	A and B -RRB-	31402
@NP	A	31402
@NP	B	31408
@NP	BDA-labeled RST axons	31427
@NP	rostrocaudal parallel alignment in the dorsolateral funiculus	31465
@NP	rostrocaudal parallel alignment	31465
@NP	the dorsolateral funiculus	31500
@NP	-LRB- C and D -RRB- BDA-labeled RST axons	31528
@NP	-LRB- C and D -RRB- BDA-labeled RST	31528
@NP	C and D	31529
@NP	C	31529
@NP	D	31535
@NP	the lesion boundary	31583
@NP	the lesion cavity in a lesion	31623
@NP	the lesion cavity	31623
@NP	a lesion	31644
@NP	animal	31658
@NP	-LRB- E -RRB- High power of	31666
@NP	-LRB- E -RRB- High power	31666
@NP	E	31667
@NP	area in D	31693
@NP	area	31693
@NP	D	31701
@NP	a few terminations of RST axons ending at the proximal boundary of lesion	31712
@NP	a few terminations	31712
@NP	RST axons ending at the proximal boundary of lesion	31734
@NP	RST axons	31734
@NP	the proximal boundary of lesion	31754
@NP	the proximal boundary	31754
@NP	lesion	31779
@NP	-LRB- F -- L -RRB-	31787
@NP	F -- L	31788
@NP	F	31788
@NP	L	31790
@NP	axons sprouting in NSFC-engrafted animals	31797
@NP	axons	31797
@NP	NSFC-engrafted animals	31816
@NP	-LRB- F and G -RRB- Numerous RST axons	31840
@NP	-LRB- F and G -RRB- Numerous RST	31840
@NP	F and G	31841
@NP	F	31841
@NP	G	31847
@NP	the region rostral	31886
@NP	the graft , some axons passed through the rostral graft -- host interface	31908
@NP	the graft	31908
@NP	some axons passed through the rostral graft -- host interface	31919
@NP	some axons	31919
@NP	the rostral graft -- host interface	31945
@NP	the rostral graft	31945
@NP	host interface	31963
@NP	the graft	31997
@NP	-LRB- H -RRB- Some small-caliber RST axons with branches	32008
@NP	-LRB- H -RRB-	32008
@NP	Some small-caliber RST	32012
@NP	axons with branches	32035
@NP	axons	32035
@NP	branches	32046
@NP	the epicenter of the graft	32072
@NP	the epicenter	32072
@NP	the graft	32089
@NP	-LRB- I -RRB-	32100
@NP	A considerable number	32104
@NP	BDA-labeled axons with sprouts	32129
@NP	BDA-labeled axons	32129
@NP	sprouts	32152
@NP	the caudal board of the graft	32167
@NP	the caudal board	32167
@NP	the graft	32187
@NP	the caudal graft -- host interface	32212
@NP	the caudal graft	32212
@NP	host interface	32229
@NP	-LRB- J -RRB- Some rostrocaudally directional RST axons	32245
@NP	-LRB- J -RRB- Some rostrocaudally directional RST	32245
@NP	-LRB- J -RRB-	32245
@NP	Some rostrocaudally directional RST	32249
@NP	axons	32285
@NP	the graft	32308
@NP	-LRB- K -RRB- High power of the corresponding areas in J	32319
@NP	-LRB- K -RRB- High power	32319
@NP	K	32320
@NP	the corresponding areas in J	32337
@NP	the corresponding areas	32337
@NP	J	32364
@NP	a larger-caliber axon	32374
@NP	two branches ending in terminal bouton-likes structures	32401
@NP	two branches	32401
@NP	terminal bouton-likes structures	32424
@NP	-LRB- L -RRB- Some small-caliber and larger-caliber RST axons	32458
@NP	-LRB- L -RRB-	32458
@NP	Some small-caliber and larger-caliber RST axons	32462
@NP	the caudal graft -- host interface -LRB- dashed line -RRB-	32536
@NP	the caudal graft	32536
@NP	host interface -LRB- dashed line -RRB-	32553
@NP	host interface	32553
@NP	line	32576
@NP	Scale	32583
@NP	A , C , ± 1 mm , others	32594
@NP	C , ± 1 mm	32597
@NP	C	32597
@NP	± 1 mm	32600
@NP	100 µm	32615
@NP	Fig. 13 .	32624
@NP	Fig.	32624
@NP	13	32629
@NP	Toluidine blue counterstained photomicrographs of C6	32633
@NP	Toluidine blue counterstained photomicrographs	32633
@NP	C6	32683
@NP	7 spinal cord sections	32686
@NP	BDA-labeled RST axons	32722
@NP	two to three segments caudal to the graft 14 weeks	32756
@NP	two to three segments	32756
@NP	the graft	32788
@NP	14 weeks	32798
@NP	engraftment	32813
@NP	-LRB- A and B -RRB- Cross C6	32826
@NP	-LRB- A and B -RRB-	32826
@NP	A	32827
@NP	B	32833
@NP	Cross C6	32836
@NP	7 section	32845
@NP	a lesion only animal	32860
@NP	a lesion	32860
@NP	only animal	32869
@NP	no BDAlabeled RST axons	32890
@NP	the dorsolateral funiculus -LRB- dlf -RRB-	32917
@NP	the dorsolateral funiculus	32917
@NP	dlf	32945
@NP	the lesion site	32959
@NP	-LRB- C and D -RRB- Cross C6	32976
@NP	-LRB- C and D -RRB-	32976
@NP	C	32977
@NP	D	32983
@NP	Cross C6	32986
@NP	7 section	32995
@NP	an NSFC-engrafted animal	33010
@NP	BDA-labeled regenerating RST axons in the dlf and gray matter	33049
@NP	BDA-labeled regenerating RST axons	33049
@NP	the dlf and gray matter	33087
@NP	the dlf	33087
@NP	gray matter	33099
@NP	-LRB- E -RRB- A few BDA-labeled axons -LRB- arrows -RRB- in the white matter	33112
@NP	-LRB- E -RRB- A few BDA-labeled axons	33112
@NP	-LRB- E -RRB-	33112
@NP	A few BDA-labeled axons	33116
@NP	arrows	33141
@NP	the white matter	33152
@NP	lamina VII of the gray matter	33186
@NP	lamina VII	33186
@NP	the gray matter	33200
@NP	-LRB- F -RRB-	33217
@NP	F	33218
@NP	BDAlabeled axons	33233
@NP	the gray matter of lamina IX	33253
@NP	the gray matter	33253
@NP	lamina IX	33272
@NP	Arrows	33283
@NP	boutonlike structures	33299
@NP	motoneuron soma	33328
@NP	Fig. 14 .	33346
@NP	Fig.	33346
@NP	14	33351
@NP	Photomicrographs of midbrain showing FG retrograde tracing of RN neurons .	33355
@NP	Photomicrographs of midbrain	33355
@NP	Photomicrographs	33355
@NP	midbrain	33375
@NP	FG	33392
@NP	RN neurons	33417
@NP	All sections	33429
@NP	approximately 400 µm	33447
@NP	the caudal pole of the RN	33473
@NP	the caudal pole	33473
@NP	the RN	33492
@NP	the normal control animals -LRB- A -RRB-	33512
@NP	the normal control animals	33512
@NP	A	33540
@NP	FG-labeled regenerated neurons	33544
@NP	the left -LRB- axotomized -RRB-	33617
@NP	the left	33617
@NP	RN region of the NSFCs recipients -LRB- C -RRB-	33639
@NP	RN region	33639
@NP	the NSFCs recipients -LRB- C -RRB-	33652
@NP	the NSFCs recipients	33652
@NP	C	33674
@NP	no FG positive cell bodies	33682
@NP	the left RN of lesion	33729
@NP	the left RN	33729
@NP	lesion	33744
@NP	group -LRB- B -RRB-	33756
@NP	group	33756
@NP	B	33763
@NP	Fig. 15 .	33768
@NP	Fig.	33768
@NP	15	33773
@NP	At 11 weeks	33777
@NP	post-engraftment , functional recovery	33789
@NP	injured limb usage in NSFC-engrafted animals	33830
@NP	injured limb usage	33830
@NP	NSFC-engrafted animals	33852
@NP	A and B -RRB-	33877
@NP	A	33877
@NP	B	33883
@NP	The lesion	33886
@NP	animals	33902
@NP	the left -LRB- uninjured -RRB-	33920
@NP	the left	33920
@NP	the wall of cylinder	33961
@NP	the wall	33961
@NP	cylinder	33973
@NP	The right -LRB- injured -RRB-	33983
@NP	The right	33983
@NP	forepaw	34003
@NP	-LRB- arrows -RRB-	34031
@NP	C and D -RRB- In contrast , engrafted animals	34042
@NP	C and D -RRB-	34042
@NP	C	34042
@NP	D	34048
@NP	contrast , engrafted animals	34054
@NP	contrast	34054
@NP	animals	34074
@NP	both paws	34094
@NP	the cylinder with normal posture -LRB- arrows -RRB-	34115
@NP	the cylinder	34115
@NP	normal posture -LRB- arrows -RRB-	34133
@NP	normal posture	34133
@NP	arrows	34149
@NP	the fingers of right forepaw extended -LRB- C -RRB-	34174
@NP	the fingers	34174
@NP	right forepaw extended	34189
@NP	right forepaw	34189
@NP	C	34213
@NP	-LRB- E -RRB- Behavioral analysis of forelimb use .	34217
@NP	-LRB- E -RRB-	34217
@NP	Behavioral analysis of forelimb use	34221
@NP	Behavioral analysis	34221
@NP	forelimb use	34244
@NP	the normal data of forelimb usage prior to surgery	34270
@NP	the normal data	34270
@NP	forelimb usage prior to surgery	34289
@NP	forelimb usage	34289
@NP	surgery	34313
@NP	the engrafted animals -LRB- n = 12 -RRB-	34322
@NP	the	34322
@NP	animals	34336
@NP	n	34345
@NP	12	34349
@NP	significant recovery of use of the injured forelimb alone or together	34360
@NP	significant recovery	34360
@NP	use of the injured forelimb alone or together	34384
@NP	use	34384
@NP	the injured forelimb alone or together	34391
@NP	the injured forelimb	34391
@NP	the uninjured forelimb	34435
@NP	lesion only animals -LRB- n = 12 -RRB-	34467
@NP	lesion only animals	34467
@NP	lesion	34467
@NP	only animals	34474
@NP	n	34488
@NP	12	34492
@NP	negligible use of the injured limb	34503
@NP	negligible use	34503
@NP	the injured limb	34521
@NP	Fig. 16 .	34546
@NP	Fig.	34546
@NP	16	34551
@NP	11 weeks	34558
@NP	horizontal rope walking	34585
@NP	animals	34633
@NP	lesion	34649
@NP	animals	34661
@NP	A and B	34671
@NP	A	34671
@NP	B	34677
@NP	The photographs	34680
@NP	the inability of lesion only animals to	34708
@NP	the inability	34708
@NP	lesion only animals to	34725
@NP	lesion	34725
@NP	animals	34737
@NP	the rope-walking test	34756
@NP	In A	34779
@NP	the animal	34785
@NP	poor posture and body position	34800
@NP	poor posture	34800
@NP	body position	34817
@NP	Slips	34832
@NP	the lesioned animals -LRB- B -RRB-	34866
@NP	the lesioned animals	34866
@NP	B	34888
@NP	C and D	34893
@NP	C	34893
@NP	D	34899
@NP	The lesion	34902
@NP	animals	34928
@NP	near-normal posture	34944
@NP	limbs	34969
@NP	their bodies and uplifted tails	34981
@NP	their bodies	34981
@NP	uplifted tails	34998
@NP	These animals	35014
@NP	the ropewalk	35050
@NP	-LRB- E -RRB- Similarly	35064
@NP	-LRB- E -RRB-	35064
@NP	the total error/step ratio	35079
@NP	the lesion	35120
@NP	group	35136
@NP	the lesion plus engrafted group -LRB- * P < 0.001 -RRB-	35154
@NP	the lesion	35154
@NP	group -LRB- * P < 0.001 -RRB-	35180
@NP	group	35180
@NP	P <	35188
@NP	P	35188
@NP	<	35190
@NP	0.001	35192
@NP	-LRB- F -RRB- The lesion only group -LRB- n = 12 -RRB-	35200
@NP	-LRB- F -RRB- The lesion only group	35200
@NP	-LRB- F -RRB-	35200
@NP	The lesion	35204
@NP	only group	35215
@NP	n	35227
@NP	12	35231
@NP	a higher deficit score -LRB- * P < 0.001 -RRB-	35245
@NP	a higher deficit score	35245
@NP	P <	35270
@NP	P	35270
@NP	<	35272
@NP	0.001	35274
@NP	those	35286
@NP	the NSFC transplants -LRB- n = 12 -RRB-	35302
@NP	the NSFC transplants	35302
@NP	n	35324
@NP	12	35328
@NP	-LRB- G -RRB- Functional performance of horizontal rope-walking test	35333
@NP	-LRB- G -RRB- Functional performance	35333
@NP	G	35334
@NP	horizontal rope-walking test	35363
@NP	RN neuronal survival	35408
@NP	Scatter graph of calculated total error	35430
@NP	Scatter graph	35430
@NP	calculated total error	35447
@NP	step ratios plotted against accompanying number of FG-labeled neurons	35471
@NP	step ratios	35471
@NP	accompanying number of FG-labeled neurons	35499
@NP	accompanying number	35499
@NP	FG-labeled neurons	35522
@NP	a negative correlation	35554
@NP	those 2 groups of parameters using Pearson 's correlation test	35585
@NP	those 2 groups	35585
@NP	parameters using Pearson 's correlation test	35603
@NP	parameters	35603
@NP	Pearson 's correlation test	35620
@NP	Pearson 's	35620
@NP	Characterization of GFP-labeled NSFCs	35649
@NP	Characterization	35649
@NP	GFP-labeled NSFCs	35669
@NP	The two selected NSFC lines	35696
@NP	GFP	35746
@NP	the LERS-EGFP vector ; approximately 60 % of viable cells 4 days	35756
@NP	the LERS-EGFP vector	35756
@NP	approximately 60 % of viable cells 4 days	35778
@NP	approximately 60 %	35778
@NP	viable cells	35799
@NP	4 days	35812
@NP	transfection	35825
@NP	Fig. 1	35856
@NP	The expression rate of GFP in NSFCs	35865
@NP	The expression rate	35865
@NP	GFP in NSFCs	35888
@NP	GFP	35888
@NP	NSFCs	35895
@NP	only a slight decrease over the initial 10 passages	35935
@NP	only a slight decrease	35935
@NP	the initial 10 passages	35963
@NP	over 40 %	36005
@NP	35 additional passages	36020
@NP	This heterogeneous population	36044
@NP	a variety of lineage specific markers	36097
@NP	a variety	36097
@NP	lineage specific markers	36110
@NP	MEM + 2.5 % FBS	36139
@NP	MEM	36139
@NP	2.5 % FBS	36145
@NP	the majority -LRB- ~ 95 % -RRB- of the GFP-labeled NSFCs	36155
@NP	the majority -LRB- ~ 95 % -RRB-	36155
@NP	the majority	36155
@NP	~ 95 %	36169
@NP	the GFP-labeled NSFCs	36178
@NP	beta-tubulin III -LRB- Fig. 2A -RRB-	36218
@NP	beta-tubulin III	36218
@NP	Fig. 2A	36236
@NP	~ 5 %	36252
@NP	~	36252
@NP	A2B5 , an antibody against a ganglioside-enriched	36274
@NP	A2B5	36274
@NP	an antibody against a ganglioside-enriched	36280
@NP	an antibody	36280
@NP	a ganglioside-enriched	36300
@NP	glial membranes -LRB- Fig. 2B -RRB-	36326
@NP	glial membranes	36326
@NP	Fig. 2B	36343
@NP	No immunoreactivity	36353
@NP	GFAP -LRB- glial fibrillary acidic protein -RRB-	36390
@NP	GFAP	36390
@NP	glial fibrillary acidic protein	36396
@NP	Approximately 20 % of the NSFCs	36430
@NP	Approximately 20 %	36430
@NP	the NSFCs	36451
@NP	Trk pan	36485
@NP	an antibody that reacts promiscuously with Trk A , B , or C -LRB- Fig. 2C -RRB-	36494
@NP	an antibody	36494
@NP	Trk A , B , or C -LRB- Fig. 2C -RRB-	36537
@NP	Trk A	36537
@NP	B	36544
@NP	C	36550
@NP	Fig. 2C	36553
@NP	Additional studies	36563
@NP	most -LRB- 65 % -RRB- of that immunoreactivity	36600
@NP	most -LRB- 65 % -RRB-	36600
@NP	most	36600
@NP	65 %	36606
@NP	that immunoreactivity	36614
@NP	Trk B -LRB- Fig. 2D -RRB- with fewer cells -LRB- 35 % -RRB-	36644
@NP	Trk B -LRB- Fig. 2D -RRB-	36644
@NP	Trk B	36644
@NP	Fig. 2D	36651
@NP	fewer cells -LRB- 35 % -RRB-	36665
@NP	fewer cells	36665
@NP	35 %	36678
@NP	Trk A -LRB- Fig. 2E -RRB-	36696
@NP	Trk A	36696
@NP	Fig. 2E	36703
@NP	none	36716
@NP	Trk C.	36734
@NP	Immunoreactivity for BDNF	36741
@NP	Immunoreactivity	36741
@NP	BDNF	36762
@NP	the cytoplasm	36791
@NP	the surface of approximately 90 % of the NSFCs -LRB- Fig. 2F -RRB-	36812
@NP	the surface	36812
@NP	approximately 90 % of the NSFCs -LRB- Fig. 2F -RRB-	36827
@NP	approximately 90 %	36827
@NP	the NSFCs -LRB- Fig. 2F -RRB-	36848
@NP	the NSFCs	36848
@NP	Fig. 2F	36859
@NP	RT-PCR	36882
@NP	the expression of mRNA for BDNF	36902
@NP	the expression	36902
@NP	mRNA for BDNF	36920
@NP	mRNA	36920
@NP	BDNF	36929
@NP	both GFP-labeled NSFC lines used in the present experiments	36937
@NP	both GFP-labeled NSFC lines	36937
@NP	the present experiments	36973
@NP	Specific bands of RNA encoding BDNF -LRB- 298 bp -RRB-	36998
@NP	Specific bands	36998
@NP	RNA encoding BDNF -LRB- 298 bp -RRB-	37016
@NP	RNA encoding BDNF	37016
@NP	298 bp	37035
@NP	the cDNA samples	37062
@NP	the two GFP-labeled NSFC lines -LRB- Fig. 3A -RRB-	37084
@NP	the two GFP-labeled NSFC lines	37084
@NP	Fig. 3A	37116
@NP	Control reactions	37126
@NP	the amplification products	37162
@NP	the PCR method and reagents used	37209
@NP	the PCR method	37209
@NP	reagents used	37228
@NP	reagents	37228
@NP	specific amplified products	37250
@NP	a cDNA source	37288
@NP	ELISA of cell lysates from each NSFC line	37316
@NP	ELISA	37316
@NP	cell lysates from each NSFC line	37325
@NP	cell lysates	37325
@NP	each NSFC line	37343
@NP	40 pg BDNF/mg protein	37371
@NP	both lines -LRB- Fig. 3B -RRB-	37396
@NP	both lines	37396
@NP	Fig. 3B	37408
@NP	two different lines	37427
@NP	our initial studies	37460
@NP	no differences	37481
@NP	the two different neurosphere-forming lines	37518
@NP	equivalent responses	37569
@NP	the NSFCs to engraftment	37593
@NP	the NSFCs	37593
@NP	engraftment	37606
@NP	the response of the host tissues to the engraftment	37629
@NP	the response	37629
@NP	the host tissues to the engraftment	37645
@NP	the host tissues	37645
@NP	the engraftment	37665
@NP	data from only one line	37695
@NP	data	37695
@NP	only one line	37705
@NP	clarity	37737
@NP	Survival and integration	37746
@NP	GFP-labeled NSFCs after engraftment into injured host	37774
@NP	GFP-labeled NSFCs	37774
@NP	engraftment into injured host	37798
@NP	engraftment	37798
@NP	injured host	37815
@NP	spinal cord	37828
@NP	A cavity 1.5	37840
@NP	A cavity	37840
@NP	1.5	37849
@NP	2.0 mm	37853
@NP	the caudal rostral direction	37868
@NP	the right side of the C3 -- 4 spinal cord 1 week	37907
@NP	the right side of the C3	37907
@NP	the right side	37907
@NP	the C3	37925
@NP	4 spinal cord 1 week	37932
@NP	4 spinal cord	37932
@NP	1 week	37946
@NP	the lesion -LRB- Fig. 4A -RRB-	37959
@NP	the lesion	37959
@NP	Fig. 4A	37971
@NP	The lesion	37981
@NP	the right side of the cervical spinal cord	38007
@NP	the right side	38007
@NP	the cervical spinal cord	38025
@NP	the ipsilateral dorsolateral and lateral funiculi	38073
@NP	the ipsilateral dorsolateral	38073
@NP	lateral funiculi	38106
@NP	the ipsilateral dorsal and ventral funiculi plus gray matter	38143
@NP	the ipsilateral dorsal and ventral funiculi	38143
@NP	gray matter	38192
@NP	the dorsal columns	38214
@NP	Figs. 5D and E	38241
@NP	Figs. 5D	38241
@NP	E	38254
@NP	One week	38258
@NP	engraftment	38273
@NP	transplanted GFP-labeled NSFCs	38286
@NP	the lesion cavity	38334
@NP	the surrounding host tissue	38368
@NP	the interface of the injury site -LRB- Fig. 4A -RRB-	38399
@NP	the interface	38399
@NP	the injury site -LRB- Fig. 4A -RRB-	38416
@NP	the injury site	38416
@NP	Fig. 4A	38433
@NP	A few GFP-labeled cells	38443
@NP	the adjacent host spinal cord -LRB- Fig. 4B -RRB-	38481
@NP	the adjacent host spinal cord	38481
@NP	Fig. 4B	38512
@NP	A relatively mild astrocytic response	38522
@NP	the graft -- host interface -LRB- Fig. 4C -RRB-	38578
@NP	the graft	38578
@NP	host interface	38588
@NP	Fig. 4C	38604
@NP	Two weeks	38614
@NP	engraftment	38630
@NP	GFP-positive cells	38643
@NP	the lesion cavity -LRB- Figs. 5C -- E and K -RRB-	38674
@NP	the lesion cavity	38674
@NP	Figs. 5C -- E and K	38693
@NP	Figs. 5C	38693
@NP	E and K	38702
@NP	These cells	38712
@NP	host blood vessels that were present throughout the transplant site	38742
@NP	host blood vessels	38742
@NP	the transplant site	38790
@NP	addition	38814
@NP	many cells	38824
@NP	the host	38852
@NP	spinal cord	38861
@NP	a longitudinal direction -LRB- Figs. 4D and E -RRB-	38886
@NP	a longitudinal direction	38886
@NP	Figs. 4D and E	38912
@NP	Figs. 4D	38912
@NP	E	38925
@NP	The majority of these cells	38929
@NP	The majority	38929
@NP	these cells	38945
@NP	the white matter of spinal cord	38973
@NP	the white matter	38973
@NP	spinal cord	38993
@NP	the dorsolateral	39019
@NP	lateral funiculi -LRB- Figs. 5B and J , G and L -RRB-	39040
@NP	lateral funiculi	39040
@NP	Figs. 5B and J , G and L	39058
@NP	Figs. 5B	39058
@NP	J , G and L	39071
@NP	some in the dorsal columns -LRB- Figs. 5A and I , H and N -RRB-	39084
@NP	some	39084
@NP	the dorsal columns	39092
@NP	Figs. 5A and I	39112
@NP	Figs. 5A	39112
@NP	I	39125
@NP	H and N	39128
@NP	H	39128
@NP	N	39134
@NP	a few in the ventral columns and ventrolateral funiculus	39142
@NP	the ventral columns	39151
@NP	Figs. 5G and M	39200
@NP	Figs. 5G	39200
@NP	M	39213
@NP	contrast	39220
@NP	only a few of the engrafted cells	39230
@NP	only a few	39230
@NP	the engrafted cells	39244
@NP	the	39244
@NP	cells	39258
@NP	the gray matter adjacent to the injury site -LRB- Figs. 5B , C , and F -RRB-	39280
@NP	the gray matter adjacent to the injury site	39280
@NP	the gray matter	39280
@NP	the injury site	39308
@NP	Figs. 5B , C , and F	39325
@NP	Figs. 5B	39325
@NP	C	39335
@NP	F	39342
@NP	The quantitative analyses	39346
@NP	the number of engrafted cells in the rostral white matter	39390
@NP	the number	39390
@NP	cells in the rostral white matter	39414
@NP	cells	39414
@NP	the rostral white matter	39423
@NP	almost 2 times that in the caudal regions of all animals evaluated	39452
@NP	almost 2 times	39452
@NP	the caudal regions of all animals	39475
@NP	the caudal regions	39475
@NP	all animals	39497
@NP	Fig. 6	39520
@NP	The cells	39529
@NP	the rostral white matter up to 2 mm	39553
@NP	the rostral white matter	39553
@NP	2 mm	39584
@NP	the lesion	39594
@NP	they	39622
@NP	a maximum of 1.5 mm -LRB- Fig. 6 -RRB-	39643
@NP	a maximum of 1.5 mm	39643
@NP	Fig. 6	39664
@NP	The majority of GFP-labeled cells	39673
@NP	The majority	39673
@NP	GFP-labeled cells	39689
@NP	the Trk B receptor -LRB- Fig. 4F -RRB-	39725
@NP	the Trk B receptor	39725
@NP	Fig. 4F	39745
@NP	h-tubulin III	39757
@NP	some	39776
@NP	characteristic neuronal shapes	39795
@NP	long processes that extended into the surrounding tissue -LRB- Fig. 4G -RRB-	39831
@NP	long processes	39831
@NP	the surrounding tissue -LRB- Fig. 4G -RRB-	39865
@NP	the surrounding tissue	39865
@NP	Fig. 4G	39889
@NP	Twelve weeks	39899
@NP	transplantation	39918
@NP	toluidine blue histological staining	39935
@NP	toluidine	39935
@NP	blue histological staining	39945
@NP	profound differences	39981
@NP	the cytoarchitecture of the lesion site between the lesion	40005
@NP	the cytoarchitecture	40005
@NP	the lesion site between the lesion	40029
@NP	the lesion site	40029
@NP	the lesion	40053
@NP	NSFC animals and the lesion only animals	40079
@NP	NSFC animals	40079
@NP	the lesion	40096
@NP	animals	40112
@NP	the lesion only animals	40124
@NP	the lesion	40124
@NP	only animals	40135
@NP	the cavity	40149
@NP	many cells but no axons -LRB- Figs. 7A and B -RRB-	40176
@NP	many cells	40176
@NP	no axons -LRB- Figs. 7A and B -RRB-	40191
@NP	no axons	40191
@NP	Figs. 7A and B	40201
@NP	Figs. 7A	40201
@NP	B	40214
@NP	the lesion site of the engrafted animals	40234
@NP	the lesion site	40234
@NP	the engrafted animals	40253
@NP	the	40253
@NP	animals	40267
@NP	NSFCs	40276
@NP	processes	40295
@NP	the site	40316
@NP	Figs. 7C -- H	40326
@NP	Figs. 7C	40326
@NP	H	40335
@NP	a large population of axons	40352
@NP	a large population	40352
@NP	axons	40374
@NP	the proximal end of the lesion site -LRB- Fig. 7C -RRB-	40400
@NP	the proximal end	40400
@NP	the lesion site -LRB- Fig. 7C -RRB-	40420
@NP	the lesion site	40420
@NP	Fig. 7C	40437
@NP	Immunocytochemistry	40447
@NP	many GFP-labeled NSFCs	40485
@NP	the lesion cavity -LRB- Figs. 7E and F -RRB-	40524
@NP	the lesion cavity	40524
@NP	Figs. 7E and F	40543
@NP	Figs. 7E	40543
@NP	F	40556
@NP	These cells	40560
@NP	GAP-43	40590
@NP	growth-associated-protein 43	40598
@NP	MAP2	40631
@NP	microtubule-associated-protein	40637
@NP	neuronal phenotypes -LRB- Figs. 7C -- H -RRB-	40678
@NP	neuronal phenotypes	40678
@NP	Figs. 7C -- H	40699
@NP	Figs. 7C	40699
@NP	H	40708
@NP	long processes that extended into the surrounding tissue	40723
@NP	long processes	40723
@NP	the surrounding tissue	40757
@NP	addition to the engrafted NSFCs , numerous GAP-43 or MAP2	40784
@NP	addition	40784
@NP	the engrafted NSFCs , numerous GAP-43 or MAP2	40796
@NP	the	40796
@NP	NSFCs , numerous GAP-43 or MAP2	40810
@NP	NSFCs	40810
@NP	numerous GAP-43	40817
@NP	MAP2	40836
@NP	positive axons from the host 's spinal cord	40841
@NP	positive axons	40841
@NP	the host 's spinal cord	40861
@NP	the host 's	40861
@NP	the center of the cavity of the NSFC-engrafted animals -LRB- Figs. 7E -- H -RRB-	40901
@NP	the center	40901
@NP	the cavity of the NSFC-engrafted animals -LRB- Figs. 7E -- H -RRB-	40915
@NP	the cavity	40915
@NP	the NSFC-engrafted animals -LRB- Figs. 7E -- H -RRB-	40929
@NP	the NSFC-engrafted animals	40929
@NP	Figs. 7E -- H	40957
@NP	Figs. 7E	40957
@NP	H	40966
@NP	No obvious GAP-43 or MAP2 positive axons	40970
@NP	No obvious GAP-43	40970
@NP	MAP2 positive axons	40991
@NP	the cavity of lesion	41032
@NP	the cavity	41032
@NP	lesion	41046
@NP	animals	41058
@NP	Effects of axotomy and NSFC engraftment	41067
@NP	Effects	41067
@NP	axotomy and NSFC engraftment	41078
@NP	RN neurons	41110
@NP	normal rats	41124
@NP	toluidine-blue-stained sections	41137
@NP	the number	41192
@NP	soma size of RN neurons	41212
@NP	soma size	41212
@NP	RN neurons	41225
@NP	Cell	41237
@NP	size and numbers	41242
@NP	the right	41262
@NP	RN	41281
@NP	Table 3	41298
@NP	no differences	41321
@NP	number	41353
@NP	soma size of neurons	41368
@NP	soma size	41368
@NP	neurons	41381
@NP	the right RN	41392
@NP	normal , lesion only , or lesion plus NSFCengrafted rats at 2 or 12 weeks	41419
@NP	normal	41419
@NP	lesion only	41427
@NP	lesion plus NSFCengrafted rats at 2 or 12 weeks	41443
@NP	lesion	41443
@NP	NSFCengrafted rats at 2 or 12 weeks	41455
@NP	NSFCengrafted rats	41455
@NP	at 2 or 12 weeks	41474
@NP	transplantation	41497
@NP	P N 0.05	41514
@NP	P N	41514
@NP	0.05	41518
@NP	Table 3 ; Fig. 8	41524
@NP	Table 3	41524
@NP	Fig. 8	41533
@NP	the normal animals	41554
@NP	the apparent number and mean soma size of neurons in the left RN	41574
@NP	the apparent number	41574
@NP	mean soma size of neurons in the left RN	41598
@NP	soma size of neurons	41603
@NP	soma size	41603
@NP	neurons	41616
@NP	the left RN	41627
@NP	the lesion	41657
@NP	the cellengrafted group at 2 or 12 weeks post transplantation	41681
@NP	group	41699
@NP	2	41708
@NP	12 weeks	41713
@NP	the lesion only animals	41747
@NP	the lesion	41747
@NP	only animals	41758
@NP	there	41772
@NP	a 27 % reduction in the apparent numbers of neurons in the RN	41782
@NP	a 27 % reduction	41782
@NP	the apparent numbers of neurons in the RN	41801
@NP	the apparent numbers	41801
@NP	neurons in the RN	41825
@NP	neurons	41825
@NP	the RN	41836
@NP	a 13 % reduction	41856
@NP	the lesion plus NSFC-engrafted animals 2 weeks following engraftment	41875
@NP	the lesion	41875
@NP	NSFC-engrafted animals 2 weeks following engraftment	41891
@NP	NSFC-engrafted animals	41891
@NP	2 weeks	41914
@NP	engraftment	41932
@NP	P < 0.05	41945
@NP	P	41945
@NP	< 0.05	41947
@NP	<	41947
@NP	0.05	41949
@NP	the mean neuronal size	41969
@NP	24 % in the lesion	42005
@NP	24 %	42005
@NP	the lesion	42012
@NP	only animals	42023
@NP	a 7 % decrease	42048
@NP	the lesion plus engrafted group	42065
@NP	the lesion	42065
@NP	group	42091
@NP	P < 0.05 ; Table 3 ; Figs. 8A and B	42098
@NP	P	42098
@NP	< 0.05 ; Table 3 ; Figs. 8A and B	42100
@NP	< 0.05	42100
@NP	<	42100
@NP	0.05	42102
@NP	Table 3	42108
@NP	Table	42108
@NP	3	42114
@NP	Figs. 8A and B	42117
@NP	Figs. 8A	42117
@NP	B	42130
@NP	12 weeks after engraftment	42137
@NP	12 weeks	42137
@NP	engraftment	42152
@NP	the neuronal atrophy of the left RN	42165
@NP	the neuronal atrophy	42165
@NP	the left RN	42189
@NP	the lesion	42228
@NP	group	42244
@NP	the lesion plus NSFC-engrafted group -LRB- Table 3 ; Figs. 8C and D -RRB-	42278
@NP	the lesion	42278
@NP	NSFC-engrafted group -LRB- Table 3 ; Figs. 8C and D -RRB-	42294
@NP	NSFC-engrafted group	42294
@NP	Table 3 ; Figs. 8C and D	42316
@NP	Table 3	42316
@NP	Figs. 8C and D	42325
@NP	The decreases in apparent neuronal number and size	42342
@NP	The decreases	42342
@NP	apparent neuronal number and size	42359
@NP	38 % and 42 %	42398
@NP	the lesion only animals	42428
@NP	the lesion	42428
@NP	only animals	42439
@NP	the lesion plus cell-engrafted animals	42462
@NP	the lesion	42462
@NP	cell-engrafted animals	42478
@NP	both parameters	42502
@NP	reductions of 24 % and 20 %	42545
@NP	reductions	42545
@NP	24 % and 20 %	42559
@NP	24 %	42559
@NP	20 %	42567
@NP	P < 0.05 ; Table 3	42586
@NP	P	42586
@NP	< 0.05 ; Table 3	42588
@NP	< 0.05	42588
@NP	<	42588
@NP	0.05	42590
@NP	Table 3	42596
@NP	The number	42606
@NP	neurons projecting to the spinal cord after axotomy in the lesion only	42620
@NP	neurons	42620
@NP	the spinal cord	42642
@NP	axotomy in the lesion	42664
@NP	axotomy	42664
@NP	the lesion	42675
@NP	lesion plus cell-engrafted animals	42695
@NP	lesion	42695
@NP	cell-engrafted animals	42707
@NP	sections with the FG labeling	42747
@NP	sections	42747
@NP	the FG labeling	42761
@NP	all groups	42781
@NP	the mean size of FG-labeled neurons	42793
@NP	the mean size	42793
@NP	FG-labeled neurons	42810
@NP	approximately 11 %	42833
@NP	the mean cell size determined from adjacent sections stained for toluidine blue	42863
@NP	the mean cell size	42863
@NP	adjacent sections stained for toluidine blue	42898
@NP	adjacent sections	42898
@NP	toluidine blue	42928
@NP	immunoflorescence	42951
@NP	visible light -LRB- Table 3 ; Figs. 9 and 10 ; Mori et al. , 1997 -RRB-	42997
@NP	visible light	42997
@NP	Table 3 ; Figs. 9 and 10 ; Mori et al. , 1997	43012
@NP	Table 3	43012
@NP	Figs. 9 and 10 ; Mori et al. , 1997	43021
@NP	Figs. 9 and 10	43021
@NP	Mori et al. , 1997	43037
@NP	Mori	43037
@NP	et al. , 1997	43042
@NP	et al.	43042
@NP	1997	43050
@NP	The FG labeling	43057
@NP	the same pattern	43086
@NP	the data obtained from the toluidine-blue-stained sections	43106
@NP	the data	43106
@NP	the toluidine-blue-stained sections	43129
@NP	Two weeks	43166
@NP	engraftment	43182
@NP	the apparent number and size of FG-labeled RN neurons	43195
@NP	the apparent number and size	43195
@NP	FG-labeled RN neurons	43227
@NP	the lesion	43264
@NP	the lesion only animals -LRB- P < 0.001 ; Figs. 9 , 10A and B -RRB-	43302
@NP	the lesion only animals	43302
@NP	the lesion	43302
@NP	P < 0.001 ; Figs. 9 , 10A and B	43327
@NP	P	43327
@NP	< 0.001 ; Figs. 9 , 10A and B	43329
@NP	< 0.001	43329
@NP	<	43329
@NP	0.001	43331
@NP	Figs. 9 , 10A and B	43338
@NP	Figs. 9	43338
@NP	10A	43347
@NP	B	43355
@NP	12 weeks	43378
@NP	the apparent number and size of FG-labeled axotomized RN neurons	43388
@NP	the apparent number and size	43388
@NP	FG-labeled axotomized RN neurons	43420
@NP	FG-labeled	43420
@NP	RN neurons	43442
@NP	the lesion	43484
@NP	group	43500
@NP	the lesion plus engraftment group -LRB- P b 0.001 ; Figs. 9 and 10C and D -RRB-	43538
@NP	the lesion	43538
@NP	engraftment group -LRB- P b 0.001 ; Figs. 9 and 10C and D -RRB-	43554
@NP	engraftment group	43554
@NP	P b	43573
@NP	0.001 ; Figs. 9 and 10C and D	43577
@NP	0.001	43577
@NP	Figs. 9 and 10C and D	43584
@NP	Figs. 9	43584
@NP	10C and D	43596
@NP	Potential	43608
@NP	NSFCs	43631
@NP	axotomized RST axonal regeneration	43648
@NP	the NSFC engraftment	43699
@NP	axonal regeneration	43729
@NP	the surviving axotomized RN neurons	43752
@NP	the distribution of RST axons in the spinal cord	43789
@NP	the distribution	43789
@NP	RST axons in the spinal cord	43809
@NP	RST axons	43809
@NP	the spinal cord	43822
@NP	injection of the anterograde tracer BDA	43844
@NP	injection	43844
@NP	the anterograde tracer BDA	43857
@NP	the magnocellular portion of the RN	43889
@NP	the magnocellular portion	43889
@NP	the RN	43918
@NP	the upper cervical segments -LRB- C1 --	43943
@NP	the upper cervical segments	43943
@NP	C1	43972
@NP	rostral	43979
@NP	the lesion site	43990
@NP	the distribution of the BDA-positive RST axons in lesion only and engrafted	44007
@NP	the distribution	44007
@NP	the BDA-positive RST axons	44027
@NP	lesion only	44057
@NP	animals	44083
@NP	normal animals in the superficial dorsolateral white matter contralateral	44106
@NP	normal animals	44106
@NP	the superficial dorsolateral white matter contralateral	44124
@NP	the BDA injection site -LRB- Fig. 11 -RRB-	44183
@NP	the BDA injection site	44183
@NP	Fig. 11	44207
@NP	A few ipsilaterally descending RST axons	44217
@NP	A few	44217
@NP	RST axons	44248
@NP	the same location	44284
@NP	The BDA-positive RST axons in the lesion	44303
@NP	The BDA-positive RST axons	44303
@NP	the lesion	44333
@NP	animals	44349
@NP	sparser	44366
@NP	the	44382
@NP	animals	44396
@NP	the result of the decreased efficiency of atrophied neurons to take up	44423
@NP	the result	44423
@NP	the decreased efficiency of atrophied neurons to take up	44437
@NP	the decreased efficiency	44437
@NP	atrophied neurons	44465
@NP	transport tracer in the lesion only animals -LRB- Fig. 11 -RRB-	44498
@NP	transport tracer	44498
@NP	the lesion only animals -LRB- Fig. 11 -RRB-	44518
@NP	the lesion only animals	44518
@NP	the lesion	44518
@NP	Fig. 11	44543
@NP	sagittal sections of lesion site	44556
@NP	sagittal sections	44556
@NP	lesion site	44577
@NP	all BDA-labeled axons	44590
@NP	the rostral host -- graft interface in lesion	44623
@NP	the rostral host	44623
@NP	graft interface in lesion	44640
@NP	graft interface	44640
@NP	lesion	44659
@NP	animals	44671
@NP	Figs. 12C -- E	44680
@NP	Figs. 12C	44680
@NP	E	44690
@NP	contrast	44697
@NP	animals	44720
@NP	axons	44729
@NP	the rostral host -- graft interface , elongated caudally , and in most cases	44743
@NP	the rostral host	44743
@NP	graft interface , elongated caudally , and in most cases	44760
@NP	graft interface	44760
@NP	most cases	44804
@NP	the caudal host -- graft interface -LRB- Figs. 12F -- I -RRB-	44829
@NP	the caudal host	44829
@NP	graft interface	44846
@NP	Figs. 12F -- I	44863
@NP	Figs. 12F	44863
@NP	I	44873
@NP	the normal linear rostrocaudal alignment	44889
@NP	the RS tract axons located in the dorsolateral funiculus	44933
@NP	the RS tract axons	44933
@NP	the dorsolateral funiculus	44963
@NP	Figs. 12A and B	44991
@NP	Figs. 12A	44991
@NP	B	45005
@NP	most of the regenerated axons	45009
@NP	most	45009
@NP	the regenerated axons	45017
@NP	a rostral	45095
@NP	caudal direction -LRB- Figs. 12G -- I -RRB-	45105
@NP	caudal direction	45105
@NP	Figs. 12G -- I	45123
@NP	Figs. 12G	45123
@NP	I	45133
@NP	addition	45140
@NP	the majority of regenerated axons	45150
@NP	the majority	45150
@NP	regenerated axons	45166
@NP	smallcaliber axons	45189
@NP	branches or terminal bouton-like structures -LRB- Figs. 12G -- J and L -RRB-	45213
@NP	branches or terminal bouton-like structures	45213
@NP	branches	45213
@NP	Figs. 12G -- J and L	45258
@NP	Figs. 12G	45258
@NP	J and L	45268
@NP	These structures	45278
@NP	normal RS tract axons	45319
@NP	the middle level -LRB- C3 -- C4 -RRB- of the cervical spinal cord	45344
@NP	the middle level -LRB- C3 -- C4 -RRB-	45344
@NP	the middle level	45344
@NP	C3 -- C4	45362
@NP	C3	45362
@NP	C4	45366
@NP	the cervical spinal cord	45373
@NP	Serial cross sections of segments	45399
@NP	Serial cross sections	45399
@NP	segments	45424
@NP	the lesion site were examined for BDA-labeled axons	45443
@NP	the lesion site	45443
@NP	BDA-labeled axons	45477
@NP	all lesion only animals	45499
@NP	all lesion	45499
@NP	only animals	45510
@NP	no BDA-labeled RST axons	45524
@NP	the dorsolateral funiculus of the host spinal cord caudal	45566
@NP	the dorsolateral funiculus	45566
@NP	the host spinal cord caudal	45596
@NP	the lesion -LRB- Figs. 13A and B -RRB-	45627
@NP	the lesion	45627
@NP	Figs. 13A and B	45639
@NP	Figs. 13A	45639
@NP	B	45653
@NP	78 % of the engrafted animals	45660
@NP	78 %	45660
@NP	the engrafted animals	45667
@NP	the	45667
@NP	animals	45681
@NP	regenerated axons	45690
@NP	caudal	45719
@NP	the lesion site	45729
@NP	some cases	45749
@NP	BDA-labeled RST axons	45761
@NP	the upper thoracic spinal cord -LRB- T1 --	45796
@NP	the upper thoracic spinal cord	45796
@NP	T1	45828
@NP	four	45835
@NP	six segments caudal to the transplant , although their distribution was sparser	45843
@NP	six segments	45843
@NP	the transplant , although their distribution was sparser	45866
@NP	the transplant	45866
@NP	their distribution	45891
@NP	the upper cervical segments	45934
@NP	The BDA-labeled RST axons in C6	45963
@NP	The BDA-labeled RST axons	45963
@NP	C6	45992
@NP	8 spinal cord segments were not as well organized as those in the C1	45995
@NP	8 spinal cord segments	45995
@NP	those in the C1	46048
@NP	those	46048
@NP	the C1	46057
@NP	2 segments -LRB- Figs. 11C and D , 13C and D -RRB-	46064
@NP	2 segments	46064
@NP	Figs. 11C and D , 13C and D	46076
@NP	Figs. 11C	46076
@NP	D , 13C and D	46090
@NP	Most	46105
@NP	the dorsolateral funiculus	46126
@NP	a few	46157
@NP	the adjoining dorsal horn -LRB- Figs. 13C and D -RRB-	46189
@NP	the adjoining dorsal horn	46189
@NP	Figs. 13C and D	46216
@NP	Figs. 13C	46216
@NP	D	46230
@NP	Many collaterals	46234
@NP	Rexed 's laminae V	46279
@NP	Rexed 's	46279
@NP	VII -LRB- Fig. 13E -RRB-	46297
@NP	VII	46297
@NP	Fig. 13E	46302
@NP	bouton-like structures near neurons in these laminae	46317
@NP	bouton-like structures	46317
@NP	neurons in these laminae	46345
@NP	neurons	46345
@NP	these laminae	46356
@NP	A few BDA-labeled fibers	46371
@NP	lamina IX in very close apposition	46413
@NP	lamina IX	46413
@NP	very close apposition	46426
@NP	motoneurons -LRB- Fig. 13F -RRB-	46451
@NP	motoneurons	46451
@NP	Fig. 13F	46464
@NP	These results	46475
@NP	axotomized RN neurons	46502
@NP	RST axons	46536
@NP	segments of spinal cord caudal	46551
@NP	segments	46551
@NP	spinal cord caudal	46563
@NP	the lesion site	46585
@NP	their target gray matter	46627
@NP	the origin	46674
@NP	the BDA-labeled axons found in the spinal cord caudal to the lesion site	46688
@NP	the BDA-labeled axons	46688
@NP	the spinal cord caudal	46719
@NP	the lesion site	46745
@NP	NSFCs grafted animals	46762
@NP	NSFCs	46762
@NP	animals	46776
@NP	T1 -- 2 for retrograde tracing of FG in the ipsiltaeral spinal cord	46801
@NP	T1	46801
@NP	2 for retrograde tracing of FG in the ipsiltaeral spinal cord	46804
@NP	2	46804
@NP	retrograde tracing of FG in the ipsiltaeral spinal cord	46810
@NP	retrograde	46810
@NP	FG in the ipsiltaeral spinal cord	46832
@NP	FG	46832
@NP	the ipsiltaeral spinal cord	46838
@NP	This injection site	46867
@NP	FG	46911
@NP	the lesion site	46931
@NP	the contralateral lesioned RN	46955
@NP	FG-labeled RST neurons	46986
@NP	all six NSFC-engrafted rats -LRB- Fig. 14C -RRB-	47026
@NP	all six NSFC-engrafted rats	47026
@NP	Fig. 14C	47055
@NP	any lesion only animals -LRB- Fig. 14B -RRB-	47077
@NP	any lesion only animals	47077
@NP	any lesion	47077
@NP	Fig. 14B	47102
@NP	the normal control -LRB- Fig. 14A -RRB-	47125
@NP	the normal control	47125
@NP	Fig. 14A	47145
@NP	the number of regenerated RST neurons in the RN of cell engrafted rats	47156
@NP	the number	47156
@NP	regenerated RST neurons in the RN of cell engrafted rats	47170
@NP	regenerated RST neurons	47170
@NP	the RN of cell engrafted rats	47197
@NP	the RN	47197
@NP	cell engrafted rats	47207
@NP	cell	47207
@NP	rats	47222
@NP	their cell body size	47242
@NP	normal RN neurons	47289
@NP	some axtomoized RST neurons	47324
@NP	some	47324
@NP	RST neurons	47340
@NP	at least 4 -- 5 segments caudal to the lesion site	47368
@NP	at least 4	47368
@NP	5 segments caudal to the lesion site	47379
@NP	5 segments	47379
@NP	the lesion	47400
@NP	The detailed morphology	47417
@NP	quantitative data for FG coexistence with GAP-43 in RST neurons	47445
@NP	quantitative data	47445
@NP	FG coexistence with GAP-43 in RST neurons	47467
@NP	FG coexistence	47467
@NP	GAP-43 in RST neurons	47487
@NP	GAP-43	47487
@NP	RST neurons	47497
@NP	evaluation	47529
@NP	Potential	47541
@NP	NSFCs	47564
@NP	functional recovery	47581
@NP	surgery , the animals used for experimental group IIB	47610
@NP	surgery	47610
@NP	the animals used for experimental group IIB	47619
@NP	the animals	47619
@NP	experimental group IIB	47640
@NP	the spontaneous vertical exploration and rope-walking tests	47687
@NP	functional recovery	47781
@NP	transplantation	47807
@NP	stable baseline data	47824
@NP	Only those animals	47863
@NP	almost equal usage	47891
@NP	the left and right forepaws -LRB- approximate 10 % respectively , Fig. 15E -RRB-	47913
@NP	the left and right forepaws	47913
@NP	approximate 10 % respectively , Fig. 15E	47942
@NP	approximate 10 % respectively	47942
@NP	approximate	47942
@NP	Fig. 15E	47972
@NP	the wall of the cylinder	47993
@NP	the wall	47993
@NP	the cylinder	48005
@NP	the rope-walking tasks	48031
@NP	a 0 deficit score	48059
@NP	surgery	48095
@NP	Eleven weeks	48104
@NP	surgery	48123
@NP	spontaneous vertical exploration by the lesion	48132
@NP	spontaneous vertical exploration	48132
@NP	the lesion	48168
@NP	only animals	48179
@NP	abnormal posture and rare use of the right forelimb	48212
@NP	abnormal posture and rare use	48212
@NP	the right forelimb	48245
@NP	a glass cylinder -LRB- Figs. 15A and B -RRB-	48280
@NP	a glass cylinder	48280
@NP	Figs. 15A and B	48298
@NP	Figs. 15A	48298
@NP	B	48312
@NP	the other hand	48319
@NP	the lesioned animals that received NSFC transplants freely	48335
@NP	the lesioned animals	48335
@NP	NSFC transplants	48370
@NP	both paws	48399
@NP	the cylinder	48420
@NP	nearly normal posture -LRB- Figs. 15C and D -RRB-	48445
@NP	nearly normal posture	48445
@NP	Figs. 15C and D	48468
@NP	Figs. 15C	48468
@NP	D	48482
@NP	pre-surgery scores	48498
@NP	bilateral forelimb use	48520
@NP	the cylinder wall	48554
@NP	approximately 80 %	48573
@NP	the lesion only animals	48593
@NP	the lesion	48593
@NP	only animals	48604
@NP	both forelimbs	48622
@NP	10 %	48643
@NP	the time	48650
@NP	only the unaffected forelimb -LRB- left ; approximately 90 % ; Fig. 15E -RRB-	48676
@NP	only the unaffected forelimb	48676
@NP	left ; approximately 90 % ; Fig. 15E	48706
@NP	left	48706
@NP	approximately 90 % ; Fig. 15E	48712
@NP	approximately 90 %	48712
@NP	Fig. 15E	48731
@NP	Fig.	48731
@NP	15E	48736
@NP	contrast	48745
@NP	the cell-engrafted group	48755
@NP	both forelimbs 75 % of the time	48785
@NP	both forelimbs	48785
@NP	the time	48807
@NP	the normal data	48827
@NP	surgery	48852
@NP	addition	48864
@NP	the ipsilateral -LRB- right -RRB- forelimb	48874
@NP	the ipsilateral -LRB- right -RRB-	48874
@NP	the ipsilateral	48874
@NP	8 %	48921
@NP	the time in NSFC-engrafted group	48927
@NP	the time	48927
@NP	NSFC-engrafted group	48939
@NP	functional recovery	48975
@NP	the injured limb	48998
@NP	the lesion	49042
@NP	animals -LRB- Fig. 15E -RRB-	49058
@NP	animals	49058
@NP	Fig. 15E	49067
@NP	the cell-engrafted animals	49089
@NP	better performance	49131
@NP	the rope-walking test 11 weeks post-engraftment	49157
@NP	the rope-walking test	49157
@NP	11 weeks	49179
@NP	the lesion	49210
@NP	group	49226
@NP	all operated animals	49236
@NP	all	49236
@NP	animals	49249
@NP	deficits in general locomotion	49258
@NP	deficits	49258
@NP	general locomotion	49270
@NP	a significant difference in deficit scores	49313
@NP	a significant difference	49313
@NP	deficit scores	49341
@NP	the lesion plus NSFC-engrafted	49374
@NP	the lesion	49374
@NP	NSFC-engrafted	49390
@NP	lesion only groups -LRB- P < 0.001 ; Fig. 16F -RRB-	49409
@NP	lesion	49409
@NP	only groups -LRB- P < 0.001 ; Fig. 16F -RRB-	49416
@NP	only groups	49416
@NP	P < 0.001 ; Fig. 16F	49429
@NP	P	49429
@NP	< 0.001 ; Fig. 16F	49431
@NP	< 0.001	49431
@NP	<	49431
@NP	0.001	49433
@NP	Fig. 16F	49440
@NP	Fig.	49440
@NP	16F	49445
@NP	Most engrafted animals	49451
@NP	Most	49451
@NP	animals	49466
@NP	consistent locomotor activity , better body posture	49478
@NP	consistent locomotor activity	49478
@NP	better body posture	49509
@NP	the task	49556
@NP	They	49566
@NP	the rope	49592
@NP	lesion	49622
@NP	animals	49634
@NP	Figs. 16A -- D	49643
@NP	Figs. 16A	49643
@NP	D	49653
@NP	The calculated total error	49657
@NP	step ratio	49685
@NP	the behavioral data obtained by the deficit-scoring method	49716
@NP	the behavioral data	49716
@NP	the deficit-scoring method	49748
@NP	A significant difference	49776
@NP	the two experimental groups -LRB- P < 0.001 ; Fig. 16E -RRB-	49824
@NP	the two experimental groups	49824
@NP	P < 0.001 ; Fig. 16E	49853
@NP	P	49853
@NP	< 0.001 ; Fig. 16E	49855
@NP	< 0.001	49855
@NP	<	49855
@NP	0.001	49857
@NP	Fig. 16E	49864
@NP	Fig.	49864
@NP	16E	49869
@NP	the surviving axotomized RN	49905
@NP	neurons	49933
@NP	the observed functional recovery	49956
@NP	the possible correlation	49990
@NP	the number of FG-labeled RN neurons and the total error/step	50023
@NP	the number	50023
@NP	FG-labeled RN neurons and the total error/step	50037
@NP	FG-labeled RN neurons	50037
@NP	the total error/step	50063
@NP	Pearson 's correlation test	50103
@NP	Pearson 's	50103
@NP	A negative correlation	50131
@NP	the morphological and physiological data	50170
@NP	= n	50214
@NP	2 = 14 , r = -0.731 , P < 0.002	50220
@NP	2 = 14	50220
@NP	2	50220
@NP	14	50224
@NP	r = -0.731	50228
@NP	r	50228
@NP	-0.731	50232
@NP	P < 0.002	50240
@NP	P <	50240
@NP	P	50240
@NP	0.002	50244
@NP	Fig. 16G	50252
@NP	Rats that performed well during horizontal rope walking	50263
@NP	Rats	50263
@NP	horizontal rope walking	50295
@NP	many surviving FG-labeled neurons in axotomized RN	50338
@NP	many surviving FG-labeled neurons	50338
@NP	axotomized RN	50375
@NP	animals that slipped or fell from the rope more frequently	50398
@NP	animals	50398
@NP	the rope	50432
@NP	a fewer neurons in axotomized RN	50474
@NP	a fewer neurons	50474
@NP	axotomized RN	50493
@NP	Discussion This study	50509
@NP	Discussion	50509
@NP	This study	50520
@NP	human adult olfactory neuroepithelial-derived progenitors -LRB- NSFCs -RRB-	50549
@NP	human adult olfactory neuroepithelial-derived progenitors	50549
@NP	NSFCs	50608
@NP	the injured adult rat cervical spinal cord remain viable	50630
@NP	the injured adult rat	50630
@NP	cervical spinal cord	50652
@NP	They	50688
@NP	the injured host spinal cord	50709
@NP	RN neurons	50761
@NP	retrograde atrophy	50777
@NP	RST axonal regeneration	50816
@NP	functional recovery either directly or by modification of the microenvironment	50854
@NP	functional recovery	50854
@NP	directly or by modification of the microenvironment	50881
@NP	directly or by modification	50881
@NP	the microenvironment	50912
@NP	the lesion site	50956
@NP	Integration	50973
@NP	human ONe-derived NSFCs in injured rat spinal cord The	50998
@NP	human ONe-derived NSFCs	50998
@NP	injured rat	51025
@NP	spinal cord	51037
@NP	NSFCs	51063
@NP	the injured rat spinal cord	51081
@NP	at least 12 weeks	51113
@NP	They	51132
@NP	the lesion cavity ; some integrated into the adjacent host spinal cord	51153
@NP	the lesion cavity	51153
@NP	some integrated into the adjacent host spinal cord	51172
@NP	some	51172
@NP	the adjacent host spinal cord	51193
@NP	a relatively continuous interface	51235
@NP	the host tissues that was not interrupted by cysts or scars	51274
@NP	the host tissues	51274
@NP	cysts or scars	51319
@NP	Several features of NSFCs and their interaction with the spinal cord likely	51335
@NP	Several features	51335
@NP	NSFCs and their interaction with the spinal cord likely	51355
@NP	NSFCs	51355
@NP	their interaction with the spinal cord likely	51365
@NP	their interaction	51365
@NP	the spinal cord likely	51388
@NP	the spinal cord	51388
@NP	their survival	51426
@NP	In vitro pilot studies	51442
@NP	the NSFC lines	51480
@NP	BDNF , irrespective of passage number	51518
@NP	BDNF	51518
@NP	passage number	51540
@NP	donor age	51556
@NP	sex	51570
@NP	ELISA and RT-PCR studies	51593
@NP	Marshall	51619
@NP	et al. , 2004	51628
@NP	et al.	51628
@NP	2004	51636
@NP	the present study	51646
@NP	RTPCR , cell lysate ELISA , and immunocytochemistry	51665
@NP	RTPCR	51665
@NP	cell lysate ELISA	51672
@NP	immunocytochemistry	51695
@NP	the two GFP-transfected NSFC lines used in this study	51733
@NP	the two GFP-transfected NSFC lines	51733
@NP	this study	51776
@NP	BDNF	51809
@NP	Preliminary studies	51815
@NP	the concentration of BDNF	51861
@NP	the concentration	51861
@NP	BDNF	51882
@NP	NSFC-conditioned media	51890
@NP	detection levels	51918
@NP	Cultures	51945
@NP	higher NSFC densities	51964
@NP	increased levels of BDNF in the conditioned medium	52002
@NP	increased levels	52002
@NP	BDNF in the conditioned medium	52022
@NP	BDNF	52022
@NP	the conditioned medium	52030
@NP	The presence	52054
@NP	Trk B receptors	52070
@NP	some NSFCs coupled with the presence of BDNF in their cell lysates	52089
@NP	some NSFCs	52089
@NP	the presence of BDNF	52113
@NP	the presence	52113
@NP	BDNF	52129
@NP	their cell lysates	52137
@NP	a possible paracrine/autocrine mechanism -LRB- Novikova et al. , 1996 -RRB-	52165
@NP	a possible paracrine/autocrine mechanism	52165
@NP	Novikova	52207
@NP	et al. , 1996	52216
@NP	et al.	52216
@NP	1996	52224
@NP	In vitro studies	52231
@NP	patient age , sex , or duration in culture	52268
@NP	patient age	52268
@NP	sex	52281
@NP	duration in culture	52289
@NP	duration	52289
@NP	culture	52301
@NP	the viability or polyamine synthetic activity	52324
@NP	the NSFCs -LRB- Marshall et al. , 2003 ; Roisen et al. , 2001 -RRB-	52373
@NP	the NSFCs	52373
@NP	Marshall	52384
@NP	et al. , 2003 ; Roisen et al. , 2001	52393
@NP	et al.	52393
@NP	2003 ; Roisen et al.	52401
@NP	2003	52401
@NP	Roisen et al.	52407
@NP	Roisen	52407
@NP	et al.	52414
@NP	2001	52422
@NP	The GFPtransfected NSFC lines	52429
@NP	their high proliferative activity and GFP expression	52470
@NP	many passages	52555
@NP	engraftment	52586
@NP	the NSFCS	52599
@NP	the absence of serum over a period of weeks	52625
@NP	the absence	52625
@NP	serum over a period of weeks	52640
@NP	serum	52640
@NP	a period of weeks	52651
@NP	a period	52651
@NP	weeks	52663
@NP	passages	52672
@NP	a series of dilutions from 10 % to 0 % serum -LRB- Zhang et al. , 2004 -RRB-	52689
@NP	a series	52689
@NP	dilutions from 10 % to 0 % serum -LRB- Zhang et al. , 2004 -RRB-	52701
@NP	dilutions	52701
@NP	10 % to 0 % serum -LRB- Zhang et al. , 2004 -RRB-	52716
@NP	10 % to 0 % serum	52716
@NP	Zhang	52733
@NP	et al. , 2004	52739
@NP	et al.	52739
@NP	2004	52747
@NP	this manner	52757
@NP	the engrafted NSFCs	52770
@NP	the	52770
@NP	NSFCs	52784
@NP	BDNF	52804
@NP	their survival	52820
@NP	the local environment	52846
@NP	they	52871
@NP	the injured adult rat spinal cord	52892
@NP	Fibroblasts genetically engineered to release BDNF	52927
@NP	Fibroblasts	52927
@NP	BDNF	52973
@NP	similar conditions	53000
@NP	RST neuronal atrophy	53031
@NP	axotomy -LRB- Liu et al. , 1999 -RRB-	53058
@NP	axotomy	53058
@NP	Liu	53067
@NP	et al. , 1999	53071
@NP	et al.	53071
@NP	1999	53079
@NP	the present studies	53097
@NP	the engrafted NSFCs	53130
@NP	the	53130
@NP	NSFCs	53144
@NP	trophic factors	53190
@NP	BDNF	53216
@NP	the axotomized RST neurons from retrograde atrophy and possible cell loss	53234
@NP	the	53234
@NP	RST neurons	53249
@NP	retrograde atrophy and possible cell loss	53266
@NP	retrograde atrophy	53266
@NP	possible cell loss	53289
@NP	Another important feature	53309
@NP	the apparent histocompatibility	53339
@NP	the engrafted NSFCs and the host spinal cord	53379
@NP	the	53379
@NP	NSFCs and the host spinal cord	53393
@NP	NSFCs	53393
@NP	the host spinal cord	53403
@NP	Only a mild astrocytic response	53425
@NP	the graft	53476
@NP	the lesion cavity	53489
@NP	The removal	53508
@NP	presumed scar issue in the lesion cavity just prior to the engraftment	53523
@NP	presumed scar issue	53523
@NP	the lesion cavity	53546
@NP	the engraftment	53578
@NP	a role	53610
@NP	the lack of scar formation	53620
@NP	the lack	53620
@NP	scar formation	53632
@NP	The mild host immune reaction	53648
@NP	immunosuppression	53696
@NP	cyclosporine	53717
@NP	The antibiotic and possible anti-inflammatory action of Penicillin	53731
@NP	The antibiotic and possible anti-inflammatory action	53731
@NP	Penicillin	53787
@NP	the NSFCs survival	53827
@NP	a preliminary study	53850
@NP	transplanted NSFCs in the normal rat spinal cord	53871
@NP	transplanted NSFCs	53871
@NP	the normal rat spinal cord	53893
@NP	the adjacent host tissues -LRB- Roisen et al. , 2002 ; Xiao et al. , 2003 -RRB-	53978
@NP	the adjacent host tissues	53978
@NP	Roisen	54005
@NP	et al. , 2002 ; Xiao et al. , 2003	54012
@NP	et al.	54012
@NP	2002 ; Xiao et al.	54020
@NP	2002	54020
@NP	Xiao et al.	54026
@NP	Xiao	54026
@NP	et al.	54031
@NP	2003	54039
@NP	the present study	54049
@NP	many of the engrafted NSFCs	54068
@NP	many	54068
@NP	the engrafted NSFCs	54076
@NP	the	54076
@NP	NSFCs	54090
@NP	some distance in the rostral , predominantly , and caudal cord	54110
@NP	some distance	54110
@NP	the rostral , predominantly , and caudal cord	54127
@NP	the rostral	54127
@NP	caudal cord	54159
@NP	The majority of the NSFCs	54172
@NP	The majority	54172
@NP	the NSFCs	54188
@NP	the white matter among the descending supraspinal or ascending sensory fibers	54214
@NP	the white matter	54214
@NP	the descending supraspinal or ascending sensory fibers	54237
@NP	the descending	54237
@NP	sensory fibers	54277
@NP	some	54293
@NP	the gray matter adjacent to the lesion site	54314
@NP	the gray matter	54314
@NP	the lesion site	54342
@NP	addition	54362
@NP	most NSFCs	54372
@NP	neuron-like morphologies	54387
@NP	h-tubulin III immunopositive processes or Trk B receptors on their surface	54417
@NP	h-tubulin III immunopositive processes	54417
@NP	h-tubulin	54417
@NP	III immunopositive processes	54427
@NP	Trk B receptors on their surface	54459
@NP	Trk B receptors	54459
@NP	their surface	54478
@NP	They	54493
@NP	spinal cord repair	54517
@NP	accessory cells -LRB- Wirth et al. , 2001 -RRB- ,	54564
@NP	accessory cells	54564
@NP	Wirth	54581
@NP	et al. , 2001	54587
@NP	et al.	54587
@NP	2001	54595
@NP	trophic factors such as BDNF	54612
@NP	trophic factors	54612
@NP	BDNF	54636
@NP	Liu	54642
@NP	et al. , 1999	54646
@NP	et al.	54646
@NP	1999	54654
@NP	growth-permissive extracellular matrix molecules	54683
@NP	regenerating axons	54758
@NP	the lesion site -LRB- Geller and Fawcett , 2002 -RRB-	54785
@NP	the lesion site	54785
@NP	Geller and Fawcett	54802
@NP	2002	54822
@NP	The numerous GAP-43 and MAP2 positive host axons	54829
@NP	the lesion cavity of engrafted animals compared to the lesion	54887
@NP	the lesion cavity	54887
@NP	animals	54918
@NP	the lesion	54938
@NP	animals	54954
@NP	these possibilities	54983
@NP	summary	55007
@NP	it	55016
@NP	the environment provided by the injured cord	55034
@NP	the environment	55034
@NP	the injured cord	55062
@NP	the survival , migration , and differentiation	55091
@NP	the	55139
@NP	NSFCs	55153
@NP	other models -LRB- McDonald et al. , 1999 -RRB-	55175
@NP	other models	55175
@NP	McDonald	55189
@NP	et al. , 1999	55198
@NP	et al.	55198
@NP	1999	55206
@NP	Effects	55213
@NP	ONe-derived NSFCs	55234
@NP	the axotomized RN neurons Injury to the RST at C3 -- 4 in this study	55255
@NP	the axotomized RN neurons Injury to the RST at C3	55255
@NP	the	55255
@NP	RN neurons	55270
@NP	Injury to the RST at C3	55281
@NP	Injury	55281
@NP	the RST at C3	55291
@NP	the RST	55291
@NP	C3	55302
@NP	4 in this study	55305
@NP	4	55305
@NP	this study	55310
@NP	an apparent reduction	55333
@NP	neuronal numbers -LRB- 27 % -RRB- and somal atrophy -LRB- 24 % -RRB-	55358
@NP	neuronal numbers	55358
@NP	27 %	55376
@NP	somal atrophy	55385
@NP	24 %	55400
@NP	2 weeks	55405
@NP	surgery	55419
@NP	more significant changes -LRB- 38 % and 42 % , respectively -RRB-	55433
@NP	more significant changes	55433
@NP	38 % and 42 % , respectively	55459
@NP	38 % and 42 %	55459
@NP	38 %	55459
@NP	42 %	55467
@NP	12 weeks post operation	55486
@NP	12 weeks	55486
@NP	These results	55511
@NP	previous reports of spinal cord injury on RST neurons	55540
@NP	previous reports	55540
@NP	spinal cord injury on RST neurons	55560
@NP	spinal cord injury	55560
@NP	RST neurons	55582
@NP	Feringa et al. , 1988 ; Houle and Ye , 1999 ; Prendergast and Stelzner , 1976	55595
@NP	Feringa	55595
@NP	et al. , 1988 ; Houle and Ye , 1999 ; Prendergast and Stelzner , 1976	55603
@NP	et al. , 1988	55603
@NP	et al.	55603
@NP	1988	55611
@NP	Houle and Ye , 1999	55617
@NP	Houle	55617
@NP	Ye , 1999	55627
@NP	Ye	55627
@NP	1999	55631
@NP	Prendergast and Stelzner , 1976	55637
@NP	Prendergast and Stelzner	55637
@NP	1976	55663
@NP	The application	55670
@NP	fetal cell transplants	55689
@NP	Bregman and Reier , 1986 ; Mori et al. , 1997	55713
@NP	Bregman and Reier	55713
@NP	1986 ; Mori et al.	55732
@NP	1986	55732
@NP	Mori et al.	55738
@NP	Mori	55738
@NP	et al.	55743
@NP	1997	55751
@NP	neurotrophic factors	55761
@NP	Houle and Ye , 1999 ; Jin et al. , 2002 ; Kobayashi et al. , 1997	55783
@NP	Houle and Ye	55783
@NP	Houle	55783
@NP	Ye	55793
@NP	1999 ; Jin et al.	55797
@NP	1999	55797
@NP	Jin et al.	55803
@NP	Jin	55803
@NP	et al.	55807
@NP	2002 ; Kobayashi et al. , 1997	55815
@NP	2002	55815
@NP	Kobayashi et al. , 1997	55821
@NP	Kobayashi	55821
@NP	et al. , 1997	55831
@NP	et al.	55831
@NP	1997	55839
@NP	BDNF secreting cells	55855
@NP	Liu	55877
@NP	et al. , 1999 , 2002	55881
@NP	et al.	55881
@NP	1999	55889
@NP	2002	55895
@NP	some axotomized RN cell atrophy	55928
@NP	some	55928
@NP	RN cell atrophy	55944
@NP	this experiment	55964
@NP	the engrafted NSFCs	55981
@NP	the	55981
@NP	NSFCs	55995
@NP	some perikaryal atrophy of axotomized RN as well as apparent cell loss	56011
@NP	some perikaryal atrophy	56011
@NP	RN as well as apparent cell loss	56049
@NP	RN	56049
@NP	apparent cell loss	56063
@NP	Two important elements	56083
@NP	rescue of RN neurons	56130
@NP	rescue	56130
@NP	RN neurons	56140
@NP	axotomy-induced retrograde atrophy	56156
@NP	One	56192
@NP	the engrafted NSFCs	56204
@NP	the	56204
@NP	NSFCs	56218
@NP	a surrogate source of BDNF	56243
@NP	a surrogate source	56243
@NP	BDNF	56265
@NP	the RST axons in proximity of the lesion/graft site	56274
@NP	the RST axons	56274
@NP	proximity of the lesion/graft site	56291
@NP	proximity	56291
@NP	the lesion/graft site	56304
@NP	The other	56327
@NP	the relatively high level of graft survival and graft -- host interface	56345
@NP	the relatively high level	56345
@NP	graft survival and graft -- host interface	56374
@NP	graft survival and graft	56374
@NP	host interface	56399
@NP	a relatively permissive environment	56423
@NP	axonal regeneration and possible synapse formation with target neurons	56475
@NP	axonal regeneration and possible synapse formation	56475
@NP	target neurons	56531
@NP	Many GAP-43 positive processes	56547
@NP	this presumption as well as the presence of BDA-labeled RST axons	56586
@NP	this presumption	56586
@NP	the presence of BDA-labeled RST axons	56614
@NP	the presence	56614
@NP	BDA-labeled RST axons	56630
@NP	the NSFCs within the lesion cavity of engrafted animals	56658
@NP	the NSFCs	56658
@NP	the lesion cavity of engrafted animals	56675
@NP	the lesion cavity	56675
@NP	animals	56706
@NP	Effects	56715
@NP	ONe-derived NSFCs on functional recovery and RST axonal regeneration The results	56736
@NP	ONe-derived NSFCs on functional recovery	56736
@NP	ONe-derived NSFCs	56736
@NP	functional recovery	56757
@NP	RST axonal regeneration The results	56781
@NP	RST axonal regeneration	56781
@NP	The results	56805
@NP	NSFC engraftment	56842
@NP	functional recovery	56860
@NP	Eleven weeks	56890
@NP	engraftment	56909
@NP	the NSFC-engrafted animals	56922
@NP	better locomotor activity	56959
@NP	horizontal rope walking	56992
@NP	lesion only animals , and significant improvements in forelimb usage ipsilateral	57021
@NP	lesion only animals	57021
@NP	lesion	57021
@NP	only animals	57028
@NP	significant improvements in forelimb usage ipsilateral	57046
@NP	significant improvements	57046
@NP	forelimb usage ipsilateral	57074
@NP	the lesion	57104
@NP	the wall of a cylinder	57130
@NP	the wall	57130
@NP	a cylinder	57142
@NP	the enhanced functions	57167
@NP	the anatomical recovery	57211
@NP	RN neurons	57249
@NP	animals	57273
@NP	higher FG labeling	57291
@NP	less atrophy	57314
@NP	RN neurons , RST axonal regeneration and innervation	57330
@NP	RN neurons	57330
@NP	RST axonal regeneration	57342
@NP	innervation	57370
@NP	target gray matter	57385
@NP	This	57405
@NP	the enhanced function	57424
@NP	repair of the RN and RST pathway	57486
@NP	repair	57486
@NP	the RN and RST pathway	57496
@NP	Further support for this	57520
@NP	Further support	57520
@NP	this	57540
@NP	studies	57556
@NP	anterograde BDA-labeled RST axons	57567
@NP	axotomized RST axons	57619
@NP	grafted animals	57643
@NP	they	57701
@NP	the graft	57721
@NP	some instances	57739
@NP	their target motoneurons	57760
@NP	It	57786
@NP	these contacts	57804
@NP	the forelimb functional recovery	57834
@NP	These results	57868
@NP	previous studies -LRB- Kuchler et al. , 2002 ; Teng et al. , 2002 -RRB-	57903
@NP	previous studies	57903
@NP	Kuchler	57921
@NP	et al. , 2002 ; Teng et al. , 2002	57929
@NP	et al.	57929
@NP	2002 ; Teng et al.	57937
@NP	2002	57937
@NP	Teng et al.	57943
@NP	Teng	57943
@NP	et al.	57948
@NP	2002	57956
@NP	The presence of MAP2 positive dendrites within the region of the lesion cavity	58563
@NP	The presence	58563
@NP	MAP2 positive dendrites within the region of the lesion cavity	58579
@NP	MAP2 positive dendrites	58579
@NP	the region of the lesion cavity	58610
@NP	the region	58610
@NP	the lesion cavity	58624
@NP	an indicator of other systems ' axonal response	58649
@NP	an indicator	58649
@NP	other systems ' axonal response	58665
@NP	other systems '	58665
@NP	the presence of the NSFCs	58699
@NP	the presence	58699
@NP	the NSFCs	58715
@NP	This hypothesis	58726
@NP	further	58746
@NP	the existence of FG-labeled regenerated neurons	58767
@NP	the existence	58767
@NP	FG-labeled regenerated neurons	58784
@NP	some vestibular and reticular nuclei	58818
@NP	animals -LRB- experimental group IIIB , data not shown -RRB-	58868
@NP	animals	58868
@NP	experimental group IIIB , data not shown	58877
@NP	experimental group IIIB	58877
@NP	data not shown	58902
@NP	data	58902
@NP	Further analysis by anterograde or retrograde tracing	58919
@NP	Further analysis	58919
@NP	anterograde or retrograde	58939
@NP	transplanted NSFCS	59006
@NP	regeneration	59033
@NP	motor	59060
@NP	sensory axons	59080
@NP	spinal cord injury	59100
@NP	This possibility , individually or collectively ,	59120
@NP	This possibility	59120
@NP	the effects on the RST pathway	59173
@NP	the effects	59173
@NP	the RST pathway	59188
@NP	the enhanced functional recovery	59220
@NP	Potential mechanisms	59254
@NP	RST axonal regeneration in NSFC-engrafted cord	59278
@NP	RST axonal regeneration	59278
@NP	NSFC-engrafted cord	59305
@NP	quantitative evaluation of anterograde-labeled axonal regeneration warrants	59329
@NP	quantitative evaluation	59329
@NP	anterograde-labeled axonal regeneration warrants	59356
@NP	further study	59405
@NP	conclusion	59423
@NP	these studies	59435
@NP	neural progenitors	59466
@NP	adult human olfactory epithelium following engraftment into host spinal cord	59499
@NP	adult human olfactory epithelium	59499
@NP	engraftment into host spinal cord	59542
@NP	engraftment	59542
@NP	host spinal cord	59559
@NP	axotomized RN neurons	59589
@NP	RST axonal regeneration	59620
@NP	enhanced function	59657
@NP	Work with olfactory bulbderived ensheathing cells	59676
@NP	Work	59676
@NP	olfactory bulbderived ensheathing cells	59686
@NP	similar effects	59736
@NP	spinal cord repair and axonal regeneration and repair	59755
@NP	spinal cord repair	59755
@NP	axonal regeneration and repair	59778
@NP	Franklin and Barnett , 2000 ; Li et al. , 1998 ; Lu et al. , 2002	59810
@NP	Franklin and Barnett	59810
@NP	2000 ; Li et al. , 1998 ; Lu et al.	59832
@NP	2000	59832
@NP	Li et al. , 1998 ; Lu et al.	59838
@NP	Li	59838
@NP	et al. , 1998 ; Lu et al.	59841
@NP	et al. , 1998	59841
@NP	et al.	59841
@NP	1998	59849
@NP	Lu et al.	59855
@NP	Lu	59855
@NP	et al.	59858
@NP	2002	59866
@NP	the highly invasive surgery that is required to obtain these cells	59882
@NP	the highly invasive surgery	59882
@NP	these cells	59937
@NP	their practical use	59957
@NP	contrast	59981
@NP	NSFCs harvested from ONe	59991
@NP	NSFCs	59991
@NP	ONe	60012
@NP	an adult neural progenitor source	60024
@NP	minimal invasive surgery	60085
@NP	a unique therapeutic potential	60123
@NP	use	60158
@NP	autologous grafting/transplantation strategies	60165
@NP	spinal cord injuries and other neurodegenerative disorders	60231
@NP	spinal cord injuries	60231
@NP	other neurodegenerative disorders	60256
@VP	axotomized rodent rubrospinal neurons	49
@VP	promote functional recovery Ming Xiaoa , b , Kathleen M.	91
@VP	undergoing nasal sinus surgery	425
@VP	demonstrated that the neurosphere-forming cells -LRB- NSFCs -RRB- produced BDNF	474
@VP	produced BDNF	530
@VP	have been shown to respond to exogenous BNDF	583
@VP	been shown to respond to exogenous BNDF	588
@VP	shown to respond to exogenous BNDF	593
@VP	to respond to exogenous BNDF	599
@VP	respond to exogenous BNDF	602
@VP	remained viable following engraftment into traumatized spinal cord	667
@VP	would rescue axotomized RS neurons from retrograde cell atrophy	740
@VP	rescue axotomized RS neurons from retrograde cell atrophy	746
@VP	axotomized RS neurons from retrograde cell atrophy	753
@VP	promote functional recovery	808
@VP	suspended in MatrigelR matrix or MatrigelR matrix	902
@VP	was injected into the lesion site	958
@VP	injected into the lesion site	962
@VP	survived up to 12 weeks in the lesion cavity	1011
@VP	migrated within the ipsilateral white matter ; the apparent number	1059
@VP	mean somal area of fluorogold -LRB- FG -RRB-	1129
@VP	labeled axotomized RST neurons	1164
@VP	were greater in the NSFC-engrafted rats than in lesion controls	1195
@VP	tracing with FG	1303
@VP	biotinylated dextran amine	1438
@VP	terminated in gray matter close to motoneurons	1604
@VP	did not elicit regeneration	1665
@VP	elicit regeneration	1673
@VP	controls 11 weeks post transplantation	1872
@VP	scaring	2190
@VP	has attracted attention	2907
@VP	attracted attention	2911
@VP	remain mitotically active	3790
@VP	makes it possible to harvest cells without lasting damage to the donor	3921
@VP	lasting damage to the donor	3964
@VP	produce brain-derived neurotrophic factor -LRB- BDNF -RRB-	4070
@VP	demonstrated by ELISA and RT-PCR studies -LRB- Marshall et al. , 2004 -RRB-	4197
@VP	To evaluate the therapeutic potential of NSFCs	4263
@VP	evaluate the therapeutic potential of NSFCs	4266
@VP	respond to exogenous BDNF -LRB- Kwon et al. , 2002 -RRB-	4384
@VP	were chosen as an ideal in vivo model	4431
@VP	chosen as an ideal in vivo model	4436
@VP	prevented atrophy in RN neurons	4708
@VP	enhanced regenerative axonal growth by rubrospinal axons in the RST	4743
@VP	aimed to determine if engrafted human adult NSFCs	4830
@VP	to determine if engrafted human adult NSFCs	4836
@VP	determine if engrafted human adult NSFCs	4839
@VP	engrafted human adult NSFCs	4852
@VP	survive	4886
@VP	axotomized adult rat RN neurons from retrograde atrophy	4930
@VP	establishing ONe-derived NSFC lines from postmortem	5475
@VP	undergoing nasal sinus surgery	5552
@VP	evaluated NSFC lines	5692
@VP	selected randomly	5878
@VP	using the LERS-EGFP vector -LRB- Kinsella and Nolan , 1996 -RRB-	5949
@VP	incubated at 378C in an atmosphere of humidified 5 % CO2 in air	6227
@VP	cultured for up to 40 passages with a feeding schedule of every other day	6329
@VP	passaged on alternate feedings	6407
@VP	were frozen in liquid nitrogen for future use	6463
@VP	frozen in liquid nitrogen for future use	6468
@VP	rapidly thawed	6605
@VP	cultured in MEM + 10 % FBS	6624
@VP	maintained in MEM + 2.5 % FBS	6705
@VP	detached	6792
@VP	pelleted by low-speed centrifugation -LRB- 900 rpm for 5 min -RRB-	6802
@VP	were maintained at 48C	6981
@VP	maintained at 48C	6986
@VP	using RNA Stat-60 reagent -LRB- Tel-Test , Inc -RRB-	7261
@VP	was used to detect BDNF RNA	7360
@VP	used to detect BDNF RNA	7364
@VP	to detect BDNF RNA	7369
@VP	detect BDNF RNA	7372
@VP	consisted of an initial step of -LRB- 958C , 2 m -RRB-	7821
@VP	was completed by using 2 % agarose gel , stained with 0.05 % ethidium bromide	7965
@VP	completed by using 2 % agarose gel , stained with 0.05 % ethidium bromide	7969
@VP	using 2 % agarose gel , stained with 0.05 % ethidium bromide	7982
@VP	stained with 0.05 % ethidium bromide	8004
@VP	were scanned with Alpha Innotech TMM-20 Transilluminator	8058
@VP	scanned with Alpha Innotech TMM-20 Transilluminator	8063
@VP	To determine BDNF protein levels in these two GFPlabeled NSFCs	8116
@VP	determine BDNF protein levels in these two GFPlabeled NSFCs	8119
@VP	GFPlabeled NSFCs	8162
@VP	was performed	8281
@VP	performed	8285
@VP	was performed to dissociate the protein	8413
@VP	performed to dissociate the protein	8417
@VP	to dissociate the protein	8427
@VP	dissociate the protein	8430
@VP	using a Bio-Rad protein assay -LRB- Bio-Rad laboratories , Hercules , CA -RRB-	8491
@VP	containing the same amounts of protein	8567
@VP	using the procedures for the BDNF ELISA following the manufacturer 's protocol	8620
@VP	were conjugated to horseradish peroxidase	8719
@VP	conjugated to horseradish peroxidase	8724
@VP	developed with tetramethylbenzidine	8773
@VP	measured at 450 nm on a standard microplate reader	8813
@VP	was quantified against a standard curve calibrated with known amounts of protein	8878
@VP	quantified against a standard curve calibrated with known amounts of protein	8882
@VP	was less than 2.9 pg/ml for BDNF	8980
@VP	was monitored during the experiment as a general measure of health	9241
@VP	monitored during the experiment as a general measure of health	9245
@VP	retrograde tracing to and from the RN	9478
@VP	suspended in MatrigelR matrix or MatrigelR matrix alone 1 week after the lesion	9703
@VP	was made	9783
@VP	made	9787
@VP	prelabeled by FG injection after the cervical spinal cord partial hemisection	10165
@VP	to promote axotomized RST axonal regeneration -LRB- Table 1 -RRB-	10653
@VP	promote axotomized RST axonal regeneration -LRB- Table 1 -RRB-	10656
@VP	biotinylated dextran amine -LRB- BDA -RRB- 12 weeks post transplantation	10789
@VP	were allowed to continue to survive an additional 2 weeks	10865
@VP	allowed to continue to survive an additional 2 weeks	10870
@VP	to continue to survive an additional 2 weeks	10878
@VP	continue to survive an additional 2 weeks	10881
@VP	to survive an additional 2 weeks	10890
@VP	survive an additional 2 weeks	10893
@VP	given an injection of FG into the right side of the spinal cord at T1 -- 2 level	10958
@VP	were sacrificed after 3 days	11040
@VP	sacrificed after 3 days	11045
@VP	engrafted	11404
@VP	administered from the day of spinal cord injury to 1 week after transplantation	11603
@VP	did not impact negatively on the animals ' health	12052
@VP	involving the RST	12200
@VP	was preformed as previously described	12219
@VP	described	12247
@VP	was exposed by dorsal laminectomy of the C3 and C4 vertebrae	12457
@VP	exposed by dorsal laminectomy of the C3 and C4 vertebrae	12461
@VP	severed the axons of the RST in the ipsilateral dorsolateral funiculus	12695
@VP	partially lesioned the ipsilateral ventral funiculus and gray matter	12767
@VP	left the dorsal columns intact	12840
@VP	was filled with a small piece of Gelfoam	12909
@VP	filled with a small piece of Gelfoam	12913
@VP	soaked with 1 Al 2 %	12950
@VP	removed from the subcutaneous tissue of the neck	13059
@VP	were closed in layers while the skin was closed with wound clips	13121
@VP	closed in layers while the skin was closed with wound clips	13126
@VP	was closed with wound clips	13158
@VP	closed with wound clips	13162
@VP	to compensate for blood loss	13279
@VP	compensate for blood loss	13282
@VP	maintained on heating pads , closely observed until awake ,	13309
@VP	closely observed until awake	13337
@VP	then returned to their home cages	13371
@VP	were anesthetized	13432
@VP	was exposed	13467
@VP	exposed	13471
@VP	was debreded with micro-scissors	13491
@VP	debreded with micro-scissors	13495
@VP	was removed by aspiration	13544
@VP	removed by aspiration	13548
@VP	was placed into the cavity to stop bleeding , and then removed after 5 -- 10 min	13591
@VP	was placed into the cavity to stop bleeding	13591
@VP	placed into the cavity to stop bleeding	13595
@VP	to stop bleeding	13618
@VP	stop bleeding	13621
@VP	then removed after 5 -- 10 min	13640
@VP	attached to a glass pipette	13861
@VP	was left undisturbed for 1 -- 2 min to allow the MatrigelR to partially solidify	13923
@VP	left undisturbed for 1 -- 2 min to allow the MatrigelR to partially solidify	13927
@VP	to allow the MatrigelR to partially solidify	13956
@VP	allow the MatrigelR to partially solidify	13959
@VP	to partially solidify	13979
@VP	partially solidify	13982
@VP	was slowly injected into the lesion site	14019
@VP	injected into the lesion site	14030
@VP	was closed following the procedures outlined above	14071
@VP	closed following the procedures outlined above	14075
@VP	outlined above	14107
@VP	tracing	14139
@VP	were anesthetized as described above and positioned in a stereotaxic apparatus	14229
@VP	described above	14250
@VP	positioned in a stereotaxic apparatus	14270
@VP	coordinates described previously -LRB- Mori et al. , 1997 -RRB-	14402
@VP	described previously -LRB- Mori et al. , 1997 -RRB-	14414
@VP	was slowly injected over 2	14570
@VP	injected over 2	14581
@VP	using a 10 µl Hamilton syringe	14625
@VP	left in place for an additional 20 min and gradually withdrawn over 2 -- 3 min	14672
@VP	left in place for an additional 20 min	14672
@VP	gradually withdrawn over 2 -- 3 min	14715
@VP	tracing	14764
@VP	were anesthetized	14808
@VP	was exposed at T1	14867
@VP	exposed at T1	14871
@VP	were sacrificed 3 days later	14971
@VP	sacrificed 3 days later	14976
@VP	Examining forelimb use during spontaneous vertical exploration	15020
@VP	were trained before surgery and baseline behavior measurements were obtained	15559
@VP	trained before surgery and baseline behavior measurements were obtained	15564
@VP	were obtained	15622
@VP	obtained	15627
@VP	contacting the wall of the cylinder during vertical posturing along the wall	16212
@VP	expressed in terms of percentage forelimb use of the left , right	16308
@VP	walking at 11 weeks after engraftment	16471
@VP	using a deficit rating scale : -LRB- 0 -RRB- normal rope locomotion	16714
@VP	cross the rope	16930
@VP	cross the rope	17001
@VP	slips -LRB- loss of balance but remains on the rope -RRB- and falls	17026
@VP	slips	17026
@VP	remains on the rope	17053
@VP	falls	17078
@VP	fell off the rope	17099
@VP	was restarted only three times	17121
@VP	restarted only three times	17125
@VP	slips and falls	17189
@VP	slips	17189
@VP	falls	17199
@VP	was calculated and defined as the following	17298
@VP	calculated and defined as the following	17302
@VP	slips	17354
@VP	falls	17375
@VP	was observed three times	17415
@VP	observed three times	17419
@VP	were the mean of the 6 scores obtained by the two independent observers	17458
@VP	obtained by the two independent observers	17488
@VP	followed by 4 % paraformaldehyde in 0.1 M PB , pH 7.4 -LRB- 48C , 500 ml -RRB-	17733
@VP	dissected out	17872
@VP	immersed in the same fixative	17890
@VP	followed by cytoprotection at 48C in PB containing 30 % sucrose for 1 -- 2 days	17937
@VP	containing 30 % sucrose for 1 --	17977
@VP	were embedded in OCT compound -LRB- Fisher Scientific , Pittsburgh , PA -RRB-	18043
@VP	embedded in OCT compound -LRB- Fisher Scientific , Pittsburgh , PA -RRB-	18048
@VP	cut on a cryostat	18114
@VP	was serially cut in either transverse or horizontal sections at 20 µm	18149
@VP	cut in either transverse or horizontal sections at 20 µm	18162
@VP	mounted onto gelatincoated slides	18223
@VP	To ensure that the entire RN was collected	18258
@VP	ensure that the entire RN was collected	18261
@VP	was collected	18287
@VP	collected	18291
@VP	were serially sectioned transversely at 20 µm from caudal to rostral extent	18316
@VP	sectioned transversely at 20 µm from caudal to rostral extent	18330
@VP	was mounted onto gelatin-coated slides in sequence	18428
@VP	mounted onto gelatin-coated slides in sequence	18432
@VP	were used for analysis of the number and size of FG-labeled RN neurons	18657
@VP	used for analysis of the number and size of FG-labeled RN neurons	18662
@VP	have been established in our laboratory -LRB- Othman et al. , 2003 -RRB-	18821
@VP	been established in our laboratory -LRB- Othman et al. , 2003 -RRB-	18826
@VP	established in our laboratory -LRB- Othman et al. , 2003 -RRB-	18831
@VP	to localize the nuclei -LRB- 378C , 30 min -RRB- prior to staining	19034
@VP	localize the nuclei -LRB- 378C , 30 min -RRB- prior to staining	19037
@VP	washing	19107
@VP	listed in Table 2	19221
@VP	washing	19246
@VP	were applied	19454
@VP	applied	19459
@VP	insured the specificity of the reaction	19512
@VP	were modified from protocols by Kelly et al. -LRB- 2003 -RRB-	19581
@VP	modified from protocols by Kelly et al. -LRB- 2003 -RRB-	19586
@VP	rinsed three times , 10 min each , in 0.1 M PB , pH 7.4 ,	19688
@VP	preincubated in 10 %	19746
@VP	incubated overnight at room temperature in avidin	19857
@VP	rinses in PB and a 10 min rinse in 0.1 M sodium acetate , pH 6.0	20045
@VP	were reacted with Sigma Fast-DAB compounds -LRB- Sigma , St.	20123
@VP	reacted with Sigma Fast-DAB compounds -LRB- Sigma , St.	20128
@VP	washes	20216
@VP	then dehydrated in ETOH	20274
@VP	coverslipped with DPX -LRB- Fluka Chemie AG , Buchs , Switzerland -RRB-	20303
@VP	To ensure consistency between animals and groups	20395
@VP	ensure consistency between animals and groups	20398
@VP	processed using Photoshop Adobe software	20724
@VP	using Photoshop Adobe software	20734
@VP	was determined using NIH image analysis software	20776
@VP	determined using NIH image analysis software	20780
@VP	using NIH image analysis software	20791
@VP	containing the lesion site	20976
@VP	were stained with GFP antibody	21003
@VP	stained with GFP antibody	21008
@VP	containing the caudal and rostral extent of the graft	21048
@VP	were found	21102
@VP	found	21107
@VP	were used for cell counts	21266
@VP	used for cell counts	21271
@VP	were counted	21357
@VP	counted	21362
@VP	containing 3 -- 10 neurons	21436
@VP	was selected as beginning of the caudal pole of the RN	21460
@VP	selected as beginning of the caudal pole of the RN	21464
@VP	project to the spinal cord	21577
@VP	were included in this study -LRB- Mori et al. , 1997 ; Kwon et al. , 2002 -RRB-	21605
@VP	included in this study -LRB- Mori et al. , 1997 ; Kwon et al. , 2002 -RRB-	21610
@VP	were measured from Sections 4 , 7 , 10 , and 13 , 16 , 19 of set I	21724
@VP	measured from Sections 4 , 7 , 10 , and 13 , 16 , 19 of set I	21729
@VP	set I	21780
@VP	were measured on Sections 5 , 8 , 11 , and 14 , 17 , 20 of set II	21832
@VP	measured on Sections 5 , 8 , 11 , and 14 , 17 , 20 of set II	21837
@VP	were counted	22015
@VP	counted	22020
@VP	to avoid overestimation of neuronal numbers	22059
@VP	avoid overestimation of neuronal numbers	22062
@VP	were examined	22148
@VP	examined	22153
@VP	appearing on 1 section	22183
@VP	were counted -LRB- Liu et al. , 1999 -RRB-	22206
@VP	counted -LRB- Liu et al. , 1999 -RRB-	22211
@VP	was measured under 200x counting box using an NIH image macro program	22315
@VP	measured under 200x counting box using an NIH image macro program	22319
@VP	using an NIH image macro program	22352
@VP	was measured	22435
@VP	measured	22439
@VP	was measured for each RN	22479
@VP	measured for each RN	22483
@VP	obtained from the histological assessments and behavioral tests	22531
@VP	using either Student 's t test or oneway ANOVA	22659
@VP	were possible relationships between different outcome parameters	22773
@VP	were considered statistically significant if P < 0.01	22842
@VP	considered statistically significant if P < 0.01	22847
@VP	< 0.01	22889
@VP	were presented as mean ± standard deviation -LRB- SD -RRB-	22919
@VP	presented as mean ± standard deviation -LRB- SD -RRB-	22924
@VP	were prepared using Microsoft Excel software	22980
@VP	prepared using Microsoft Excel software	22985
@VP	using Microsoft Excel software	22994
@VP	Table 3 Neuronal counts and mean soma size in RN	23086
@VP	Table 3 Neuronal counts	23086
@VP	mean soma size in RN	23114
@VP	mean ± SD Fig. 1	23153
@VP	using the LERS-EGFP vector	23232
@VP	were fluorescent	23289
@VP	were replated , cultured for 3 -- 4 DIV and found to be heterogeneous	23505
@VP	replated , cultured for 3 -- 4 DIV and found to be heterogeneous	23510
@VP	replated	23510
@VP	cultured for 3 -- 4 DIV	23520
@VP	found to be heterogeneous	23545
@VP	to be heterogeneous	23551
@VP	be heterogeneous	23554
@VP	produce BDNF	23575
@VP	stained with 4V	23639
@VP	were immunopositive for the neuronal marker , h-tubulin III	23699
@VP	were immunoreactive for A2B5	23775
@VP	was identified on some GFP positive and negative cells	23834
@VP	identified on some GFP positive and negative cells	23838
@VP	was observed on some cellular surfaces	23917
@VP	observed on some cellular surfaces	23921
@VP	frequently appeared as an intensely stained region -LRB- arrow -RRB-	23960
@VP	stained	23996
@VP	were Trk A positive	24036
@VP	were immunopositive for BDNF -LRB- DIC -RRB- , confocal optics	24079
@VP	used in these studies	24204
@VP	expressed BDNF mRNA and protein , respectively	24226
@VP	did not arise from contaminating or genomic DNA	24537
@VP	arise from contaminating or genomic DNA	24545
@VP	demonstrated that BDNF protein was produced in each of the two NSFC lines	24617
@VP	was produced in each of the two NSFC lines	24648
@VP	produced in each of the two NSFC lines	24652
@VP	engrafted rat cervical spinal cord reveal NSFCs within the lesion cavity	24749
@VP	reveal NSFCs within the lesion cavity	24784
@VP	was left-caudal and right-rostral	24928
@VP	bridging the injury site	25090
@VP	can be seen within the adjacent host spinal cord -LRB- arrows -RRB-	25142
@VP	be seen within the adjacent host spinal cord -LRB- arrows -RRB-	25146
@VP	seen within the adjacent host spinal cord -LRB- arrows -RRB-	25149
@VP	outlined in A	25247
@VP	showing the host	25262
@VP	interface -LRB- dashed line -RRB- -LRB- B -RRB-	25285
@VP	dashed line	25296
@VP	was observed , with few astrocytes being detected in the graft -LRB- C -RRB-	25356
@VP	observed , with few astrocytes being detected in the graft -LRB- C -RRB-	25360
@VP	being detected in the graft -LRB- C -RRB-	25390
@VP	detected in the graft -LRB- C -RRB-	25396
@VP	distributed rostrally in the white matter for up to 2.0 mm	25580
@VP	extended into the surrounding tissue -LRB- box in D -RRB-	25685
@VP	were positive for Trk B receptors	25768
@VP	labeled	25831
@VP	were h-tubulin III positive	25845
@VP	cross sections from a single rat at 750-Am intervals	26055
@VP	to show the extent of the lesion and the distribution of engrafted NSFCs	26136
@VP	show the extent of the lesion and the distribution of engrafted NSFCs	26139
@VP	were in the corticospinal tract -LRB- cst -RRB- -LRB- I -RRB-	26432
@VP	penetrated into the transplant site -LRB- arrows in K -RRB-	26703
@VP	contained many engrafted NSFCs	26795
@VP	engrafted NSFCs	26810
@VP	dashed line	26839
@VP	containing the rubrospinal tract	26882
@VP	partially lesioned the vlf and the gray matter -LRB- GM -RRB-	26949
@VP	were also found at the rostral interface of lesion cavity	27012
@VP	found at the rostral interface of lesion cavity	27022
@VP	were observed rostrally in the white matter up to 2.0 mm from the lesion cavity	27087
@VP	observed rostrally in the white matter up to 2.0 mm from the lesion cavity	27092
@VP	applies to A -- G.	27344
@VP	applies to I , K -- M.	27379
@VP	were in the rostral than the caudal white matter	27819
@VP	were filled with many cells -LRB- arrows -RRB- but no axons	28011
@VP	filled with many cells -LRB- arrows -RRB- but no axons	28016
@VP	engrafted animals	28107
@VP	extended processes -LRB- arrows -RRB-	28150
@VP	were observed throughout the site	28178
@VP	observed throughout the site	28183
@VP	was observed within the rostral end of the lesion site -LRB- arrowheads -RRB-	28254
@VP	observed within the rostral end of the lesion site -LRB- arrowheads -RRB-	28258
@VP	engrafted cells -LRB- arrows -RRB-	28370
@VP	were approximately 380 µm from the caudal pole of the RN	28799
@VP	was found following NSFCs engraftment	29075
@VP	found following NSFCs engraftment	29079
@VP	Compared to 2 weeks	29118
@VP	were further exacerbated at 12 weeks in the lesion only group	29189
@VP	exacerbated at 12 weeks in the lesion only group	29202
@VP	plus engrafted NSFCs group	29280
@VP	had a survival of approximately 80 % of the left RN neurons	29307
@VP	exhibited less atrophy at 12 weeks	29370
@VP	comparing the relative number -LRB- A -RRB-	29425
@VP	engrafted animals 2 and 12 weeks after surgery	29549
@VP	were labeled in the	29630
@VP	labeled in the	29635
@VP	was	29834
@VP	were approximately 400 µm from the caudal pole of the RN	30181
@VP	-LRB- A and B -RRB- Two weeks after surgery	30239
@VP	mean soma area	30298
@VP	engrafted group -LRB- B -RRB- than in the lesion only group -LRB- A -RRB-	30369
@VP	-LRB- C and D -RRB- Twelve weeks after surgery	30424
@VP	slightly decreased in the lesion and engrafted group -LRB- D -RRB-	30578
@VP	slightly decreased in the lesion	30578
@VP	engrafted group -LRB- D -RRB-	30615
@VP	illustrating the distribution of BDAlabeled RST axons rostral to the lesion site	30742
@VP	engrafted animals -LRB- C and D -RRB- 14 weeks after injury and engraftment	30930
@VP	found in the engrafted animals	31070
@VP	engrafted animals	31083
@VP	tracing RST axons in the lesion region 14 weeks after transplantation	31197
@VP	left	31286
@VP	is rostral -LRB- proximal to the lesion cavity -RRB-	31291
@VP	is caudal	31345
@VP	dashed	31356
@VP	indicate graft -- host interfaces	31369
@VP	were present in rostrocaudal parallel alignment in the dorsolateral funiculus	31449
@VP	were found proximal to the lesion boundary	31560
@VP	found proximal to the lesion boundary	31565
@VP	failed to enter the lesion cavity in a lesion only animal	31607
@VP	to enter the lesion cavity in a lesion only animal	31614
@VP	enter the lesion cavity in a lesion only animal	31617
@VP	ending at the proximal boundary of lesion	31744
@VP	RST axons sprouting in NSFC-engrafted animals	31793
@VP	sprouting in NSFC-engrafted animals	31803
@VP	passed through the rostral graft -- host interface	31930
@VP	extended into the graft	31983
@VP	were observed at the epicenter of the graft	32055
@VP	observed at the epicenter of the graft	32060
@VP	exited the caudal board of the graft	32160
@VP	penetrated the caudal graft -- host interface	32201
@VP	were observed at the graft	32291
@VP	observed at the graft	32296
@VP	ending in terminal bouton-likes structures	32414
@VP	dashed line	32569
@VP	regenerated two to three segments caudal to the graft 14 weeks after engraftment	32744
@VP	demonstrating BDA-labeled regenerating RST axons in the dlf and gray matter	33035
@VP	projected toward lamina VII of the gray matter	33169
@VP	Close up of BDAlabeled axons in the gray matter of lamina IX	33221
@VP	point to boutonlike structures around motoneuron soma	33290
@VP	showing FG retrograde tracing of RN neurons	33384
@VP	tracing of RN neurons	33406
@VP	were approximately 400 µm from the caudal pole of the RN	33442
@VP	were sparse	33575
@VP	were slightly atrophic in the left -LRB- axotomized -RRB-	33591
@VP	axotomized	33627
@VP	were observed at in the left RN of lesion only group -LRB- B -RRB-	33709
@VP	observed at in the left RN of lesion only group -LRB- B -RRB-	33714
@VP	used the left -LRB- uninjured -RRB- forelimb to explore the wall of cylinder	33915
@VP	to explore the wall of cylinder	33950
@VP	explore the wall of cylinder	33953
@VP	injured	33994
@VP	was strongly flexed -LRB- arrows -RRB-	34011
@VP	flexed -LRB- arrows -RRB-	34024
@VP	engrafted animals	34064
@VP	extended	34203
@VP	engrafted animals	34326
@VP	showed negligible use of the injured limb alone	34496
@VP	was better in engrafted animals than in lesion only animals	34609
@VP	engrafted animals than in lesion only animals	34623
@VP	demonstrate the inability of lesion only animals to	34696
@VP	perform the rope-walking test	34748
@VP	has poor posture and body position	34796
@VP	falls	34842
@VP	were common among the lesioned animals -LRB- B -RRB-	34848
@VP	plus engrafted	34913
@VP	assumed near-normal posture with limbs under their bodies and uplifted tails	34936
@VP	were able to complete the ropewalk	35028
@VP	to complete the ropewalk	35038
@VP	complete the ropewalk	35041
@VP	plus engrafted group -LRB- * P < 0.001 -RRB-	35165
@VP	receiving the NSFC transplants -LRB- n = 12 -RRB-	35292
@VP	correlated with RN neuronal survival	35392
@VP	plotted against accompanying number of FG-labeled neurons	35483
@VP	using Pearson 's correlation test	35614
@VP	were fluorescent -LRB- Fig. 1 -RRB-	35838
@VP	undergoing only a slight decrease over the initial 10 passages	35924
@VP	remaining at over 40 % after 35 additional passages	35992
@VP	was immunoreactive for a variety of lineage specific markers	36074
@VP	was observed for GFAP -LRB- glial fibrillary acidic protein -RRB-	36373
@VP	observed for GFAP -LRB- glial fibrillary acidic protein -RRB-	36377
@VP	reacts promiscuously with Trk A , B , or C -LRB- Fig. 2C -RRB-	36511
@VP	used in the present experiments	36965
@VP	used	37237
@VP	yielded specific amplified products only	37242
@VP	was included	37302
@VP	included	37306
@VP	demonstrated 40 pg BDNF/mg protein in both lines -LRB- Fig. 3B -RRB-	37358
@VP	were used in our initial studies	37447
@VP	used in our initial studies	37452
@VP	were observed between the two different neurosphere-forming lines	37496
@VP	observed between the two different neurosphere-forming lines	37501
@VP	were similar	37681
@VP	are presented for clarity	37719
@VP	presented for clarity	37723
@VP	was limited to the right side of the cervical spinal cord	37992
@VP	limited to the right side of the cervical spinal cord	37996
@VP	completely severed the ipsilateral dorsolateral and lateral funiculi	38054
@VP	partially lesioned the ipsilateral dorsal and ventral funiculi plus gray matter	38124
@VP	left the dorsal columns intact -LRB- Figs. 5D and E -RRB-	38209
@VP	seen within the lesion cavity	38322
@VP	migrated into the adjacent host spinal cord -LRB- Fig. 4B -RRB-	38467
@VP	was visible along the graft -- host interface -LRB- Fig. 4C -RRB-	38560
@VP	remained in the lesion cavity -LRB- Figs. 5C -- E and K -RRB-	38662
@VP	supported by host blood vessels that were present throughout the transplant site	38729
@VP	were present throughout the transplant site	38766
@VP	dispersed in a longitudinal direction -LRB- Figs. 4D and E -RRB-	38873
@VP	engrafted cells	39248
@VP	engrafted cells in the rostral white matter	39404
@VP	evaluated	39509
@VP	were found in the rostral white matter up to 2 mm from the lesion	39539
@VP	found in the rostral white matter up to 2 mm from the lesion	39544
@VP	were seen up to a maximum of 1.5 mm -LRB- Fig. 6 -RRB-	39627
@VP	seen up to a maximum of 1.5 mm -LRB- Fig. 6 -RRB-	39632
@VP	were positive for the Trk B receptor -LRB- Fig. 4F -RRB- or h-tubulin III	39707
@VP	extended into the surrounding tissue -LRB- Fig. 4G -RRB-	39851
@VP	engrafted NSFC animals and the lesion only animals	40069
@VP	was filled with many cells but no axons -LRB- Figs. 7A and B -RRB-	40160
@VP	filled with many cells but no axons -LRB- Figs. 7A and B -RRB-	40164
@VP	engrafted animals	40257
@VP	had extended processes throughout the site -LRB- Figs. 7C -- H -RRB-	40282
@VP	extended processes throughout the site -LRB- Figs. 7C -- H -RRB-	40286
@VP	was observed within the proximal end of the lesion site -LRB- Fig. 7C -RRB-	40380
@VP	observed within the proximal end of the lesion site -LRB- Fig. 7C -RRB-	40384
@VP	remained within the lesion cavity -LRB- Figs. 7E and F -RRB-	40508
@VP	assumed neuronal phenotypes -LRB- Figs. 7C -- H -RRB-	40670
@VP	formed long processes that extended into the surrounding tissue	40716
@VP	extended into the surrounding tissue	40743
@VP	engrafted NSFCs , numerous GAP-43 or MAP2	40800
@VP	were observed within the cavity of lesion only animals	41011
@VP	observed within the cavity of lesion only animals	41016
@VP	were used to determine the number and mean soma size of RN neurons	41169
@VP	used to determine the number and mean soma size of RN neurons	41174
@VP	to determine the number and mean soma size of RN neurons	41179
@VP	determine the number and mean soma size of RN neurons	41182
@VP	determine the number	41182
@VP	mean soma size of RN neurons	41207
@VP	size and numbers in the right and left RN were similar -LRB- Table 3 -RRB-	41242
@VP	size and numbers in the right	41242
@VP	left RN were similar -LRB- Table 3 -RRB-	41276
@VP	were similar -LRB- Table 3 -RRB-	41284
@VP	observed in number	41341
@VP	mean soma size of neurons	41598
@VP	cellengrafted group at 2	41685
@VP	plus engrafted group	42076
@VP	was further exacerbated in the lesion only group	42201
@VP	exacerbated in the lesion only group	42213
@VP	projecting to the spinal cord after axotomy in the lesion only	42628
@VP	were compared in sections with the FG labeling	42730
@VP	compared in sections with the FG labeling	42735
@VP	determined from adjacent sections stained for toluidine blue	42882
@VP	stained for toluidine blue	42916
@VP	obtained from the toluidine-blue-stained sections	43115
@VP	axotomized RN neurons	43431
@VP	decreased in the lesion only group	43471
@VP	was evaluated	43925
@VP	evaluated	43929
@VP	engrafted	44073
@VP	ipsilaterally descending RST axons	44223
@VP	could also be observed in the same location	44258
@VP	be observed in the same location	44269
@VP	observed in the same location	44272
@VP	to take up	44483
@VP	take up	44486
@VP	engrafted animals	44710
@VP	elongated caudally , and in most cases	44777
@VP	elongated caudally	44777
@VP	in most cases	44801
@VP	extended past the caudal host -- graft interface -LRB- Figs. 12F -- I -RRB-	44815
@VP	orientated in a rostral	45081
@VP	caudal to the lesion site were examined for BDA-labeled axons	45433
@VP	were examined for BDA-labeled axons	45459
@VP	examined for BDA-labeled axons	45464
@VP	engrafted animals	45671
@VP	were found caudal to the lesion site	45708
@VP	found caudal to the lesion site	45713
@VP	was sparser	45910
@VP	were not as well organized as those in the C1	46018
@VP	as well organized as those in the C1	46027
@VP	were present in the dorsolateral funiculus	46110
@VP	were diffusely located in the adjoining dorsal horn -LRB- Figs. 13C and D -RRB-	46163
@VP	regenerated RST axons into segments of spinal cord caudal to the lesion site	46524
@VP	possibly reinnervated their target gray matter	46605
@VP	found in the spinal cord caudal to the lesion site	46710
@VP	grafted animals	46768
@VP	injected at T1 -- 2 for retrograde tracing of FG in the ipsiltaeral spinal cord	46789
@VP	tracing of FG in the ipsiltaeral spinal cord	46821
@VP	was selected to prevent FG from penetrating the lesion site	46887
@VP	selected to prevent FG from penetrating the lesion site	46891
@VP	to prevent FG from penetrating the lesion site	46900
@VP	prevent FG from penetrating the lesion site	46903
@VP	penetrating the lesion site	46919
@VP	engrafted rats	47212
@VP	was small	47227
@VP	axtomoized RST neurons	47329
@VP	had regenerated at least 4 -- 5 segments caudal to the lesion site	47352
@VP	regenerated at least 4 -- 5 segments caudal to the lesion site	47356
@VP	are currently under evaluation	47509
@VP	used for experimental group IIB	47631
@VP	preconditioned for the spontaneous vertical exploration and rope-walking tests	47668
@VP	to objectively evaluate functional recovery after transplantation	47757
@VP	objectively evaluate functional recovery after transplantation	47760
@VP	were established	47845
@VP	established	47850
@VP	explore the wall of the cylinder	47985
@VP	complete the rope-walking tasks with a 0 deficit score	48022
@VP	were selected for surgery	48077
@VP	selected for surgery	48082
@VP	exploring a glass cylinder -LRB- Figs. 15A and B -RRB-	48270
@VP	received NSFC transplants freely	48361
@VP	used both paws to explore the cylinder	48394
@VP	to explore the cylinder	48409
@VP	explore the cylinder	48412
@VP	assumed nearly normal posture -LRB- Figs. 15C and D -RRB-	48437
@VP	to explore the cylinder wall -LRB- approximately 80 % -RRB-	48543
@VP	explore the cylinder wall -LRB- approximately 80 % -RRB-	48546
@VP	was not observed in the lesion only animals -LRB- Fig. 15E -RRB-	49022
@VP	observed in the lesion only animals -LRB- Fig. 15E -RRB-	49030
@VP	operated animals	49240
@VP	were observed	49289
@VP	observed	49294
@VP	engrafted animals	49456
@VP	had consistent locomotor activity , better body posture	49474
@VP	were able to complete the task	49534
@VP	to complete the task	49544
@VP	complete the task	49547
@VP	slipped	49571
@VP	was consistent with the behavioral data obtained by the deficit-scoring method	49696
@VP	obtained by the deficit-scoring method	49736
@VP	found between the two experimental groups -LRB- P < 0.001 ; Fig. 16E -RRB-	49810
@VP	contributed to the observed functional recovery	49941
@VP	was analyzed using Pearson 's correlation test	50084
@VP	analyzed using Pearson 's correlation test	50088
@VP	using Pearson 's correlation test	50097
@VP	performed well during horizontal rope walking	50273
@VP	slipped or fell from the rope more frequently	50411
@VP	slipped	50411
@VP	fell from the rope more frequently	50422
@VP	had a fewer neurons in axotomized RN	50470
@VP	engrafted into the injured adult rat cervical spinal cord remain viable	50615
@VP	remain viable	50673
@VP	integrated into the injured host spinal cord	50693
@VP	axotomized RN neurons from retrograde atrophy	50750
@VP	surrounding the lesion site	50944
@VP	engrafted human ONe-derived NSFCs in injured rat spinal cord The engrafted NSFCs	50988
@VP	engrafted NSFCs	51053
@VP	survived in the injured rat spinal cord for at least 12 weeks	51069
@VP	filled the lesion cavity ; some integrated into the adjacent host spinal cord	51146
@VP	integrated into the adjacent host spinal cord	51177
@VP	was not interrupted by cysts or scars	51296
@VP	interrupted by cysts or scars	51304
@VP	contributed to their survival	51411
@VP	demonstrated by ELISA and RT-PCR studies	51577
@VP	used in this study	51768
@VP	produced and secreted BDNF	51787
@VP	produced	51787
@VP	secreted BDNF	51800
@VP	were performed to examine the concentration of BDNF in NSFC-conditioned media	51835
@VP	performed to examine the concentration of BDNF in NSFC-conditioned media	51840
@VP	to examine the concentration of BDNF in NSFC-conditioned media	51850
@VP	examine the concentration of BDNF in NSFC-conditioned media	51853
@VP	were low	51935
@VP	did not exhibit increased levels of BDNF in the conditioned medium	51986
@VP	exhibit increased levels of BDNF in the conditioned medium	51994
@VP	coupled with the presence of BDNF in their cell lysates	52100
@VP	decreased only slightly through many passages	52523
@VP	engrafted NSFCs	52774
@VP	support their survival	52812
@VP	integrated into the injured adult rat spinal cord	52876
@VP	to release BDNF	52962
@VP	release BDNF	52965
@VP	to decrease RST neuronal atrophy after axotomy -LRB- Liu et al. , 1999 -RRB-	53019
@VP	decrease RST neuronal atrophy after axotomy -LRB- Liu et al. , 1999 -RRB-	53022
@VP	engrafted NSFCs	53134
@VP	survived	53159
@VP	axotomized RST neurons from retrograde atrophy and possible cell loss	53238
@VP	engrafted NSFCs and the host spinal cord	53383
@VP	was visible within the graft at the lesion cavity	53457
@VP	may have played a role in the lack of scar formation	53594
@VP	have played a role in the lack of scar formation	53598
@VP	played a role in the lack of scar formation	53603
@VP	was attributed to immunosuppression by cyclosporine	53678
@VP	attributed to immunosuppression by cyclosporine	53682
@VP	may also have contributed to the NSFCs survival	53798
@VP	have contributed to the NSFCs survival	53807
@VP	contributed to the NSFCs survival	53812
@VP	remained aggregated	53920
@VP	engrafted NSFCs	54080
@VP	were found at some distance in the rostral , predominantly , and caudal cord	54096
@VP	found at some distance in the rostral , predominantly , and caudal cord	54101
@VP	ascending sensory fibers	54267
@VP	were located in the gray matter adjacent to the lesion site	54298
@VP	located in the gray matter adjacent to the lesion site	54303
@VP	releasing trophic factors such as BDNF	54602
@VP	engrafted animals compared to the lesion	54908
@VP	were consistent with these possibilities	54962
@VP	provided by the injured cord	55050
@VP	engrafted NSFCs as reported for other models -LRB- McDonald et al. , 1999 -RRB-	55143
@VP	reported for other models -LRB- McDonald et al. , 1999 -RRB-	55162
@VP	axotomized RN neurons Injury to the RST at C3	55259
@VP	have been shown to prevent some axotomized RN cell atrophy	55901
@VP	been shown to prevent some axotomized RN cell atrophy	55906
@VP	shown to prevent some axotomized RN cell atrophy	55911
@VP	to prevent some axotomized RN cell atrophy	55917
@VP	prevent some axotomized RN cell atrophy	55920
@VP	axotomized RN cell atrophy	55933
@VP	engrafted NSFCs	55985
@VP	prevented some perikaryal atrophy of axotomized RN as well as apparent cell loss	56001
@VP	axotomized RN as well as apparent cell loss	56038
@VP	have contributed to rescue of RN neurons from axotomy-induced retrograde atrophy	56110
@VP	contributed to rescue of RN neurons from axotomy-induced retrograde atrophy	56115
@VP	engrafted NSFCs	56208
@VP	fostered axonal regeneration and possible synapse formation with target neurons	56466
@VP	engrafted animals	56696
@VP	demonstrated that , after NSFC engraftment , functional recovery occurred	56817
@VP	occurred	56880
@VP	exploring the wall of a cylinder	57120
@VP	can be attributed at least partially to repair of the RN and RST pathway	57446
@VP	be attributed at least partially to repair of the RN and RST pathway	57450
@VP	attributed at least partially to repair of the RN and RST pathway	57453
@VP	passed through the graft , and in some instances found their target motoneurons	57706
@VP	passed through the graft	57706
@VP	in some instances found their target motoneurons	57736
@VP	is likely that these contacts contributed to the forelimb functional recovery	57789
@VP	contributed to the forelimb functional recovery	57819
@VP	be an indicator of other systems ' axonal response to the presence of the NSFCs	58646
@VP	engrafted animals -LRB- experimental group IIIB , data not shown -RRB-	58858
@VP	not shown	58907
@VP	tracing	58965
@VP	descending motor and ascending sensory axons after spinal cord injury	59049
@VP	descending motor	59049
@VP	ascending sensory axons after spinal cord injury	59070
@VP	may have led to the enhanced functional recovery	59204
@VP	have led to the enhanced functional recovery	59208
@VP	led to the enhanced functional recovery	59213
@VP	maintain axotomized RN neurons	59580
@VP	promote RST axonal regeneration	59612
@VP	lead to enhanced function	59649
@VP	is required to obtain these cells	59915
@VP	required to obtain these cells	59918
@VP	to obtain these cells	59927
@VP	obtain these cells	59930
@VP	negates their practical use	59949
@VP	harvested from ONe	59997
@VP	can be obtained with minimal invasive surgery	60064
@VP	be obtained with minimal invasive surgery	60068
@VP	obtained with minimal invasive surgery	60071
@VP	aimed at repairing spinal cord injuries and other neurodegenerative disorders	60212
@VP	repairing spinal cord injuries and other neurodegenerative disorders	60221
